ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Penis disorder,Penile disorders NEC (excl erection and ejaculation),Penile and scrotal disorders (excl infections and inflammations),Repro,N
2,1,Hodgkin's disease,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
3,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
3,2,Aplasia pure red cell,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
3,3,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
3,4,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3,5,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
3,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3,7,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
4,1,Gingival hypertrophy,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
5,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
5,2,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6,1,Gingival hypertrophy,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
7,1,Cardiomegaly,Myocardial disorders NEC,Myocardial disorders,Card,N
8,1,Lip and/or oral cavity cancer,Lip and oral cavity neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
9,1,Dental caries,Dental and periodontal infections and inflammations,Dental and gingival conditions,Gastr,N
9,2,Gingival hypoplasia,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
10,1,Gingival hypertrophy,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
11,1,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,N
12,1,Gingival hypertrophy,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
13,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
13,2,Cerebellar syndrome,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
13,3,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
13,4,Electroencephalogram abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
14,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
15,1,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,Y
16,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
16,2,Cachexia,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
16,3,Oesophageal carcinoma,Oesophageal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,Y
17,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
18,1,Akinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
18,2,Locked-in syndrome,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
19,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
19,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
20,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
21,1,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
22,1,Nasal obstruction,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
22,2,Vasomotor rhinitis,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
23,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
24,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
25,1,Pneumococcal sepsis,Streptococcal infections,Bacterial infectious disorders,Infec,Y
26,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
26,2,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
27,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
28,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
28,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
28,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
29,1,Renal cancer,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
30,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
31,1,Paraparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
32,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
33,1,Eye infection,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
33,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
33,3,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
34,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
35,1,Conjunctival oedema,"Conjunctival infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
35,2,Retinal oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
36,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
36,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
36,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
36,4,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
36,5,Vasculitic rash,Skin vasculitides,Skin vascular abnormalities,Skin,N
36,6,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
37,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
38,1,Conjunctival oedema,"Conjunctival infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
38,2,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
39,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
40,1,Gingival swelling,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
41,1,Bursitis,Bursal disorders,Synovial and bursal disorders,Musc,N
41,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
42,1,Breast enlargement,Breast disorders NEC,Breast disorders,Repro,N
43,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
43,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
43,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
43,4,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
44,1,Conjunctival oedema,"Conjunctival infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
45,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
45,2,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
45,3,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
46,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
46,2,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
47,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
47,2,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
48,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
48,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
48,3,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
49,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
49,2,Vitamin B12 deficiency,Water soluble vitamin deficiencies,Vitamin related disorders,Metab,N
50,1,Erythema annulare,Papulosquamous conditions,Epidermal and dermal conditions,Skin,N
51,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
51,2,Inappropriate antidiuretic hormone secretion,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
51,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
52,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,Y
53,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
54,1,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
55,1,Headache,Headaches NEC,Headaches,Nerv,N
55,2,Idiopathic intracranial hypertension,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
55,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
55,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
56,1,Atrioventricular block,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
57,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
57,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
58,1,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
59,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
59,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
59,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
59,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
60,1,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
61,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
62,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
63,1,Adenocarcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
64,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
64,2,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
65,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
66,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
67,1,Headache,Headaches NEC,Headaches,Nerv,N
67,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
68,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
69,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
69,2,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
70,1,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
71,1,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
72,1,Intestinal infarction,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,N
73,1,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
74,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
74,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
74,3,Drug level fluctuating,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
74,4,Headache,Headaches NEC,Headaches,Nerv,N
74,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
74,6,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
75,1,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
76,1,Necrotising colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
76,2,Small for dates baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
77,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
77,2,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
77,3,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
77,4,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
78,1,Thrombotic thrombocytopenic purpura,Thrombocytopenias,Platelet disorders,Blood,N
79,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
80,1,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
80,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
80,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
81,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
82,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
83,1,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
84,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
84,2,Capillary leak syndrome,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
85,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
86,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
86,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
86,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
86,4,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
86,5,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
86,6,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
87,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
87,2,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
87,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
88,1,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
89,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
89,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
90,1,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
91,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
92,1,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
92,2,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
93,1,Cleft palate,Palate disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
94,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
95,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
96,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
97,1,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,Y
98,1,Hair disorder,Pilar disorders NEC,Skin appendage conditions,Skin,N
99,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
99,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
100,1,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
101,1,Migraine,Migraine headaches,Headaches,Nerv,N
101,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
102,1,Tooth discolouration,Dental surface disorders,Dental and gingival conditions,Gastr,N
103,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
103,2,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
103,3,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
104,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
105,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
106,1,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
107,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
107,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
107,3,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
108,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
108,2,Laryngeal papilloma,Pharyngeal and laryngeal neoplasms benign,Respiratory and mediastinal neoplasms benign (excl mesotheliomas),Neopl,N
108,3,Papilloma,Neoplasms benign site unspecified NEC,Miscellaneous and site unspecified neoplasms benign,Neopl,N
108,4,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
108,5,Stridor,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
109,1,Cutaneous T-cell lymphoma,Mycoses fungoides,Lymphomas non-Hodgkin's T-cell,Neopl,N
110,1,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
111,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
111,2,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
111,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
112,1,Scar,Skin injuries NEC,Injuries NEC,Inj&P,N
113,1,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
113,2,Headache,Headaches NEC,Headaches,Nerv,N
114,1,Cutaneous sarcoidosis,Granulomatous and deep cutaneous inflammatory conditions,Epidermal and dermal conditions,Skin,N
114,2,Granuloma,Inflammations,General system disorders NEC,Genrl,N
115,1,T-cell lymphoma,Anaplastic large cell lymphomas T- and null-cell types,Lymphomas non-Hodgkin's T-cell,Neopl,N
116,1,Loss of libido,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
117,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
117,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
117,3,T-cell lymphoma,Anaplastic large cell lymphomas T- and null-cell types,Lymphomas non-Hodgkin's T-cell,Neopl,N
118,1,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
118,2,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
119,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
119,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
120,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
120,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
121,1,Intracranial pressure increased,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
122,1,Hyperaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
123,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
123,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
123,3,Oliguria,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
123,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
123,5,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
123,6,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
124,1,Lung abscess,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
124,2,Nocardiosis,Nocardia infections,Bacterial infectious disorders,Infec,N
125,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
126,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
126,2,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
127,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
127,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
128,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
129,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
129,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
129,3,Cerebral artery embolism,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
129,4,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
129,5,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
129,6,Endocarditis,Cardiac infections,Infections - pathogen unspecified,Infec,N
129,7,Leukocytosis,Leukocytoses NEC,White blood cell disorders,Blood,N
129,8,Meningitis staphylococcal,Staphylococcal infections,Bacterial infectious disorders,Infec,N
129,9,Peripheral ischaemia,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
129,10,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
130,1,Myopathy,Myopathies,Muscle disorders,Musc,N
131,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
132,1,Gingival hypertrophy,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
133,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
133,2,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
133,3,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
133,4,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
133,5,Status epilepticus,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
134,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
134,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
134,3,Muscle disorder,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
134,4,Nocardiosis,Nocardia infections,Bacterial infectious disorders,Infec,N
134,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
135,1,Blindness transient,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
136,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
137,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
137,2,Food interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
137,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
138,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
139,1,Fibroma,Neoplasms benign site unspecified NEC,Miscellaneous and site unspecified neoplasms benign,Neopl,N
140,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
141,1,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
142,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
142,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
143,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
143,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
143,3,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
144,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
144,2,Guillain-Barre syndrome,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
145,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
146,1,Alopecia areata,Alopecias,Skin appendage conditions,Skin,N
147,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
147,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
148,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
148,2,Headache,Headaches NEC,Headaches,Nerv,N
148,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
149,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
149,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
150,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
150,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
151,1,Breast enlargement,Breast disorders NEC,Breast disorders,Repro,N
151,2,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
151,3,Hirsutism,Hypertrichoses,Skin appendage conditions,Skin,N
152,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
152,2,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
153,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
154,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
155,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
155,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
156,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
156,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
156,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
157,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
158,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
159,1,Excessive granulation tissue,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
160,1,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
161,1,Hypertrophic scar,Skin dystrophies,Cornification and dystrophic skin disorders,Skin,N
161,2,Skin papilloma,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
162,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
162,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
163,1,Sticky skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
164,1,Rectal adenocarcinoma,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
165,1,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
166,1,Osteoarthritis,Osteoarthropathies,Joint disorders,Musc,N
167,1,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
167,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
168,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
168,2,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
168,3,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
169,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
170,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
171,1,Mouth cyst,Benign oral cavity neoplasms,Benign neoplasms gastrointestinal,Gastr,N
172,1,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
172,2,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
173,1,Lip and/or oral cavity cancer,Lip and oral cavity neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
173,2,Metastases to lymph nodes,Metastases to specified sites,Metastases,Neopl,N
173,3,Tongue neoplasm malignant stage unspecified,Lip and oral cavity neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
174,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
175,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
176,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
176,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
177,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
177,2,Rash follicular,Pustular conditions,Epidermal and dermal conditions,Skin,N
178,1,Ovarian cancer,Ovarian neoplasms malignant (excl germ cell),Reproductive neoplasms female malignant and unspecified,Neopl,N
179,1,Rash follicular,Pustular conditions,Epidermal and dermal conditions,Skin,N
180,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
181,1,Gouty arthritis,Crystal arthropathic disorders,Joint disorders,Musc,N
182,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
183,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
184,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
185,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
186,1,Alopecia areata,Alopecias,Skin appendage conditions,Skin,N
186,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
186,3,Penile wart,Reproductive neoplasms male benign NEC,Reproductive neoplasms male benign,Neopl,N
187,1,Alopecia areata,Alopecias,Skin appendage conditions,Skin,N
188,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
189,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
190,1,Colon cancer,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,Y
191,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
192,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
192,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
193,1,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
194,1,Migraine,Migraine headaches,Headaches,Nerv,N
195,1,Hemiplegic migraine,Migraine headaches,Headaches,Nerv,N
196,1,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
197,1,Headache,Headaches NEC,Headaches,Nerv,N
197,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
198,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
198,2,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
199,1,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
200,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
200,2,Hypertonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
200,3,Leukoencephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
201,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
202,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
202,2,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
203,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
204,1,Coombs positive haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
205,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
206,1,Neuroendocrine carcinoma of the skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,Y
207,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
207,2,Headache,Headaches NEC,Headaches,Nerv,N
207,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
208,1,Headache,Headaches NEC,Headaches,Nerv,N
208,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
208,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
209,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
209,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
210,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
211,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
211,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
211,3,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
211,4,Normochromic normocytic anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
211,5,Red blood cell sedimentation rate increased,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
211,6,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
212,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
212,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
212,3,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
213,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
214,1,Myopathy,Myopathies,Muscle disorders,Musc,N
215,1,Blindness transient,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
215,2,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
216,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
216,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
216,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
216,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
216,5,Myalgia,Muscle pains,Muscle disorders,Musc,N
216,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
216,7,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
216,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
217,1,Behcet's syndrome,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
218,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
218,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
219,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
220,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
221,1,Glioblastoma,Glial tumours malignant,Nervous system neoplasms malignant and unspecified NEC,Neopl,Y
222,1,Paralysis recurrent laryngeal nerve,Vagus nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
223,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
223,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
223,3,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
224,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
224,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
225,1,Hypertensive encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
225,2,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
225,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
226,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
226,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
227,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
227,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
228,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
229,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
230,1,Gastrointestinal lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,Y
231,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
231,2,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
231,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
232,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
232,2,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
232,3,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
232,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
233,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
233,2,Myopathy,Myopathies,Muscle disorders,Musc,N
234,1,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
235,1,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
236,1,Sunburn,Radiation injuries,Injuries by physical agents,Inj&P,N
237,1,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
238,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
238,2,Paraparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
239,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
240,1,Myelopathy,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
240,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
240,3,Paraparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
241,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
242,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
242,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
243,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
244,1,Alopecia areata,Alopecias,Skin appendage conditions,Skin,N
245,1,Cholestasis,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
245,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
246,1,Peroneal nerve palsy,Mononeuropathies,Peripheral neuropathies,Nerv,N
247,1,Hodgkin's disease,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
248,1,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
249,1,Paraneoplastic syndrome,Paraneoplastic syndromes NEC,Neoplasm related morbidities,Neopl,N
250,1,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
250,2,Pregnancy on oral contraceptive,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
251,1,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
252,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
252,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
253,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
253,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
253,3,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
253,4,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
253,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
253,6,Duodenal ulcer perforation,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
253,7,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
253,8,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
253,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
254,1,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
255,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
256,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
256,2,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
256,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
257,1,Cutaneous T-cell lymphoma,Mycoses fungoides,Lymphomas non-Hodgkin's T-cell,Neopl,N
258,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
258,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
258,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
259,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
259,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
260,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
261,1,Anaemia macrocytic,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
261,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
261,3,Mean cell volume increased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
261,4,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
261,5,Red blood cell count decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
262,1,Fibroadenoma of breast,Breast and nipple neoplasms benign,Breast neoplasms benign (incl nipple),Neopl,N
263,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
263,2,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
264,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
265,1,Breast enlargement,Breast disorders NEC,Breast disorders,Repro,N
266,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
266,2,Kidney fibrosis,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
266,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
266,4,Suprapubic pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
266,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
266,6,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
267,1,Acute psychosis,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
267,2,B-cell type acute leukaemia,Leukaemias acute lymphocytic,Leukaemias,Neopl,N
267,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
268,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
269,1,Cutaneous T-cell lymphoma,Mycoses fungoides,Lymphomas non-Hodgkin's T-cell,Neopl,N
270,1,Cutaneous T-cell lymphoma,Mycoses fungoides,Lymphomas non-Hodgkin's T-cell,Neopl,N
270,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
271,1,Cardiopulmonary failure,Heart failures NEC,Heart failures,Card,Y
271,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
271,3,Obstructive airways disorder,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
272,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
272,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
272,3,Malnutrition,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
272,4,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
273,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
273,2,Lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
274,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
275,1,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
276,1,Astrocytoma,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,Y
277,1,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
278,1,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,Y
279,1,Psoas abscess,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
279,2,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
280,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
281,1,Hepatitis viral,Viral infections NEC,Viral infectious disorders,Infec,Y
282,1,Hepatitis viral,Viral infections NEC,Viral infectious disorders,Infec,Y
282,2,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
283,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
284,1,Coombs positive haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
285,1,Breast cancer male,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
286,1,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
287,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
287,2,Mycobacterial infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
287,3,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
287,4,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
288,1,Myopathy,Myopathies,Muscle disorders,Musc,N
289,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
289,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
289,3,Myopathy,Myopathies,Muscle disorders,Musc,N
289,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
290,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
291,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
291,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
292,1,Acne,Acnes,Skin appendage conditions,Skin,N
293,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
293,2,Rheumatoid nodule,Rheumatoid arthropathies,Joint disorders,Musc,N
294,1,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
294,2,Hirsutism,Hypertrichoses,Skin appendage conditions,Skin,N
294,3,Nail dystrophy,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
294,4,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
295,1,Hodgkin's disease,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,Y
296,1,Hodgkin's disease,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
297,1,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
297,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
297,3,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
298,1,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
299,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
299,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
300,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
301,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
302,1,Macrocytosis,Red blood cell abnormal findings NEC,Red blood cell disorders,Blood,N
303,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,Y
304,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
305,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
305,2,Alcohol interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
305,3,Amylase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
305,4,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
305,5,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
306,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
306,2,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
306,3,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
306,4,Peripancreatic fluid collection,Gastrointestinal and hepatobiliary procedural complications,Procedural related injuries and complications NEC,Inj&P,N
306,5,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
306,6,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
307,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
308,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
309,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
310,1,Deafness,Hearing losses,Hearing disorders,Ear,N
311,1,Deafness,Hearing losses,Hearing disorders,Ear,N
312,1,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
313,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
313,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
314,1,Hirsutism,Hypertrichoses,Skin appendage conditions,Skin,N
315,1,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
315,2,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
316,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
316,2,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
316,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
317,1,Breast cancer female,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
317,2,Fibroadenoma of breast,Breast and nipple neoplasms benign,Breast neoplasms benign (incl nipple),Neopl,N
317,3,Gingival hypertrophy,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
317,4,Hirsutism,Hypertrichoses,Skin appendage conditions,Skin,N
318,1,Breast cancer female,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
318,2,Breast enlargement,Breast disorders NEC,Breast disorders,Repro,N
318,3,Fibroadenoma of breast,Breast and nipple neoplasms benign,Breast neoplasms benign (incl nipple),Neopl,N
318,4,Gingival hypertrophy,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
318,5,Hirsutism,Hypertrichoses,Skin appendage conditions,Skin,N
319,1,Cerebellar syndrome,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
320,1,Lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
321,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
321,2,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
321,3,Leukoencephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,Y
321,4,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
321,5,Myalgia,Muscle pains,Muscle disorders,Musc,N
321,6,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
321,7,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
322,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
323,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
324,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
325,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
326,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
327,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
328,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
329,1,Hypertrichosis,Hypertrichoses,Skin appendage conditions,Skin,N
329,2,Neoplasm,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
329,3,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
330,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
331,1,Kidney transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
332,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
332,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
333,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
334,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
335,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
335,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
335,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
335,4,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,Y
336,1,Headache,Headaches NEC,Headaches,Nerv,N
337,1,"Hallucinations, mixed",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
338,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
338,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
338,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
339,1,Acute respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
339,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
339,3,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,Y
339,4,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
340,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
340,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,Y
341,1,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
341,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
341,3,Oliguria,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
341,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
342,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
343,1,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
344,1,Herpes virus infection,Herpes viral infections,Viral infectious disorders,Infec,N
344,2,Myelitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
344,3,Neurogenic bladder,Myoneurogenic bladder disorders,Bladder and bladder neck disorders (excl calculi),Renal,N
344,4,Paraparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
344,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
344,6,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
345,1,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
346,1,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
347,1,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
348,1,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
349,1,Ototoxicity,Ear disorders NEC,Aural disorders NEC,Ear,N
350,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
351,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
352,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
352,2,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
353,1,Hirsutism,Hypertrichoses,Skin appendage conditions,Skin,N
353,2,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
354,1,Hypertensive encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
354,2,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
354,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
355,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
355,2,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
356,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
356,2,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
357,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
357,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
357,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
358,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
358,2,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
359,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
359,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
360,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
360,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
360,3,Restless legs syndrome,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
361,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
362,1,Gingival hypertrophy,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
363,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
363,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
363,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
363,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
363,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
364,1,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
365,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
365,2,Polymenorrhoea,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
366,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
366,2,Oliguria,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
366,3,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,Y
366,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
367,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
367,2,Hypertensive encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
367,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
367,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
368,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
368,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
369,1,Acne,Acnes,Skin appendage conditions,Skin,N
370,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
371,1,Acne,Acnes,Skin appendage conditions,Skin,N
372,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
373,1,Generalised oedema,Oedema NEC,General system disorders NEC,Genrl,N
374,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
375,1,Coagulation time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
376,1,Limb reduction defect,Musculoskeletal and connective tissue disorders of limbs congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
377,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,Y
378,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
378,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
378,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
378,4,Lacrimation disorder,Lacrimation disorders,Eye disorders NEC,Eye,N
378,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
379,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
379,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
379,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
379,4,Lacrimation disorder,Lacrimation disorders,Eye disorders NEC,Eye,N
379,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
380,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
380,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
381,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
382,1,Headache,Headaches NEC,Headaches,Nerv,N
382,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
382,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
383,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
384,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
384,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
385,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
385,2,Headache,Headaches NEC,Headaches,Nerv,N
385,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
385,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
385,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
386,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
387,1,Headache,Headaches NEC,Headaches,Nerv,N
387,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
387,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
387,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
387,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
388,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
389,1,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
390,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
391,1,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
391,2,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
391,3,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
392,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
393,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
393,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
393,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
393,4,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
393,5,Headache,Headaches NEC,Headaches,Nerv,N
393,6,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
394,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
394,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
394,3,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
395,1,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
395,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
395,3,Stupor,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
396,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
396,2,Eye movement disorder,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
396,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
397,1,Coombs positive haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
398,1,Abdominal mass,Abdominal findings abnormal,Gastrointestinal signs and symptoms,Gastr,N
398,2,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
398,3,Actinomycosis,Actinomycotic infectious disorders,Bacterial infectious disorders,Infec,N
398,4,Arterial rupture,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
398,5,Arteriosclerosis,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
398,6,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
398,7,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
398,8,Cytomegalovirus test,Virus identification and serology,Microbiology and serology investigations,Inv,N
398,9,Groin pain,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
398,10,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
398,11,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
398,12,Red blood cell sedimentation rate increased,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
398,13,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
399,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
400,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
401,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
402,1,Anencephaly,Cerebral disorders congenital,Neurological disorders congenital,Cong,N
403,1,Anencephaly,Cerebral disorders congenital,Neurological disorders congenital,Cong,N
404,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
404,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
405,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
406,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
407,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
408,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
409,1,Anencephaly,Cerebral disorders congenital,Neurological disorders congenital,Cong,N
410,1,Disseminated intravascular coagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
410,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
411,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
412,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
412,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
413,1,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
414,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
414,2,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
415,1,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
416,1,Thrombotic thrombocytopenic purpura,Thrombocytopenias,Platelet disorders,Blood,Y
417,1,Thrombotic thrombocytopenic purpura,Thrombocytopenias,Platelet disorders,Blood,Y
418,1,Partial seizures,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
419,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
420,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
421,1,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,Y
421,2,Microangiopathy,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
421,3,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
422,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
422,2,Electromyogram abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
422,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
422,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
422,5,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
422,6,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
423,1,Disseminated intravascular coagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
423,2,Hypoglycaemia neonatal,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
423,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
424,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
424,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
424,3,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
424,4,Microangiopathy,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
424,5,Nephropathy,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
424,6,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
424,7,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
424,8,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
425,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
425,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
425,3,Microangiopathy,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
425,4,Nephropathy,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
426,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
427,1,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
428,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
428,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
428,3,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
428,4,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
428,5,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
428,6,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
428,7,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
428,8,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
428,9,Leukoencephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
428,10,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
429,1,Guillain-Barre syndrome,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
430,1,Pseudolymphoma,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
431,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
431,2,Thrombocytopenic purpura,Thrombocytopenias,Platelet disorders,Blood,Y
432,1,Neuroendocrine carcinoma of the skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,Y
433,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
434,1,Blood potassium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
435,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
436,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
436,2,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
437,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
437,2,Extrasystoles,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
438,1,Thrombotic thrombocytopenic purpura,Thrombocytopenias,Platelet disorders,Blood,Y
439,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
439,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
439,3,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
440,1,Adenoma benign,Neoplasms benign site unspecified NEC,Miscellaneous and site unspecified neoplasms benign,Neopl,N
440,2,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
441,1,Adenoma benign,Neoplasms benign site unspecified NEC,Miscellaneous and site unspecified neoplasms benign,Neopl,N
442,1,Skin cancer,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
443,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
443,2,Carcinoid tumour,Carcinoid tumours,Endocrine neoplasms malignant and unspecified,Neopl,N
443,3,Skin cancer,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
443,4,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
444,1,Adenocarcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
444,2,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
444,3,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
445,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
445,2,Rectal polyp,Benign neoplasms gastrointestinal (excl oral cavity),Benign neoplasms gastrointestinal,Gastr,N
445,3,Skin cancer,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
445,4,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
446,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
446,2,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
446,3,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
447,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
447,2,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
447,3,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
448,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
448,2,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
448,3,Sweat gland tumour,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
449,1,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,N
449,2,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
449,3,Sweat gland tumour,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
450,1,Sweat gland tumour,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
451,1,Sweat gland tumour,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
452,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
452,2,Hair follicle tumour benign,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
452,3,Neoplasm skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
453,1,Hair follicle tumour benign,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
454,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
455,1,Blindness cortical,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
455,2,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
455,3,Headache,Headaches NEC,Headaches,Nerv,N
455,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
456,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
457,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
458,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
459,1,B-cell lymphoma,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
460,1,Disseminated tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
461,1,Microangiopathy,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
461,2,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
462,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
463,1,Paraplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
464,1,Spinal fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
464,2,Status epilepticus,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
465,1,Ileal ulcer perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
466,1,Colectomy,Large intestine therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
466,2,Megacolon,Non-mechanical ileus,Gastrointestinal motility and defaecation conditions,Gastr,N
467,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
468,1,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
468,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
468,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
468,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
468,5,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
469,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
470,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
471,1,Myopathy,Myopathies,Muscle disorders,Musc,N
472,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
472,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
472,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
473,1,Lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
474,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
474,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,Y
475,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
476,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
477,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
478,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
479,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
480,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,Y
481,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
482,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
482,2,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
483,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
484,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
485,1,Blindness cortical,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
485,2,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
485,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
485,4,Leukoencephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
485,5,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
486,1,Blindness cortical,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
486,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
486,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
486,4,Leukoencephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
486,5,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
487,1,Blindness cortical,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
487,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
487,3,Leukoencephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
487,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
488,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
488,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
488,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
488,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
489,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
489,2,Blood lactate dehydrogenase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
489,3,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
489,4,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
489,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
489,6,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,Y
489,7,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
489,8,Kidney transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
489,9,Lung infiltration,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
489,10,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
489,11,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
490,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
490,2,Microangiopathy,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
491,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
492,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
493,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
493,2,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
494,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
494,2,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
494,3,Peripheral vascular disorder,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
495,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
496,1,Coombs direct test positive,Blood grouping and cross-matching analyses,Haematology investigations (incl blood groups),Inv,N
497,1,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
498,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
498,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
499,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
499,2,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
499,3,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
500,1,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
501,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
501,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
501,3,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
502,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
502,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
503,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
503,2,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
503,3,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
503,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
503,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
504,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
505,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
505,2,Hirsutism,Hypertrichoses,Skin appendage conditions,Skin,N
505,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
506,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
506,2,Aplasia pure red cell,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
506,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
506,4,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
506,5,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
506,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
507,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
507,2,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
507,3,Eyelid oedema,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
508,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
508,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
509,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
509,2,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
510,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
511,1,Galactorrhoea,Lactation disorders,Breast disorders,Repro,N
512,1,Congenital musculoskeletal disorder,Musculoskeletal disorders congenital NEC,Musculoskeletal and connective tissue disorders congenital,Cong,N
513,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
513,2,Hypertensive encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
513,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
514,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
514,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
515,1,Gingival hypertrophy,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
516,1,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
516,2,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
517,1,Foetal distress syndrome,Foetal complications NEC,Foetal complications,Preg,N
517,2,Growth retardation,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
518,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
518,2,Intestinal ulcer,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
519,1,Breast enlargement,Breast disorders NEC,Breast disorders,Repro,N
519,2,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
520,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
521,1,Cholestasis,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
521,2,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
521,3,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
521,4,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
521,5,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
521,6,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
521,7,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
521,8,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
522,1,Aphthous ulcer,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
523,1,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
524,1,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
525,1,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
525,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
526,1,Goitre,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
527,1,Parkinsonism,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
528,1,Pseudolymphoma,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
529,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
530,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
531,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
531,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
531,3,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
532,1,Pseudolymphoma,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
533,1,Dysmorphism,Musculoskeletal disorders congenital NEC,Musculoskeletal and connective tissue disorders congenital,Cong,N
534,1,Intracranial pressure increased,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
534,2,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
534,3,Papilloedema,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
535,1,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
536,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
536,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
536,3,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
536,4,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
536,5,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
536,6,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
537,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
537,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
538,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
539,1,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
540,1,Hodgkin's disease,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
540,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
541,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
541,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
542,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
543,1,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
544,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
545,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
545,2,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
545,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
545,4,Microangiopathic haemolytic anaemia,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
545,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
546,1,Fibroadenoma of breast,Breast and nipple neoplasms benign,Breast neoplasms benign (incl nipple),Neopl,N
547,1,Mastitis,Breast infections,Infections - pathogen unspecified,Infec,N
548,1,Goitre,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
549,1,Agnosia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
549,2,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
549,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
549,4,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
549,5,Muscle rigidity,Muscle tone abnormalities,Muscle disorders,Musc,N
549,6,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
549,7,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
550,1,Headache,Headaches NEC,Headaches,Nerv,N
551,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
551,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
551,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
552,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
553,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
553,2,Hirsutism,Hypertrichoses,Skin appendage conditions,Skin,N
553,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
554,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
554,2,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
554,3,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
555,1,Headache,Headaches NEC,Headaches,Nerv,N
555,2,Hemiplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
555,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
555,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
556,1,Fibroadenoma of breast,Breast and nipple neoplasms benign,Breast neoplasms benign (incl nipple),Neopl,N
557,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,Y
558,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
559,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
560,1,Clostridium test positive,Bacteria identification and serology (excl mycobacteria),Microbiology and serology investigations,Inv,N
561,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
561,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
562,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
562,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
563,1,Acidosis,Mixed acid-base disorders,Acid-base disorders,Metab,N
563,2,Cerebral palsy,Cerebral disorders congenital,Neurological disorders congenital,Cong,N
563,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
564,1,Thrombocytopenic purpura,Thrombocytopenias,Platelet disorders,Blood,N
565,1,Optic atrophy,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
566,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
567,1,Optic atrophy,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
568,1,Gingival hypertrophy,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
569,1,Nail disorder,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
570,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
571,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
571,2,B-cell lymphoma,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
571,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
571,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
572,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
573,1,Gingivitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
574,1,Gingival hypertrophy,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
575,1,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
576,1,Gastric cancer,Gastric neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
577,1,Neuroendocrine carcinoma of the skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
578,1,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,Y
578,2,Cutaneous T-cell lymphoma,Mycoses fungoides,Lymphomas non-Hodgkin's T-cell,Neopl,N
579,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
579,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
580,1,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
580,2,Ventricular tachycardia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
581,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
582,1,Pigmentation disorder,Pigmentation changes NEC,Pigmentation disorders,Skin,N
583,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
583,2,Blood oestrogen increased,Reproductive hormone analyses,Endocrine investigations (incl sex hormones),Inv,N
583,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
583,4,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
583,5,Headache,Headaches NEC,Headaches,Nerv,N
583,6,Hypopituitarism,Anterior pituitary hypofunction,Hypothalamus and pituitary gland disorders,Endo,N
583,7,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
584,1,Aphthous ulcer,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
584,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
584,3,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
585,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
586,1,Hepatic cancer,Hepatic neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,Y
587,1,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,Y
588,1,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
588,2,Visual field defect,Visual field disorders,Vision disorders,Eye,N
589,1,Pigmentation disorder,Pigmentation changes NEC,Pigmentation disorders,Skin,N
590,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
590,2,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
591,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
592,1,Hydrocephalus,Hydrocephalic conditions,Increased intracranial pressure and hydrocephalus,Nerv,N
593,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
593,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
594,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
595,1,Maculopathy,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
595,2,Retinal pigmentation,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
596,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
597,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
598,1,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
599,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
599,2,Respiratory gas exchange disorder,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
600,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
600,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
600,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
601,1,Microangiopathic haemolytic anaemia,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
602,1,Skin hypertrophy,Skin hyperplasias and hypertrophies,Cornification and dystrophic skin disorders,Skin,N
603,1,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
604,1,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
605,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
606,1,Brain stem ischaemia,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
606,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
606,3,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
607,1,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
608,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
608,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
608,3,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
609,1,Headache,Headaches NEC,Headaches,Nerv,N
609,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
610,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
611,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
612,1,Idiopathic intracranial hypertension,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
613,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
613,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
613,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
613,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
614,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
614,2,Joint effusion,Joint related signs and symptoms,Joint disorders,Musc,N
614,3,Mycobacterial infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
615,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
615,2,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
616,1,Pseudolymphoma,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
617,1,Burning sensation mucosal,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
617,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
618,1,Neuroendocrine carcinoma of the skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,Y
619,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
619,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
619,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
619,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
620,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
620,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
620,3,Myoglobinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
620,4,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
621,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
621,2,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
622,1,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
622,2,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,Y
622,3,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
623,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
623,2,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
623,3,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
623,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
624,1,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
625,1,Nephrotic syndrome,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
625,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
626,1,Retinopathy,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
627,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
627,2,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
627,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
627,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
628,1,Neonatal respiratory distress syndrome,Neonatal hypoxic conditions,Neonatal respiratory disorders,Resp,N
629,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
629,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
629,3,Kidney transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
629,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
630,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
630,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
630,3,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
630,4,Staphylococcal sepsis,Staphylococcal infections,Bacterial infectious disorders,Infec,N
630,5,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
631,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
631,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
631,3,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
631,4,Headache,Headaches NEC,Headaches,Nerv,N
631,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
632,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
633,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
633,2,Lymphocytosis,Leukocytoses NEC,White blood cell disorders,Blood,N
633,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
634,1,Skin cancer,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
635,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
635,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
635,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
636,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
636,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
636,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
637,1,Laryngeal oedema,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
637,2,Pharyngeal oedema,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
637,3,Vocal cord paralysis,Vagus nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
638,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
639,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
640,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
641,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
641,2,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
642,1,Gingival hypertrophy,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
643,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
643,2,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
643,3,Diarrhoea haemorrhagic,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
644,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
644,2,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
645,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
645,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
645,3,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
646,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
646,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
646,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
647,1,Blindness cortical,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
647,2,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
648,1,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
649,1,Pseudolymphoma,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
650,1,Skin hypertrophy,Skin hyperplasias and hypertrophies,Cornification and dystrophic skin disorders,Skin,N
651,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
652,1,Plasmacytoma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
653,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
654,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
655,1,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
656,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
656,2,Headache,Headaches NEC,Headaches,Nerv,N
656,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
657,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
658,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
658,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
659,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
659,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
660,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
660,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
660,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
661,1,Macrocytosis,Red blood cell abnormal findings NEC,Red blood cell disorders,Blood,N
662,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
663,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
664,1,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
665,1,Peripheral ischaemia,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
666,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
666,2,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
666,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
667,1,Pustular psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
667,2,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
668,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
668,2,Drug level fluctuating,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
669,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
670,1,Bowen's disease,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
671,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
671,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
672,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
673,1,Coma,Coma states,Neurological disorders NEC,Nerv,Y
673,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
673,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
673,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
674,1,Leukoencephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
674,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
675,1,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
676,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
677,1,Fibroadenoma of breast,Breast and nipple neoplasms benign,Breast neoplasms benign (incl nipple),Neopl,N
678,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
679,1,Ventricular septal defect,Cardiac septal defects congenital,Cardiac and vascular disorders congenital,Cong,N
680,1,Hypercholesterolaemia,Elevated cholesterol,Lipid metabolism disorders,Metab,N
681,1,Laryngeal cancer,Laryngeal neoplasms malignant,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
682,1,Alcohol intolerance,Food malabsorption and intolerance syndromes (excl sugar intolerance),Food intolerance syndromes,Metab,N
682,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
682,3,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
683,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
683,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
684,1,Uterine cancer,Uterine neoplasms malignant NEC,Reproductive neoplasms female malignant and unspecified,Neopl,N
685,1,Goitre,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
686,1,Nail disorder,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
687,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
688,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
689,1,Biliary colic,Bile duct infections and inflammations,Bile duct disorders,Hepat,N
690,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
690,2,Gingival hypertrophy,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
690,3,Headache,Headaches NEC,Headaches,Nerv,N
690,4,Hirsutism,Hypertrichoses,Skin appendage conditions,Skin,N
691,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
691,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
692,1,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
692,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
692,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
693,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
693,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
694,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
695,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
696,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,Y
696,2,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
696,3,Hepatitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
697,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,Y
697,2,Hepatitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
698,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
698,2,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
698,3,Hepatitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
698,4,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
698,5,Pneumonia viral,Viral infections NEC,Viral infectious disorders,Infec,N
699,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,Y
699,2,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
699,3,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
699,4,Hepatitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
700,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
700,2,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
701,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
701,2,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
702,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
702,2,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
703,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
703,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
703,3,Pneumonia viral,Viral infections NEC,Viral infectious disorders,Infec,N
704,1,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
705,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
706,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
706,2,Diarrhoea haemorrhagic,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
706,3,Inflammatory bowel disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
706,4,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
706,5,Pyoderma gangrenosum,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
706,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
706,7,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
706,8,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
707,1,Bell's palsy,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
708,1,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
709,1,Microangiopathic haemolytic anaemia,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
710,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
710,2,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,Y
711,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
711,2,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
712,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
712,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
713,1,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
714,1,Acne,Acnes,Skin appendage conditions,Skin,N
715,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
716,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
717,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
717,2,Eyelid oedema,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
718,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
718,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
718,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
719,1,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
720,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
720,2,Neuroendocrine carcinoma of the skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
720,3,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
720,4,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
721,1,Gingival hypertrophy,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
721,2,Virilism,Female gonadal function disorders,Endocrine disorders of gonadal function,Endo,N
722,1,Foetal growth restriction,Foetal growth complications,Foetal complications,Preg,N
722,2,Neonatal respiratory distress syndrome,Neonatal hypoxic conditions,Neonatal respiratory disorders,Resp,N
722,3,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
723,1,Placental insufficiency,Placental abnormalities (excl neoplasms),"Placental, amniotic and cavity disorders (excl haemorrhages)",Preg,N
723,2,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
724,1,Blood lactate dehydrogenase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
724,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
725,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
725,2,Hepatic necrosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
725,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
725,4,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
725,5,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
726,1,Headache,Headaches NEC,Headaches,Nerv,N
726,2,Meningitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
726,3,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
726,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
726,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
726,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
727,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
727,2,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
728,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
729,1,Optic atrophy,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
729,2,Pulmonary sarcoidosis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
729,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
730,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
731,1,B-cell lymphoma,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,Y
732,1,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
733,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
733,2,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
733,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
733,4,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
733,5,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
734,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
734,2,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
734,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
734,4,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
735,1,Malignant hypertension,Accelerated and malignant hypertension,Vascular hypertensive disorders,Vasc,N
735,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
736,1,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
737,1,Seminoma,Testicular neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
738,1,Gingival hypertrophy,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
739,1,Retinal pigmentation,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
740,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
740,2,Polymyositis,Muscle infections and inflammations,Muscle disorders,Musc,N
741,1,Blindness cortical,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
742,1,Cerebellar ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
742,2,Cerebral atrophy,Structural brain disorders NEC,Structural brain disorders,Nerv,N
743,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
743,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
744,1,Pulmonary function test decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
744,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
745,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
745,2,Obliterative bronchiolitis,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,Y
746,1,Pulmonary function test decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
747,1,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
748,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
748,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
748,3,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
749,1,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
750,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
750,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
750,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
751,1,Porphyria acute,Inborn errors of porphyrin metabolism,Metabolic and nutritional disorders congenital,Cong,N
751,2,Urine porphobilinogen increased,Haem metabolism analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
752,1,Ingrowing nail,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
753,1,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
753,2,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
753,3,Nocturia,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
754,1,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
754,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
754,3,Thrombotic thrombocytopenic purpura,Thrombocytopenias,Platelet disorders,Blood,N
755,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
755,2,Headache,Headaches NEC,Headaches,Nerv,N
755,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
756,1,Pyogenic granuloma,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
757,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
757,2,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
757,3,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
757,4,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
757,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
757,6,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
758,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
759,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
760,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
761,1,Rectal cancer,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
762,1,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
763,1,Precancerous cells present,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
764,1,Sjogren's syndrome,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
765,1,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
765,2,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
766,1,Obliterative bronchiolitis,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
766,2,Pulmonary function test decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
767,1,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
767,2,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
768,1,Non-Hodgkin's lymphoma stage III,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,Y
769,1,Gingivitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
769,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
769,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
770,1,Sperm concentration abnormal,Fertility analyses and other reproductive function procedures,Reproductive organ and breast investigations (excl hormone analyses),Inv,N
770,2,Spermatozoa progressive motility decreased,Fertility analyses and other reproductive function procedures,Reproductive organ and breast investigations (excl hormone analyses),Inv,N
771,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
771,2,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
771,3,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
772,1,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
773,1,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
774,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
774,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
774,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
775,1,Gingival hypertrophy,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
776,1,Meningitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
777,1,Acne,Acnes,Skin appendage conditions,Skin,N
777,2,Dermatitis papillaris capillitii,Hyperkeratoses,Cornification and dystrophic skin disorders,Skin,N
778,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
778,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
779,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
779,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
779,3,Cutaneous T-cell lymphoma,Mycoses fungoides,Lymphomas non-Hodgkin's T-cell,Neopl,N
779,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
779,5,Follicular mucinosis,Alopecias,Skin appendage conditions,Skin,N
779,6,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
779,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
779,8,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
779,9,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
780,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
780,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
780,3,Proctitis,Rectal inflammations NEC,Gastrointestinal inflammatory conditions,Gastr,N
781,1,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
781,2,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
782,1,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
782,2,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
783,1,Azoospermia,Spermatogenesis and semen disorders,Sexual function and fertility disorders,Repro,N
784,1,Glioma,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
785,1,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
785,2,Thrombotic thrombocytopenic purpura,Thrombocytopenias,Platelet disorders,Blood,N
786,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
786,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
786,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
786,4,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
786,5,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
786,6,Protein-losing gastroenteropathy,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
787,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
787,2,Myopathy,Myopathies,Muscle disorders,Musc,N
788,1,B-cell lymphoma,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
789,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
789,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
789,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
789,4,Duodenal ulcer,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
789,5,Gastroenteritis vibrio,Vibrio infections,Bacterial infectious disorders,Infec,N
789,6,Helicobacter gastritis,Helicobacter infections,Bacterial infectious disorders,Infec,N
789,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
789,8,Rectal polyp,Benign neoplasms gastrointestinal (excl oral cavity),Benign neoplasms gastrointestinal,Gastr,N
789,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
789,10,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
790,1,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
790,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
790,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
791,1,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
791,2,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
792,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
792,2,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
792,3,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
792,4,Disseminated intravascular coagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
792,5,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
792,6,Necrotising fasciitis,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
793,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
794,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
795,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
795,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
795,3,Granuloma,Inflammations,General system disorders NEC,Genrl,N
795,4,Organising pneumonia,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
795,5,Pulmonary granuloma,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
796,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
796,2,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
796,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
797,1,Cutaneous T-cell lymphoma,Mycoses fungoides,Lymphomas non-Hodgkin's T-cell,Neopl,N
798,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
799,1,Candida pneumonia,Candida infections,Fungal infectious disorders,Infec,N
799,2,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
799,3,Enterococcal infection,Enterococcal infections,Bacterial infectious disorders,Infec,N
799,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
799,5,Fungal sepsis,Fungal infections NEC,Fungal infectious disorders,Infec,N
799,6,Fusarium infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
799,7,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
800,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
800,2,Hypertensive encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
800,3,Intracranial pressure increased,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
800,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
801,1,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
801,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
801,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
801,4,Mucormycosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
801,5,Parosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
802,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
802,2,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
802,3,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
802,4,Kidney transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
802,5,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
803,1,Alopecia areata,Alopecias,Skin appendage conditions,Skin,N
804,1,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
804,2,Obliterative bronchiolitis,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
805,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
805,2,Eating disorder,Eating disorders NEC,Eating disorders and disturbances,Psych,N
805,3,Laryngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
805,4,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
805,5,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
805,6,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
806,1,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
807,1,Agnosia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
807,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
807,3,"Hallucinations, mixed",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
807,4,Headache,Headaches NEC,Headaches,Nerv,N
807,5,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
807,6,Muscle rigidity,Muscle tone abnormalities,Muscle disorders,Musc,N
807,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
807,8,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
807,9,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
807,10,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
808,1,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
809,1,Choroid melanoma,Ocular melanomas,Ocular neoplasms,Neopl,N
810,1,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
810,2,Prostatism,"Prostatic signs, symptoms and disorders NEC",Prostatic disorders (excl infections and inflammations),Repro,N
811,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
812,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
812,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
812,3,Muscle tightness,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
812,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
812,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
813,1,Abnormal uterine bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
814,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
814,2,Polymyositis,Muscle infections and inflammations,Muscle disorders,Musc,N
815,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
816,1,Alopecia totalis,Alopecias,Skin appendage conditions,Skin,N
817,1,Complications of transplanted kidney,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
817,2,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
817,3,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
817,4,Hepatosplenomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
817,5,Laryngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
817,6,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
817,7,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
817,8,Lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
817,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
817,10,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
817,11,Tonsillar disorder,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
817,12,Tonsillar hypertrophy,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
818,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
819,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
820,1,Anosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
821,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
821,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
821,3,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
821,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
821,5,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
822,1,Congenital hydrocephalus,Cerebral disorders congenital,Neurological disorders congenital,Cong,N
823,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
824,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
824,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
824,3,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
825,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
826,1,Heart transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
827,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
827,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
827,3,Gangrene,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
827,4,Heart transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
828,1,Heart transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
829,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
829,2,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
830,1,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
831,1,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
831,2,Hepatitis B surface antigen positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
831,3,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
831,4,Nocardiosis,Nocardia infections,Bacterial infectious disorders,Infec,N
831,5,Respiratory rate decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
831,6,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
832,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
832,2,Idiopathic intracranial hypertension,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
833,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
834,1,Acidosis,Mixed acid-base disorders,Acid-base disorders,Metab,N
834,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
834,3,Pneumonia legionella,Legionella infections,Bacterial infectious disorders,Infec,N
834,4,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
835,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
835,2,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
835,3,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
836,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
837,1,Creatinine renal clearance decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
838,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
839,1,Haemorrhoids,Haemorrhoids and gastrointestinal varices (excl oesophageal),Gastrointestinal vascular conditions,Gastr,N
839,2,Rectal cancer,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
839,3,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
840,1,Escherichia infection,Escherichia infections,Bacterial infectious disorders,Infec,N
840,2,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
840,3,Hepatitis B reactivation,Hepatitis virus infections,Viral infectious disorders,Infec,Y
840,4,Pneumonia cytomegaloviral,Cytomegaloviral infections,Viral infectious disorders,Infec,N
840,5,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
841,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
841,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
842,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
842,2,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
842,3,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
842,4,Haemorrhage in pregnancy,Haemorrhagic complications of pregnancy,Maternal complications of pregnancy,Preg,N
842,5,Placenta praevia,Placental abnormalities (excl neoplasms),"Placental, amniotic and cavity disorders (excl haemorrhages)",Preg,N
843,1,Retinopathy,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
843,2,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
844,1,Cutaneous T-cell lymphoma,Mycoses fungoides,Lymphomas non-Hodgkin's T-cell,Neopl,N
844,2,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
844,3,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
844,4,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
845,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
845,2,Granuloma skin,Granulomatous and deep cutaneous inflammatory conditions,Epidermal and dermal conditions,Skin,N
845,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
845,4,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
845,5,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
846,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
846,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
847,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
847,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
847,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
848,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
849,1,Richter's syndrome,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
850,1,Heart rate abnormal,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
851,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
852,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
852,2,Pustular psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
853,1,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,Y
854,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
855,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
856,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
856,2,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
857,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,Y
857,2,Bone marrow disorder,Haematological disorders,Haematological disorders NEC,Blood,N
857,3,Chromosome analysis abnormal,Chromosome analyses,Cytogenetic investigations and genetic analyses,Inv,N
857,4,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
857,5,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
857,6,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
857,7,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
857,8,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
858,1,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
859,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
859,2,Apnoeic attack,Breathing abnormalities,Respiratory disorders NEC,Resp,N
859,3,CSF cell count increased,Cerebrospinal fluid tests (excl microbiology),"Neurological, special senses and psychiatric investigations",Inv,N
859,4,CSF protein increased,Cerebrospinal fluid tests (excl microbiology),"Neurological, special senses and psychiatric investigations",Inv,N
859,5,Cerebral atrophy,Structural brain disorders NEC,Structural brain disorders,Nerv,N
859,6,Clonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
859,7,Encephalitis viral,Viral infections NEC,Viral infectious disorders,Infec,Y
859,8,Head lag abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
859,9,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
859,10,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
859,11,Opisthotonus,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
859,12,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
859,13,Pericarditis,Noninfectious pericarditis,Pericardial disorders,Card,N
859,14,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
859,15,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
859,16,Reflexes abnormal,Abnormal reflexes,Neurological disorders NEC,Nerv,N
859,17,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
859,18,T-lymphocyte count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
859,19,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
860,1,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
861,1,Cholestasis,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
861,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
862,1,Autoimmune disorder,Autoimmune disorders NEC,Autoimmune disorders,Immun,N
862,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
863,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
863,2,Extraocular muscle disorder,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
863,3,Headache,Headaches NEC,Headaches,Nerv,N
863,4,Heterophoria,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
863,5,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
863,6,Retinal vascular disorder,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
863,7,Strabismus,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
863,8,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
863,9,VIth nerve paralysis,Eye movement disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
864,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
865,1,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,Y
866,1,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
866,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
867,1,Hirsutism,Hypertrichoses,Skin appendage conditions,Skin,N
867,2,Intracranial pressure increased,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
868,1,Encephalitis viral,Viral infections NEC,Viral infectious disorders,Infec,Y
869,1,Encephalitis viral,Viral infections NEC,Viral infectious disorders,Infec,Y
869,2,Pericarditis,Noninfectious pericarditis,Pericardial disorders,Card,N
869,3,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
870,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
870,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
870,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
870,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
870,5,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
870,6,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
871,1,Blood calcium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
871,2,Breast enlargement,Breast disorders NEC,Breast disorders,Repro,N
872,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
873,1,Squamous cell carcinoma of lung,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,Y
874,1,Biopsy lymph gland abnormal,Bone marrow and immune tissue histopathology procedures,Haematology investigations (incl blood groups),Inv,N
874,2,Biopsy skin abnormal,Skin histopathology and skin investigations NEC,Skin investigations,Inv,N
874,3,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
874,4,Folliculitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
874,5,Immunology test abnormal,Immunology analyses NEC,Immunology and allergy investigations,Inv,N
874,6,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
874,7,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
874,8,Lymphomatoid papulosis,Papulosquamous conditions,Epidermal and dermal conditions,Skin,N
874,9,Lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
874,10,Neurodermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
874,11,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
874,12,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
874,13,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
874,14,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
874,15,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
874,16,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
875,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
875,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
875,3,Headache,Headaches NEC,Headaches,Nerv,N
875,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
876,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
877,1,Barrett's oesophagus,Gastrointestinal mucosal dystrophies and secretion disorders,Gastrointestinal conditions NEC,Gastr,N
877,2,Iron deficiency anaemia,Anaemia deficiencies,Anaemias nonhaemolytic and marrow depression,Blood,N
877,3,Oesophageal carcinoma,Oesophageal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
878,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
878,2,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
878,3,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
878,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
878,5,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
878,6,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
879,1,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,Y
879,2,T-cell lymphoma,Anaplastic large cell lymphomas T- and null-cell types,Lymphomas non-Hodgkin's T-cell,Neopl,N
880,1,Biliary dilatation,Structural and other bile duct disorders,Bile duct disorders,Hepat,N
880,2,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
880,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
880,4,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
880,5,Metastases to bone,Metastases to specified sites,Metastases,Neopl,Y
880,6,Renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
880,7,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
880,8,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
881,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
882,1,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
883,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
883,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
883,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
884,1,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
884,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
885,1,Biliary dilatation,Structural and other bile duct disorders,Bile duct disorders,Hepat,N
885,2,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
886,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
886,2,Myopathy,Myopathies,Muscle disorders,Musc,N
887,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
888,1,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
889,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
889,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
889,3,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
890,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
891,1,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,N
892,1,Bronchial carcinoma,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
892,2,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
893,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
894,1,Cerebral venous thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,Y
894,2,Hypertrichosis,Hypertrichoses,Skin appendage conditions,Skin,N
894,3,Otitis externa,Ear infections,Infections - pathogen unspecified,Infec,N
894,4,Vernet's syndrome,Mixed cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
895,1,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
895,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
895,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
896,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
897,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
898,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
899,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
899,2,Clostridium difficile colitis,Clostridia infections,Bacterial infectious disorders,Infec,N
899,3,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
900,1,Gastroenteritis adenovirus,Adenoviral infections,Viral infectious disorders,Infec,N
901,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
902,1,Neutrophilia,Leukocytoses NEC,White blood cell disorders,Blood,N
902,2,Premature rupture of membranes,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
903,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
904,1,Coronary artery disease,Coronary artery disorders NEC,Coronary artery disorders,Card,N
905,1,Colon cancer,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
906,1,Adenocarcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
907,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
907,2,Angiodysplasia,Vascular malformations and acquired anomalies,Vascular disorders NEC,Vasc,N
907,3,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
907,4,Retinopathy sickle cell,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
907,5,Vitreous haemorrhage,Choroid and vitreous haemorrhages and vascular disorders,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
908,1,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,N
909,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
909,2,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
909,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
910,1,Cancer pain,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
910,2,Seminoma,Testicular neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
910,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
911,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
911,2,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
912,1,Idiopathic intracranial hypertension,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
913,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
913,2,Large intestine perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
914,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
914,2,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,Y
915,1,Ephelides,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
916,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
916,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
917,1,Adenocarcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
918,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
918,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
919,1,Hypertensive crisis,Accelerated and malignant hypertension,Vascular hypertensive disorders,Vasc,N
920,1,Pelvi-ureteric obstruction,Renal obstructive disorders,Renal disorders (excl nephropathies),Renal,N
920,2,Renal dysplasia,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,N
921,1,Dermatitis herpetiformis,Bullous conditions,Epidermal and dermal conditions,Skin,N
921,2,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
921,3,Headache,Headaches NEC,Headaches,Nerv,N
921,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
921,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
922,1,Kidney transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
923,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
923,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
923,3,Streptococcal sepsis,Streptococcal infections,Bacterial infectious disorders,Infec,N
924,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
924,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
925,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
926,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
926,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
926,3,Ureteric obstruction,Ureteric disorders NEC,Ureteric disorders,Renal,N
926,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
927,1,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,N
928,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
928,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
929,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
929,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
930,1,Diffuse alopecia,Alopecias,Skin appendage conditions,Skin,N
931,1,Adenoma benign,Neoplasms benign site unspecified NEC,Miscellaneous and site unspecified neoplasms benign,Neopl,N
931,2,Colon cancer,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,Y
931,3,Hepatic lesion,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
931,4,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
932,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
932,2,Tenderness,Pain and discomfort NEC,General system disorders NEC,Genrl,N
933,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
934,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
935,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
936,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
936,2,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
936,3,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
937,1,Delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
937,2,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
938,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
939,1,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
939,2,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
940,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
940,2,Selective IgA immunodeficiency,Primary immunodeficiency syndromes,Immunodeficiency syndromes,Immun,N
941,1,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
942,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
942,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
942,3,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
942,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
943,1,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
943,2,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
944,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
945,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
945,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
946,1,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
947,1,Skin papilloma,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
948,1,Myopathy,Myopathies,Muscle disorders,Musc,N
949,1,Macrocytosis,Red blood cell abnormal findings NEC,Red blood cell disorders,Blood,N
950,1,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
950,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
951,1,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
952,1,Acute coronary syndrome,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
952,2,Arteriospasm coronary,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
952,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
952,4,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
953,1,Gingival hypertrophy,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
954,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
955,1,Lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
956,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
956,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
956,3,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
956,4,Gingival hypertrophy,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
956,5,Graft complication,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
956,6,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
956,7,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
956,8,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
956,9,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
956,10,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
956,11,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
956,12,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
956,13,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
956,14,Skin hyperpigmentation,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
956,15,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
956,16,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
957,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
957,2,Immunosuppressant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
957,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
958,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
958,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
958,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
958,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
958,5,Myopathy,Myopathies,Muscle disorders,Musc,N
958,6,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
958,7,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
959,1,Talipes,Musculoskeletal and connective tissue disorders of limbs congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
960,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
961,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
961,2,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
961,3,Chest X-ray abnormal,Respiratory tract and thoracic imaging procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
961,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
961,5,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
961,6,Fundoscopy abnormal,Ophthalmic histopathology and imaging procedures,"Neurological, special senses and psychiatric investigations",Inv,N
961,7,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
961,8,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
961,9,Papilloedema,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
961,10,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
961,11,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
961,12,Retinal detachment,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
961,13,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
961,14,Visual field defect,Visual field disorders,Vision disorders,Eye,N
961,15,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
962,1,Skin cancer,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
963,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
963,2,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
963,3,Haemangioma,Cardiovascular neoplasms benign,Miscellaneous and site unspecified neoplasms benign,Neopl,N
963,4,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
963,5,Lesion excision,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
963,6,Scleroderma,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
963,7,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
964,1,Hyperplasia,Trophic disorders,Tissue disorders NEC,Genrl,N
964,2,Lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
965,1,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
966,1,Anal incontinence,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
966,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
967,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
967,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
967,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
967,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
967,5,Myopathy toxic,Myopathies,Muscle disorders,Musc,N
967,6,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
967,7,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
968,1,Rectal cancer,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,Y
969,1,Cardiac flutter,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
969,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
970,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
970,2,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
970,3,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
970,4,Computerised tomogram abnormal,Imaging procedures NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
970,5,Coronary artery stenosis,Coronary artery disorders NEC,Coronary artery disorders,Card,N
970,6,Creatinine renal clearance decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
970,7,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
970,8,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
970,9,Glucose tolerance impaired,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
970,10,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
970,11,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
970,12,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
970,13,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
970,14,Rales,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
970,15,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
970,16,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
970,17,Vascular graft complication,Cardiac and vascular procedural complications,Procedural related injuries and complications NEC,Inj&P,N
971,1,Abdominal mass,Abdominal findings abnormal,Gastrointestinal signs and symptoms,Gastr,N
971,2,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
971,3,Aortic aneurysm rupture,Aortic aneurysms and dissections,Aneurysms and artery dissections,Vasc,Y
971,4,Arteriosclerosis,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
971,5,Bladder neoplasm surgery,Bladder therapeutic procedures,Renal and urinary tract therapeutic procedures,Surg,N
971,6,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
971,7,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
971,8,Cytomegalovirus test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
971,9,Diverticulum,Diverticula,Diverticular disorders,Gastr,N
971,10,Groin pain,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
971,11,Large intestine anastomosis,Large intestine therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
971,12,Large intestine polyp,Benign neoplasms gastrointestinal (excl oral cavity),Benign neoplasms gastrointestinal,Gastr,N
971,13,Mass excision,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
971,14,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
971,15,Polypectomy,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
971,16,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
971,17,Red blood cell sedimentation rate increased,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
971,18,Red blood cells urine positive,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
971,19,Transitional cell carcinoma,Urinary tract neoplasms malignant NEC,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
971,20,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
972,1,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
972,2,Transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
973,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
973,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
973,3,Peptic ulcer perforation,Peptic ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
973,4,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
974,1,Thrombotic thrombocytopenic purpura,Thrombocytopenias,Platelet disorders,Blood,N
975,1,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
975,2,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
975,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
976,1,Dysplastic naevus syndrome,Skin and subcutaneous tissue disorders congenital NEC,Skin and subcutaneous tissue disorders congenital,Cong,N
976,2,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
977,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
977,2,Nodule,Mass conditions NEC,Tissue disorders NEC,Genrl,N
977,3,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
978,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
978,2,Acute myeloid leukaemia recurrent,Leukaemias acute myeloid,Leukaemias,Neopl,Y
978,3,Cerebellar syndrome,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
978,4,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
978,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
978,6,Eye movement disorder,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
978,7,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
978,8,Opsoclonus myoclonus,Encephalopathies NEC,Encephalopathies,Nerv,N
978,9,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
978,10,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
979,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
979,2,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
979,3,Leukoencephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
979,4,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
980,1,Intestinal infarction,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,Y
981,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
982,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
982,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
982,3,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
983,1,Cranial nerve disorder,Cranial nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
983,2,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
983,3,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
983,4,Meningism,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
983,5,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
983,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
984,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
984,2,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
984,3,Pneumonia viral,Viral infections NEC,Viral infectious disorders,Infec,N
984,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
984,5,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
984,6,Rhinitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
985,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,Y
985,2,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
985,3,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
986,1,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,Y
986,2,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
986,3,Drug tolerance decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
986,4,Enteritis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
986,5,Gastroenteritis adenovirus,Adenoviral infections,Viral infectious disorders,Infec,N
986,6,Gastrointestinal mucosal necrosis,Gastrointestinal necrosis and gangrene (excl gangrenous hernia),Gastrointestinal vascular conditions,Gastr,N
986,7,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
986,8,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
986,9,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
986,10,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
986,11,Small intestinal obstruction,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
986,12,Thrombotic thrombocytopenic purpura,Thrombocytopenias,Platelet disorders,Blood,N
986,13,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
987,1,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
987,2,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
987,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
988,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
988,2,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
989,1,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
989,2,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
989,3,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
989,4,Lung infiltration,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
989,5,Lung transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
989,6,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
990,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
990,2,Bowen's disease,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
990,3,Cutaneous T-cell lymphoma,Mycoses fungoides,Lymphomas non-Hodgkin's T-cell,Neopl,Y
990,4,Cutaneous T-cell lymphoma,Mycoses fungoides,Lymphomas non-Hodgkin's T-cell,Neopl,N
990,5,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
990,6,Skin abrasion,Skin injuries NEC,Injuries NEC,Inj&P,N
990,7,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
990,8,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
991,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
991,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
991,3,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
992,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
992,2,Eye movement disorder,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
992,3,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
992,4,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
992,5,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
993,1,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
993,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
994,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
994,2,Acanthosis,Skin hyperplasias and hypertrophies,Cornification and dystrophic skin disorders,Skin,N
994,3,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
994,4,Epidermal necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
994,5,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
994,6,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
994,7,Hyperkeratosis,Hyperkeratoses,Cornification and dystrophic skin disorders,Skin,N
994,8,Inflammation,Inflammations,General system disorders NEC,Genrl,N
994,9,Lichen planus,Papulosquamous conditions,Epidermal and dermal conditions,Skin,N
994,10,Lymphocytic infiltration,Leukocytoses NEC,White blood cell disorders,Blood,N
994,11,Nodule,Mass conditions NEC,Tissue disorders NEC,Genrl,N
994,12,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
994,13,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
994,14,Skin hyperpigmentation,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
994,15,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
994,16,Skin oedema,Skin vascular conditions NEC,Skin vascular abnormalities,Skin,N
994,17,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
994,18,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
995,1,Molluscum contagiosum,Molluscum contagiosum viral infections,Viral infectious disorders,Infec,N
995,2,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
996,1,Liver transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
997,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
997,2,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
997,3,Obstructive airways disorder,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
997,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
998,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
998,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
998,3,T-cell lymphoma,Anaplastic large cell lymphomas T- and null-cell types,Lymphomas non-Hodgkin's T-cell,Neopl,Y
999,1,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
999,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
999,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
999,4,Drug level below therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
999,5,Faeces discoloured,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
999,6,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
999,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
999,8,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
1000,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1000,2,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1000,3,CSF protein increased,Cerebrospinal fluid tests (excl microbiology),"Neurological, special senses and psychiatric investigations",Inv,N
1000,4,Communication disorder,Communications disorders,Communication disorders and disturbances,Psych,N
1000,5,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
1000,6,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1000,7,Facial paresis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1000,8,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
1000,9,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1000,10,Hyperreflexia,Abnormal reflexes,Neurological disorders NEC,Nerv,N
1000,11,Hyporeflexia,Abnormal reflexes,Neurological disorders NEC,Nerv,N
1000,12,Measles,Rubeola viral infections,Viral infectious disorders,Infec,N
1000,13,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1000,14,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1000,15,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
1000,16,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1000,17,Retinitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
1000,18,Status epilepticus,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1000,19,Subacute sclerosing panencephalitis,Inflammatory disorders following infection,Ancillary infectious topics,Infec,N
1000,20,Upper motor neurone lesion,Motor neurone diseases,Neuromuscular disorders,Nerv,N
1001,1,Chronic allograft nephropathy,Transplant rejections,Immune disorders NEC,Immun,N
1001,2,Subacute sclerosing panencephalitis,Inflammatory disorders following infection,Ancillary infectious topics,Infec,N
1002,1,Blood albumin decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1002,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
1002,3,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1002,4,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1002,5,Blood magnesium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1002,6,Blood potassium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1002,7,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1002,8,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
1002,9,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1002,10,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1002,11,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1002,12,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1003,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1003,2,Consciousness fluctuating,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1003,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1003,4,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
1003,5,Leukoencephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
1003,6,Motor dysfunction,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1003,7,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1003,8,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1004,1,Graft versus host disease in gastrointestinal tract,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1004,2,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
1004,3,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1005,1,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1006,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1006,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1006,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1007,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1008,1,Infertility,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
1009,1,Acute febrile neutrophilic dermatosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1009,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1009,3,Necrosis,Necrosis NEC,Tissue disorders NEC,Genrl,N
1009,4,Necrotising fasciitis,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
1009,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1010,1,High grade B-cell lymphoma Burkitt-like lymphoma,High grade B-cell lymphomas Burkitt-like lymphoma,Lymphomas non-Hodgkin's B-cell,Neopl,N
1011,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1011,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1011,3,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
1012,1,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,Y
1013,1,Lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1014,1,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1015,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1015,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1015,3,Lung transplant,Bronchial and pulmonary therapeutic procedures,Respiratory tract therapeutic procedures,Surg,N
1015,4,Lung transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
1015,5,Obliterative bronchiolitis,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,Y
1015,6,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
1015,7,Pulmonary function test decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
1016,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
1016,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1016,3,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
1016,4,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
1016,5,Pulmonary function test decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
1016,6,Respiratory gas exchange disorder,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
1016,7,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1017,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
1017,2,Drug level below therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1017,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1017,4,Pulmonary function test decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
1017,5,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
1017,6,Respiratory gas exchange disorder,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
1017,7,Stenotrophomonas infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1018,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1018,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1018,3,Lung transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
1018,4,Obliterative bronchiolitis,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,Y
1018,5,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
1018,6,Pulmonary function test decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
1019,1,Deafness,Hearing losses,Hearing disorders,Ear,N
1020,1,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1020,2,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1021,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1021,2,Gastric haemorrhage,Gastric and oesophageal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1021,3,Headache,Headaches NEC,Headaches,Nerv,N
1021,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1022,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1022,2,Clostridium difficile colitis,Clostridia infections,Bacterial infectious disorders,Infec,N
1022,3,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1022,4,Debridement,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1022,5,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
1022,6,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1022,7,Mediastinitis,Infections NEC,Infections - pathogen unspecified,Infec,N
1022,8,Necrosis,Necrosis NEC,Tissue disorders NEC,Genrl,N
1022,9,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1022,10,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1022,11,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1022,12,Tracheostomy,Tracheal therapeutic procedures,Respiratory tract therapeutic procedures,Surg,N
1023,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
1023,2,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1023,3,Increased bronchial secretion,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1023,4,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
1023,5,Lung transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
1023,6,Spirometry abnormal,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
1023,7,Tracheobronchitis,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1024,1,Biopsy lymph gland abnormal,Bone marrow and immune tissue histopathology procedures,Haematology investigations (incl blood groups),Inv,N
1024,2,Epstein-Barr virus antigen positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
1024,3,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1024,4,Eyelid oedema,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
1024,5,Lacrimal gland enlargement,"Lid, lash and lacrimal structural disorders","Anterior eye structural change, deposit and degeneration",Eye,N
1024,6,Lymphadenectomy,Lymphoid tissue therapeutic procedures,Haematological and lymphoid tissue therapeutic procedures,Surg,N
1024,7,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1025,1,Gingival hypertrophy,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
1025,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1025,3,Skin cancer,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1026,1,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1026,2,Hepatitis B,Hepatitis virus infections,Viral infectious disorders,Infec,N
1026,3,Hepatitis B DNA increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
1026,4,Hepatitis B e antigen positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
1026,5,Hepatitis B surface antigen positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
1027,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1028,1,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
1029,1,Malabsorption,Malabsorption syndromes,Malabsorption conditions,Gastr,N
1030,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1030,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1031,1,Pustular psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1032,1,Blood creatine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1032,2,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
1032,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1032,4,Fibrin D dimer increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
1032,5,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1032,6,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
1032,7,Tenderness,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1033,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1033,2,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1033,3,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1034,1,Nephropathy,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1034,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1035,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1035,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1035,3,Meningitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1035,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1036,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1036,2,Extraskeletal ossification,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1036,3,Myopathy,Myopathies,Muscle disorders,Musc,N
1037,1,Headache,Headaches NEC,Headaches,Nerv,N
1037,2,Idiopathic intracranial hypertension,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
1038,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
1038,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1038,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1038,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1039,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1039,2,Cholestasis of pregnancy,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1039,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1040,1,Bile acids increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1040,2,Cholestasis of pregnancy,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1040,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1041,1,Bile acids increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1041,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1041,3,Cholestasis of pregnancy,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1041,4,Pre-eclampsia,Hypertension associated disorders of pregnancy,Maternal complications of pregnancy,Preg,N
1041,5,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
1041,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1042,1,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1043,1,Bile acids increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1043,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1043,3,Cholestasis of pregnancy,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1043,4,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
1043,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1043,6,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1044,1,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1045,1,Bile acids increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1045,2,Cholestasis of pregnancy,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1045,3,Foetal distress syndrome,Foetal complications NEC,Foetal complications,Preg,N
1045,4,Kidney transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
1045,5,Pre-eclampsia,Hypertension associated disorders of pregnancy,Maternal complications of pregnancy,Preg,N
1045,6,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
1045,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1046,1,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1047,1,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,Y
1047,2,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1047,3,Superficial spreading melanoma stage unspecified,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
1048,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1048,2,Lentigo maligna,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
1048,3,Skin neoplasm excision,Skin lesion excisions,Skin and subcutaneous tissue therapeutic procedures,Surg,N
1049,1,Lentigo maligna,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
1049,2,Metastatic malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,Y
1050,1,Lentigo maligna,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
1050,2,Skin neoplasm excision,Skin lesion excisions,Skin and subcutaneous tissue therapeutic procedures,Surg,N
1050,3,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1051,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1052,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1053,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1053,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1053,3,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1053,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1053,5,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
1053,6,Inguinal mass,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1053,7,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
1053,8,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1053,9,Mass excision,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1053,10,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1053,11,Rash pustular,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1053,12,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1053,13,Skin hypertrophy,Skin hyperplasias and hypertrophies,Cornification and dystrophic skin disorders,Skin,N
1053,14,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1053,15,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
1053,16,Skin oedema,Skin vascular conditions NEC,Skin vascular abnormalities,Skin,N
1054,1,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1054,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1055,1,Kidney transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
1055,2,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1056,1,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1056,2,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1056,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1057,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
1057,2,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1057,3,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1057,4,Chest X-ray abnormal,Respiratory tract and thoracic imaging procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
1057,5,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1057,6,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1057,7,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1057,8,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1057,9,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1058,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
1058,2,Renal colic,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
1059,1,Hepatorenal failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
1059,2,Lymph node palpable,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1059,3,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1059,4,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
1059,5,Neuroendocrine carcinoma of the skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1060,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1060,2,Necrosis,Necrosis NEC,Tissue disorders NEC,Genrl,N
1060,3,Necrotising fasciitis,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
1060,4,Neutrophilic dermatosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1060,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1061,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
1061,2,Cerebral toxoplasmosis,Toxoplasma infections,Protozoal infectious disorders,Infec,N
1061,3,Graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1061,4,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1061,5,Leukaemia recurrent,Leukaemias NEC,Leukaemias,Neopl,Y
1061,6,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1062,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1062,2,CSF protein increased,Cerebrospinal fluid tests (excl microbiology),"Neurological, special senses and psychiatric investigations",Inv,N
1062,3,Cerebral toxoplasmosis,Toxoplasma infections,Protozoal infectious disorders,Infec,Y
1062,4,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1062,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1062,6,Toxoplasma serology positive,Parasite identification and serology,Microbiology and serology investigations,Inv,N
1063,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
1063,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1063,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1064,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1064,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1065,1,Cerebral toxoplasmosis,Toxoplasma infections,Protozoal infectious disorders,Infec,Y
1066,1,Cerebral toxoplasmosis,Toxoplasma infections,Protozoal infectious disorders,Infec,N
1066,2,Graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1066,3,Leukaemia recurrent,Leukaemias NEC,Leukaemias,Neopl,Y
1067,1,Spermatozoa progressive motility decreased,Fertility analyses and other reproductive function procedures,Reproductive organ and breast investigations (excl hormone analyses),Inv,N
1068,1,Hepatorenal failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
1068,2,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1068,3,Lymph node palpable,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1068,4,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1068,5,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
1068,6,Neuroendocrine carcinoma of the skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1069,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1069,2,Acute graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1069,3,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1069,4,Joint contracture,Joint related disorders NEC,Joint disorders,Musc,N
1069,5,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
1070,1,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1070,2,Light chain analysis abnormal,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
1070,3,Lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1070,4,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1070,5,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
1071,1,Deafness,Hearing losses,Hearing disorders,Ear,N
1072,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1073,1,Folliculitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1073,2,Hypertrichosis,Hypertrichoses,Skin appendage conditions,Skin,N
1073,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1073,4,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1073,5,Sebaceous hyperplasia,Sebaceous gland disorders,Skin appendage conditions,Skin,N
1073,6,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1074,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1075,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1076,1,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1077,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1077,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
1078,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1079,1,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1079,2,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1079,3,Eyelid disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
1079,4,Gingival hypertrophy,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
1079,5,Gingival swelling,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
1079,6,Kidney transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
1079,7,Lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1079,8,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
1079,9,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1079,10,Osteolysis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
1079,11,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1079,12,Tonsillectomy,Tonsillar therapeutic procedures,Head and neck therapeutic procedures,Surg,N
1079,13,Tonsillitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1079,14,Tooth disorder,Dental disorders NEC,Dental and gingival conditions,Gastr,N
1080,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1080,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1080,3,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1080,4,Gastroenteritis cryptosporidial,Cryptosporidia infections,Protozoal infectious disorders,Infec,N
1080,5,Growth retardation,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1080,6,Kidney transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
1080,7,Motor dysfunction,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1080,8,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1080,9,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1080,10,Musculoskeletal discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1080,11,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1080,12,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1081,1,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1081,2,Fungal peritonitis,Fungal infections NEC,Fungal infectious disorders,Infec,N
1081,3,Gastrointestinal perforation,"Gastrointestinal ulcers and perforation, site unspecified",Gastrointestinal ulceration and perforation,Gastr,N
1081,4,Growth retardation,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1081,5,Heart transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
1081,6,Hypotonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
1081,7,Kidney transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
1081,8,Muscle fatigue,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1081,9,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1081,10,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1081,11,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1081,12,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1081,13,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
1081,14,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1082,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1082,2,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1082,3,Growth retardation,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1082,4,Heart transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
1082,5,Muscle fatigue,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1082,6,Myalgia,Muscle pains,Muscle disorders,Musc,N
1082,7,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1082,8,Oral herpes,Herpes viral infections,Viral infectious disorders,Infec,N
1082,9,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1083,1,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
1084,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1084,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1084,3,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
1084,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1084,5,Personality change,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1084,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1084,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1084,8,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1084,9,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1084,10,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1084,11,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1085,1,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
1086,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1087,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1087,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1087,3,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1088,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1089,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,Y
1090,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1091,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1091,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1092,1,Mycobacterium chelonae infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
1093,1,Intestinal resection,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
1093,2,Post procedural haematoma,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1093,3,Road traffic accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1094,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1094,2,Graft versus host disease in gastrointestinal tract,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1095,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1095,2,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
1096,1,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,Y
1097,1,Azotaemia,Renal failure complications,Renal disorders (excl nephropathies),Renal,N
1097,2,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
1097,3,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,Y
1098,1,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
1099,1,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
1099,2,Lymphoedema,Lymphoedemas,Lymphatic vessel disorders,Vasc,N
1100,1,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
1101,1,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
1102,1,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
1103,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1103,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1103,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1103,4,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1103,5,Macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
1103,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1103,7,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1103,8,Vitreous opacities,"Choroid and vitreous structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
1104,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
1105,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1106,1,Thrombotic thrombocytopenic purpura,Thrombocytopenias,Platelet disorders,Blood,Y
1107,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1107,2,Drug level below therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1107,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1108,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1108,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1108,3,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
1108,4,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1108,5,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1108,6,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
1108,7,Idiopathic pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1108,8,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1108,9,Nodular regenerative hyperplasia,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
1108,10,Obliterative bronchiolitis,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1108,11,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1108,12,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
1108,13,Portal hypertension,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
1108,14,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1108,15,Varices oesophageal,Oesophageal varices,Gastrointestinal vascular conditions,Gastr,N
1108,16,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1109,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1109,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1109,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1110,1,Folliculitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1110,2,Hyperplasia,Trophic disorders,Tissue disorders NEC,Genrl,N
1111,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1111,2,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
1112,1,Immunosuppressant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1112,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1113,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1113,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1113,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1113,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1114,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1115,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1115,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1115,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1116,1,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1116,2,Immunosuppressant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1117,1,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1118,1,Blindness cortical,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1118,2,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1118,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1118,4,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,Y
1118,5,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
1118,6,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1119,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1119,2,Abdominal mass,Abdominal findings abnormal,Gastrointestinal signs and symptoms,Gastr,N
1119,3,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1119,4,Acid fast bacilli infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1119,5,Bacterial test positive,Bacteria identification and serology (excl mycobacteria),Microbiology and serology investigations,Inv,N
1119,6,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
1119,7,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1119,8,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1119,9,Disseminated tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
1119,10,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1119,11,Gastrointestinal necrosis,Gastrointestinal necrosis and gangrene (excl gangrenous hernia),Gastrointestinal vascular conditions,Gastr,N
1119,12,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1119,13,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1119,14,Ileus,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
1119,15,Immunosuppressant drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1119,16,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1119,17,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1119,18,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1119,19,Purulence,Infections NEC,Infections - pathogen unspecified,Infec,N
1119,20,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1119,21,Systemic inflammatory response syndrome,Inflammations,General system disorders NEC,Genrl,N
1119,22,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1120,1,Acanthamoeba infection,Amoebic infections,Protozoal infectious disorders,Infec,N
1120,2,Alcohol abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1120,3,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
1120,4,Brain abscess,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1120,5,Brain lobectomy,Skull and brain therapeutic procedures,"Nervous system, skull and spine therapeutic procedures",Surg,N
1120,6,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1120,7,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1120,8,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1120,9,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
1120,10,Encephalitis haemorrhagic,Encephalitis NEC,Central nervous system infections and inflammations,Nerv,N
1120,11,Gastrostomy,Gastric therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
1120,12,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
1120,13,Laryngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1120,14,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1120,15,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1120,16,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1120,17,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1120,18,Quadriplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1120,19,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1120,20,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1120,21,Sputum purulent,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1120,22,Toxoplasmosis,Toxoplasma infections,Protozoal infectious disorders,Infec,N
1121,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1121,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1122,1,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1122,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1122,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1122,4,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1122,5,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
1122,6,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1122,7,Orthopnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1122,8,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,Y
1122,9,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1122,10,Renal cancer,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
1123,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1124,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1125,1,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1125,2,Hodgkin's disease,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
1126,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1126,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1126,3,Headache,Headaches NEC,Headaches,Nerv,N
1126,4,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
1127,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1127,2,Metastases to lymph nodes,Metastases to specified sites,Metastases,Neopl,N
1127,3,Pulmonary mass,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
1127,4,Renal cell carcinoma stage III,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
1128,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1128,2,Chronic graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1128,3,Extremity contracture,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1128,4,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1128,5,Joint contracture,Joint related disorders NEC,Joint disorders,Musc,N
1128,6,Lichenification,Papulosquamous conditions,Epidermal and dermal conditions,Skin,N
1128,7,Scleroderma,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
1128,8,Skin hyperpigmentation,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
1128,9,Skin hypopigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
1128,10,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1129,1,B-cell lymphoma stage I,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
1129,2,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1129,3,Hodgkin's disease,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
1129,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1129,5,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1129,6,Lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1129,7,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1130,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1130,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1131,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1131,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1132,1,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1133,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1133,2,Nephrotic syndrome,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
1134,1,Necrotising fasciitis,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
1135,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1135,2,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
1135,3,Kidney enlargement,Renal structural abnormalities and trauma,Renal disorders (excl nephropathies),Renal,N
1135,4,Obstruction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1135,5,Ureteric stenosis,Ureteric disorders NEC,Ureteric disorders,Renal,N
1136,1,Myopathy,Myopathies,Muscle disorders,Musc,N
1136,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1136,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1137,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1137,2,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1137,3,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1137,4,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
1137,5,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1137,6,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1137,7,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1137,8,Skin plaque,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1137,9,Thyroid disorder,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
1137,10,Tracheal obstruction,Chest and respiratory tract injuries NEC,Injuries NEC,Inj&P,N
1138,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1138,2,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
1138,3,Cardiac murmur,Cardiac auscultatory investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1138,4,Cardiac valve vegetation,Cardiac infections,Infections - pathogen unspecified,Infec,N
1138,5,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,Y
1138,6,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1138,7,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
1138,8,Fungal endocarditis,Fungal infections NEC,Fungal infectious disorders,Infec,N
1138,9,Fungal sepsis,Fungal infections NEC,Fungal infectious disorders,Infec,N
1138,10,Intestinal infarction,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,N
1138,11,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
1138,12,Mitral valve incompetence,Mitral valvular disorders,Cardiac valve disorders,Card,N
1138,13,Mycotic endophthalmitis,Fungal infections NEC,Fungal infectious disorders,Infec,N
1138,14,Septic embolus,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1138,15,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1139,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1139,2,Cancer surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1139,3,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1140,1,Abscess fungal,Fungal infections NEC,Fungal infectious disorders,Infec,N
1140,2,Acute pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1140,3,Aortic valve incompetence,Aortic valvular disorders,Cardiac valve disorders,Card,N
1140,4,Aortic valve replacement,Cardiac valve therapeutic procedures,Cardiac therapeutic procedures,Surg,N
1140,5,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,Y
1140,6,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1140,7,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1140,8,Cardiac murmur,Cardiac auscultatory investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1140,9,Cardiac valve vegetation,Cardiac infections,Infections - pathogen unspecified,Infec,N
1140,10,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1140,11,Forced expiratory volume decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
1140,12,Fungal endocarditis,Fungal infections NEC,Fungal infectious disorders,Infec,N
1140,13,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1140,14,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
1140,15,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1140,16,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1140,17,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1140,18,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1140,19,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1140,20,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
1141,1,Granuloma,Inflammations,General system disorders NEC,Genrl,N
1141,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
1141,3,Lymph node tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
1141,4,Lymphadenitis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1141,5,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
1141,6,Wound secretion,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1142,1,BK virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
1142,2,Cystitis haemorrhagic,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
1142,3,Graft versus host disease in gastrointestinal tract,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1142,4,Graft versus host disease in liver,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1142,5,Urinary tract infection viral,Viral infections NEC,Viral infectious disorders,Infec,N
1143,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1143,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1143,3,Dilatation ventricular,Myocardial disorders NEC,Myocardial disorders,Card,N
1143,4,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
1143,5,Lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1143,6,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1143,7,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
1143,8,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
1143,9,Tricuspid valve incompetence,Tricuspid valvular disorders,Cardiac valve disorders,Card,N
1144,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1144,2,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
1145,1,Hodgkin's disease,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
1146,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1146,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1146,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1147,1,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1147,2,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1148,1,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
1148,2,Mass excision,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1149,1,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
1150,1,CSF glucose decreased,Cerebrospinal fluid tests (excl microbiology),"Neurological, special senses and psychiatric investigations",Inv,N
1150,2,CSF lymphocyte count abnormal,Cerebrospinal fluid tests (excl microbiology),"Neurological, special senses and psychiatric investigations",Inv,N
1150,3,CSF protein increased,Cerebrospinal fluid tests (excl microbiology),"Neurological, special senses and psychiatric investigations",Inv,N
1150,4,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1150,5,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1150,6,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1150,7,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1150,8,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1150,9,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
1150,10,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1150,11,Skull fracture,"Skull fractures, facial bone fractures and dislocations",Bone and joint injuries,Inj&P,N
1150,12,Transplant dysfunction,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1151,1,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1151,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1152,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1152,2,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1152,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1152,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1153,1,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1153,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1153,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1153,4,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1153,5,Tonsillar inflammation,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
1154,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1154,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1154,3,Epstein-Barr virus infection reactivation,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1154,4,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
1154,5,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
1154,6,Obstructive airways disorder,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1154,7,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1154,8,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,Y
1154,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1154,10,Sinus congestion,Paranasal sinus disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
1155,1,Organising pneumonia,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
1156,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1156,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1156,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1156,4,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1156,5,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1156,6,Eye inflammation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1156,7,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1156,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1156,9,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
1156,10,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1156,11,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1156,12,Vitreous disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
1156,13,Vitreous floaters,"Choroid and vitreous structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
1156,14,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1157,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1157,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1158,1,Beta haemolytic streptococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
1158,2,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
1158,3,Choroidal haemorrhage,Choroid and vitreous haemorrhages and vascular disorders,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
1158,4,Corneal transplant,Corneal and scleral therapeutic procedures,Eye therapeutic procedures,Surg,N
1158,5,Eye infection staphylococcal,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1158,6,Keratitis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1158,7,Pneumonia streptococcal,Streptococcal infections,Bacterial infectious disorders,Infec,N
1158,8,Stem cell transplant,Haematological therapeutic procedures NEC,Haematological and lymphoid tissue therapeutic procedures,Surg,N
1159,1,Corneal perforation,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
1159,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1159,3,Keratitis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1159,4,Moraxella infection,Moraxella infections,Bacterial infectious disorders,Infec,N
1159,5,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
1159,6,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1159,7,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1160,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1160,2,Eye infection staphylococcal,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1161,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1161,2,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
1162,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1163,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1163,2,Blood immunoglobulin G increased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
1163,3,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
1163,4,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,Y
1163,5,Chest X-ray abnormal,Respiratory tract and thoracic imaging procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
1163,6,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1163,7,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
1164,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1165,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1165,2,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1165,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1165,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1166,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1166,2,Epstein-Barr virus infection reactivation,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1166,3,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1166,4,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1166,5,Pulmonary hilum mass,Mediastinal disorders,Thoracic disorders (excl lung and pleura),Resp,N
1166,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1167,1,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
1167,2,Photopsia,Visual disorders NEC,Vision disorders,Eye,N
1168,1,Device related infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1169,1,Cystoscopy,Urinary tract imaging procedures,Renal and urinary tract investigations and urinalyses,Inv,N
1169,2,Urethral dilatation,Urethral disorders NEC,Urethral disorders (excl calculi),Renal,N
1170,1,Corneal perforation,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
1170,2,Eye infection bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1170,3,Keratitis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1171,1,Affective disorder,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
1171,2,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1171,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1171,4,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1172,1,Toxic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
1173,1,Acute lymphocytic leukaemia recurrent,Leukaemias acute lymphocytic,Leukaemias,Neopl,Y
1173,2,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1173,3,Epstein-Barr virus infection reactivation,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1174,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1174,2,Toxic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
1175,1,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1176,1,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1177,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1177,2,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
1178,1,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1178,2,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1178,3,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1178,4,Stem cell transplant,Haematological therapeutic procedures NEC,Haematological and lymphoid tissue therapeutic procedures,Surg,N
1179,1,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1179,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
1179,3,Epstein-Barr virus infection reactivation,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1180,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
1180,2,Toxic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
1181,1,Acute graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1181,2,Adenoviral hepatitis,Adenoviral infections,Viral infectious disorders,Infec,Y
1181,3,Evans syndrome,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
1182,1,Acute graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1182,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1183,1,Orthopaedic examination abnormal,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1184,1,Acne,Acnes,Skin appendage conditions,Skin,N
1184,2,Acute generalised exanthematous pustulosis,Pustular conditions,Epidermal and dermal conditions,Skin,N
1184,3,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1184,4,Gingival hypertrophy,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
1184,5,Inflammation,Inflammations,General system disorders NEC,Genrl,N
1184,6,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1184,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1185,1,Acne,Acnes,Skin appendage conditions,Skin,N
1185,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1185,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1185,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1186,1,Abdominal tenderness,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1186,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1186,3,Campylobacter infection,Campylobacter infections,Bacterial infectious disorders,Infec,N
1186,4,Complications of transplant surgery,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1186,5,Cytomegalovirus colitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1186,6,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1186,7,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1186,8,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1186,9,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1186,10,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1186,11,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
1186,12,Renal cyst,Renal neoplasms,Renal disorders (excl nephropathies),Renal,N
1186,13,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1186,14,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1187,1,Cerebral aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
1188,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
1189,1,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1189,2,Disturbance in social behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1190,1,Bladder transitional cell carcinoma,Bladder neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
1190,2,Kidney transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
1190,3,Polyomavirus-associated nephropathy,Polyomavirus infections,Viral infectious disorders,Infec,N
1190,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1191,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1192,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1193,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1194,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1195,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1196,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1197,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1198,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1199,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1200,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1201,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1202,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1203,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1204,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1205,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1206,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1207,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1208,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1209,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1210,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1211,1,Eosinophilic pustular folliculitis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1211,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1211,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1211,4,Urticaria papular,Urticarias,Angioedema and urticaria,Skin,N
1212,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1213,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1213,2,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
1213,3,Eosinophilic pustular folliculitis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1213,4,Mumps,Mumps viral infections,Viral infectious disorders,Infec,N
1213,5,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1213,6,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1214,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1214,2,End stage renal disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1214,3,Haemodialysis,Renal therapeutic procedures,Renal and urinary tract therapeutic procedures,Surg,N
1214,4,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1214,5,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,Y
1215,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,Y
1215,2,Antinuclear antibody positive,Autoimmunity analyses,Immunology and allergy investigations,Inv,N
1215,3,Aspiration bone marrow abnormal,Bone marrow and immune tissue histopathology procedures,Haematology investigations (incl blood groups),Inv,N
1215,4,Fibrosis,Fibrosis NEC,Tissue disorders NEC,Genrl,N
1215,5,Microangiopathy,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1215,6,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
1215,7,Myelofibrosis,Myeloproliferative disorders (excl leukaemias),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1215,8,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1215,9,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1215,10,Platelet count abnormal,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1215,11,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1215,12,Red blood cell abnormality,Red blood cell abnormal findings NEC,Red blood cell disorders,Blood,N
1215,13,Rheumatoid factor positive,Autoimmunity analyses,Immunology and allergy investigations,Inv,N
1215,14,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1216,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1217,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1218,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,Y
1218,2,Transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1219,1,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,Y
1219,2,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
1220,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1221,1,Bacterial disease carrier,Infectious disorders carrier,Ancillary infectious topics,Infec,N
1221,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1221,3,Blood lactate dehydrogenase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
1221,4,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1221,5,Peritonitis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1221,6,Red blood cell schistocytes present,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1221,7,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1221,8,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1222,1,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1223,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1224,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1225,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1225,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1226,1,Acute graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1226,2,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1226,3,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,Y
1227,1,Acute graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1227,2,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1227,3,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1227,4,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1228,1,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1228,2,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1229,1,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1229,2,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1229,3,Thyroiditis,Acute and chronic thyroiditis,Thyroid gland disorders,Endo,N
1230,1,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1230,2,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1230,3,Thyroiditis,Acute and chronic thyroiditis,Thyroid gland disorders,Endo,N
1231,1,Proctocolectomy,Large intestine therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
1232,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1232,2,Alopecia totalis,Alopecias,Skin appendage conditions,Skin,N
1232,3,Blood pressure fluctuation,Blood pressure disorders NEC,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1232,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1232,5,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1232,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1232,7,Self esteem decreased,Personality disorders NEC,Personality disorders and disturbances in behaviour,Psych,N
1233,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1233,2,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1234,1,Hyperaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1235,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1235,2,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1236,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1236,2,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1237,1,Endocarditis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1238,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1238,2,Epstein-Barr virus associated lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1238,3,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1239,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1240,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
1241,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
1241,2,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1242,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1242,2,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
1242,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1242,4,Myopathy,Myopathies,Muscle disorders,Musc,N
1242,5,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1242,6,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
1242,7,Ubiquinone decreased,Metabolism tests NEC,"Metabolic, nutritional and blood gas investigations",Inv,N
1243,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1243,2,Craniotomy,Skull and brain therapeutic procedures,"Nervous system, skull and spine therapeutic procedures",Surg,N
1243,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1243,4,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
1243,5,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
1243,6,Tuberculosis of central nervous system,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
1243,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1244,1,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
1244,2,Hair growth abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
1245,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1245,2,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1245,3,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
1245,4,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
1245,5,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1245,6,Headache,Headaches NEC,Headaches,Nerv,N
1245,7,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1245,8,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1245,9,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1245,10,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1246,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1246,2,Gastrointestinal tube insertion,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
1246,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1246,4,Transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1247,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
1247,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1248,1,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1248,2,Vulvitis,Female reproductive tract infections,Infections - pathogen unspecified,Infec,N
1249,1,Acute graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1249,2,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
1249,3,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
1249,4,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1249,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1249,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1250,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1250,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1250,3,Myopathy,Myopathies,Muscle disorders,Musc,N
1251,1,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1251,2,Beta haemolytic streptococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
1251,3,Body tinea,Tinea infections,Fungal infectious disorders,Infec,N
1251,4,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
1251,5,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
1251,6,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
1251,7,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1251,8,Malassezia infection,Tinea infections,Fungal infectious disorders,Infec,N
1251,9,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
1251,10,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1251,11,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1251,12,Trichophytosis,Tinea infections,Fungal infectious disorders,Infec,N
1251,13,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
1252,1,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,Y
1253,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1253,2,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1254,1,Acute graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1254,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
1255,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
1256,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
1257,1,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1257,2,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1257,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1257,4,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,Y
1258,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1259,1,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,Y
1260,1,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1261,1,Acute graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1261,2,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
1262,1,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1263,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
1263,2,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1264,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1265,1,Varicella zoster virus infection,Herpes viral infections,Viral infectious disorders,Infec,N
1266,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
1267,1,Cryptococcosis,Cryptococcal infections,Fungal infectious disorders,Infec,N
1268,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1268,2,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1269,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1269,2,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
1269,3,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1270,1,Acute graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1270,2,Candida pneumonia,Candida infections,Fungal infectious disorders,Infec,N
1270,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1270,4,Engraft failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1271,1,Acute graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1271,2,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
1271,3,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1271,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1272,1,Acute graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1272,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1272,3,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
1273,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
1273,2,Chronic graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1273,3,Cystitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
1273,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1273,5,Human polyomavirus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
1273,6,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1273,7,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1273,8,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
1273,9,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1273,10,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1273,11,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1274,1,Arterial haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,Y
1274,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1274,3,Scedosporium infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
1274,4,Systemic mycosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
1274,5,Tracheostomy malfunction,Respiratory tract and thoracic cavity procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1275,1,Chronic graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1275,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1275,3,Graft versus host disease in liver,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1275,4,Graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1276,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,Y
1276,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1276,3,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1277,1,Varicella zoster virus infection,Herpes viral infections,Viral infectious disorders,Infec,N
1278,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
1279,1,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1279,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
1280,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1280,2,Myopathy toxic,Myopathies,Muscle disorders,Musc,N
1280,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
1280,4,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
1281,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
1282,1,Blood lactate dehydrogenase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
1282,2,Catheter removal,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1282,3,Dialysis,Renal therapeutic procedures,Renal and urinary tract therapeutic procedures,Surg,N
1282,4,Enterococcal infection,Enterococcal infections,Bacterial infectious disorders,Infec,N
1282,5,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1282,6,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1282,7,Red blood cell schistocytes present,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1282,8,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1282,9,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1282,10,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1283,1,Acute graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1283,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1284,1,Acute graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1284,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1284,3,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
1285,1,Anti-thyroid antibody positive,Thyroid analyses,Endocrine investigations (incl sex hormones),Inv,N
1286,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
1287,1,Acute graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1287,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1288,1,Cytomegalovirus test,Virus identification and serology,Microbiology and serology investigations,Inv,N
1289,1,Acute graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1289,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1290,1,Chronic graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1290,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1291,1,Anti-thyroid antibody positive,Thyroid analyses,Endocrine investigations (incl sex hormones),Inv,N
1291,2,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
1292,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1292,2,Acute graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1292,3,Blood lactate dehydrogenase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
1292,4,Colectomy,Large intestine therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
1292,5,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1292,6,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1292,7,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1292,8,Intestinal anastomosis,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
1292,9,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
1292,10,Laparotomy,Abdominal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
1292,11,Mucosal ulceration,Mucosal findings abnormal,General system disorders NEC,Genrl,N
1292,12,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1292,13,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1292,14,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1292,15,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1293,1,Nephropathy,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1293,2,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1293,3,Nephrotic syndrome,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
1294,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1294,2,Acute lymphocytic leukaemia,Leukaemias acute lymphocytic,Leukaemias,Neopl,N
1294,3,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1294,4,Burkitt's lymphoma stage III,Burkitt's lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
1294,5,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1294,6,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1294,7,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1294,8,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1294,9,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1294,10,Vascular graft complication,Cardiac and vascular procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1295,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1296,1,Gingival disorder,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
1296,2,Gingival hypertrophy,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
1296,3,Tooth hypoplasia,Dental disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
1297,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1298,1,Cardiac pacemaker insertion,Cardiac device therapeutic procedures,Cardiac therapeutic procedures,Surg,N
1298,2,Nodal rhythm,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1298,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1298,4,Sinus bradycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1299,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
1299,2,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1299,3,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
1299,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1299,5,Dilated cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
1299,6,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1299,7,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1299,8,Epstein-Barr virus infection reactivation,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1299,9,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1299,10,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1299,11,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
1299,12,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
1299,13,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
1299,14,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
1299,15,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1299,16,Orthopnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1299,17,Parvovirus infection,Parvoviral infections,Viral infectious disorders,Infec,N
1299,18,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1299,19,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1299,20,Rhinitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1299,21,Serum ferritin increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1299,22,Sinus tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1299,23,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1299,24,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1299,25,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1300,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1300,2,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1300,3,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1300,4,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1300,5,Homicidal ideation,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1300,6,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1300,7,Personality change,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1300,8,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
1301,1,Eyelid ptosis,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
1301,2,Petit mal epilepsy,Absence seizures,Seizures (incl subtypes),Nerv,N
1302,1,Acute lymphocytic leukaemia,Leukaemias acute lymphocytic,Leukaemias,Neopl,N
1302,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1302,3,Burkitt's lymphoma stage III,Burkitt's lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
1302,4,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1302,5,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1302,6,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1303,1,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1303,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1303,3,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
1303,4,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1304,1,Acinetobacter infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1304,2,Biliary dilatation,Structural and other bile duct disorders,Bile duct disorders,Hepat,N
1304,3,Cholecystectomy,Biliary tract and gallbladder therapeutic procedures,Hepatobiliary therapeutic procedures,Surg,N
1304,4,Disseminated intravascular coagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1304,5,Escherichia sepsis,Escherichia infections,Bacterial infectious disorders,Infec,N
1304,6,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1304,7,Hepatic cyst,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
1304,8,Infected cyst,Infections NEC,Infections - pathogen unspecified,Infec,N
1304,9,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1304,10,Liver operation,Hepatic therapeutic procedures,Hepatobiliary therapeutic procedures,Surg,N
1304,11,Lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1304,12,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1304,13,Purulence,Infections NEC,Infections - pathogen unspecified,Infec,N
1304,14,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1304,15,Renal cyst,Renal neoplasms,Renal disorders (excl nephropathies),Renal,N
1304,16,Umbilical hernia repair,Hernia repairs,Gastrointestinal therapeutic procedures,Surg,N
1304,17,Wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1305,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1306,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1306,2,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,Y
1306,3,Perineal abscess,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
1306,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1307,1,Physical disability,Disability issues,Lifestyle issues,SocCi,N
1307,2,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1308,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
1308,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1308,3,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1309,1,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,Y
1310,1,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
1311,1,Eosinophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1311,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1311,3,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1311,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1311,5,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1311,6,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1311,7,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1312,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1312,2,Spinal cord abscess,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1312,3,Staphylococcal sepsis,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1313,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1313,2,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1313,3,Toxic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
1314,1,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1315,1,CSF glucose increased,Cerebrospinal fluid tests (excl microbiology),"Neurological, special senses and psychiatric investigations",Inv,N
1315,2,CSF protein increased,Cerebrospinal fluid tests (excl microbiology),"Neurological, special senses and psychiatric investigations",Inv,N
1315,3,Colour blindness,Ocular disorders congenital NEC,Eye disorders congenital,Cong,N
1315,4,Eye haemorrhage,Ocular bleeding and vascular disorders NEC,Ocular haemorrhages and vascular disorders NEC,Eye,N
1315,5,Intracranial pressure increased,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
1315,6,Optic neuropathy,Visual pathway disorders,Vision disorders,Eye,N
1315,7,Papilloedema,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
1315,8,Pleocytosis,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1315,9,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1315,10,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1315,11,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1315,12,Visual field defect,Visual field disorders,Vision disorders,Eye,N
1316,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
1317,1,Epstein-Barr virus associated lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1317,2,Hepatosplenomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
1317,3,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1317,4,Obstructive airways disorder,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1317,5,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1317,6,Pulmonary mass,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
1317,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1317,8,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1317,9,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1318,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1318,2,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1318,3,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1318,4,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1318,5,Toxic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
1319,1,Acute graft versus host disease in intestine,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1319,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1319,3,Gastroenteritis norovirus,Caliciviral infections,Viral infectious disorders,Infec,N
1319,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1319,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1319,6,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1320,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1320,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1320,3,Gastroenteritis norovirus,Caliciviral infections,Viral infectious disorders,Infec,N
1320,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1320,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1321,1,Acute graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1321,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1321,3,Gastroenteritis norovirus,Caliciviral infections,Viral infectious disorders,Infec,Y
1321,4,Malnutrition,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1321,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1321,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1322,1,Acute graft versus host disease in intestine,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1322,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1322,3,Gastroenteritis norovirus,Caliciviral infections,Viral infectious disorders,Infec,N
1322,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1322,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1323,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1323,2,Gastroenteritis norovirus,Caliciviral infections,Viral infectious disorders,Infec,N
1323,3,Graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1323,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1323,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1324,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1324,2,Gastroenteritis norovirus,Caliciviral infections,Viral infectious disorders,Infec,N
1324,3,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1325,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1325,2,Gastroenteritis norovirus,Caliciviral infections,Viral infectious disorders,Infec,N
1325,3,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1325,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1325,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1326,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1326,2,Gastroenteritis norovirus,Caliciviral infections,Viral infectious disorders,Infec,N
1326,3,Graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1326,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1326,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1327,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1327,2,Gastroenteritis norovirus,Caliciviral infections,Viral infectious disorders,Infec,N
1327,3,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1327,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1327,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1328,1,Haemodialysis,Renal therapeutic procedures,Renal and urinary tract therapeutic procedures,Surg,N
1328,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1329,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1329,2,Aneurysm ruptured,Aneurysms and dissections non-site specific,Aneurysms and artery dissections,Vasc,N
1329,3,Aortic aneurysm,Aortic aneurysms and dissections,Aneurysms and artery dissections,Vasc,N
1329,4,Arterial disorder,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,Y
1329,5,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1329,6,Colectomy,Large intestine therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
1329,7,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1329,8,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1329,9,Haemodynamic instability,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1329,10,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1329,11,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
1329,12,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1329,13,Lung transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
1329,14,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1329,15,Oedema mucosal,Mucosal findings abnormal,General system disorders NEC,Genrl,N
1329,16,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1329,17,Pulmonary hilum mass,Mediastinal disorders,Thoracic disorders (excl lung and pleura),Resp,N
1329,18,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1329,19,Splenic artery aneurysm,Gastrointestinal vascular malformations,Gastrointestinal vascular conditions,Gastr,N
1330,1,Epstein-Barr viraemia,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1331,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1331,2,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1332,1,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1333,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
1333,2,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1333,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1333,4,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1334,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1334,2,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1335,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1335,2,Headache,Headaches NEC,Headaches,Nerv,N
1335,3,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1336,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1336,2,Gastroenteritis norovirus,Caliciviral infections,Viral infectious disorders,Infec,N
1336,3,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1337,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1337,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1337,3,Abdominal tenderness,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1337,4,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1337,5,Biliary dilatation,Structural and other bile duct disorders,Bile duct disorders,Hepat,N
1337,6,Cardio-respiratory arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1337,7,Chronic allograft nephropathy,Transplant rejections,Immune disorders NEC,Immun,N
1337,8,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1337,9,Hodgkin's disease,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
1337,10,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1337,11,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
1337,12,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1337,13,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1337,14,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1337,15,Pancreatic carcinoma,Pancreatic neoplasms malignant (excl islet cell and carcinoid),Gastrointestinal neoplasms malignant and unspecified,Neopl,N
1337,16,Pancreatic mass,Pancreatic disorders NEC,Exocrine pancreas conditions,Gastr,N
1337,17,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,Y
1337,18,Pancreatitis haemorrhagic,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1337,19,Pancreatitis necrotising,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1337,20,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1337,21,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
1337,22,Resuscitation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1337,23,Retroperitoneal haemorrhage,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,N
1338,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1338,2,Cholangitis,Bile duct infections and inflammations,Bile duct disorders,Hepat,N
1338,3,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
1338,4,Cholelithotomy,Biliary tract and gallbladder therapeutic procedures,Hepatobiliary therapeutic procedures,Surg,N
1338,5,Hepatic cyst,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
1338,6,Pancreatic sphincterotomy,Pancreatic therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
1338,7,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1338,8,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1339,1,Complications of bone marrow transplant,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1339,2,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1340,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
1340,2,Complications of bone marrow transplant,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1340,3,Epstein-Barr viraemia,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1340,4,Viraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1341,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
1341,2,Complications of bone marrow transplant,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1341,3,Viraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1342,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
1342,2,Complications of bone marrow transplant,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1342,3,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1342,4,Viraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1343,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1343,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1343,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1344,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1344,2,Mechanical ventilation,Respiratory tract therapeutic procedures NEC,Respiratory tract therapeutic procedures,Surg,N
1344,3,Neonatal respiratory distress syndrome,Neonatal hypoxic conditions,Neonatal respiratory disorders,Resp,N
1344,4,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1344,5,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1344,6,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1345,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1345,2,Mechanical ventilation,Respiratory tract therapeutic procedures NEC,Respiratory tract therapeutic procedures,Surg,N
1345,3,Neonatal respiratory distress syndrome,Neonatal hypoxic conditions,Neonatal respiratory disorders,Resp,N
1345,4,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1345,5,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1345,6,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1346,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1346,2,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
1346,3,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1346,4,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
1346,5,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1347,1,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1348,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1348,2,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
1349,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1349,2,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
1349,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1350,1,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1350,2,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1351,1,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1351,2,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1352,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
1352,2,Hyperlipidaemia,Hyperlipidaemias NEC,Lipid metabolism disorders,Metab,N
1353,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
1353,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1354,1,Epstein-Barr virus associated lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1354,2,Graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1354,3,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
1354,4,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1354,5,Microangiopathy,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1354,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1354,7,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1355,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1355,2,Pneumonia adenoviral,Adenoviral infections,Viral infectious disorders,Infec,N
1355,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1356,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1356,2,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1356,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1356,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1357,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1357,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1357,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1358,1,Debridement,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1358,2,Neoplasm skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1358,3,Oesophageal squamous cell carcinoma,Oesophageal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
1358,4,Oesophagectomy,Oesophageal therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
1358,5,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1358,6,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1358,7,Skin lesion removal,Skin lesion excisions,Skin and subcutaneous tissue therapeutic procedures,Surg,N
1358,8,Sweat gland tumour,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
1358,9,Sweat gland tumour,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
1359,1,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1360,1,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1361,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1361,2,Haemorrhage in pregnancy,Haemorrhagic complications of pregnancy,Maternal complications of pregnancy,Preg,N
1361,3,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
1361,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1362,1,Cytoreductive surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1362,2,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1362,3,Skin papilloma,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
1363,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
1363,2,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
1364,1,Epstein-Barr virus infection reactivation,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1364,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1364,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1364,4,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1364,5,Tonsillitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1365,1,Immunosuppressant drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1366,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1367,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
1367,2,Cerebral aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
1367,3,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
1367,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1367,5,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
1367,6,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1367,7,Vitreous abscess,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
1367,8,Vitreous haemorrhage,Choroid and vitreous haemorrhages and vascular disorders,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
1368,1,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1368,2,Graft versus host disease in liver,Immune and associated conditions NEC,Immune disorders NEC,Immun,Y
1368,3,Graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1369,1,Myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
1370,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1371,1,Coma scale abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
1371,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1371,3,Endotracheal intubation,Tracheal therapeutic procedures,Respiratory tract therapeutic procedures,Surg,N
1371,4,Left ventricular failure,Left ventricular failures,Heart failures,Card,N
1372,1,Anaplastic large cell lymphoma T- and null-cell types,Anaplastic large cell lymphomas T- and null-cell types,Lymphomas non-Hodgkin's T-cell,Neopl,N
1372,2,Gingival disorder,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
1372,3,Lymphadenitis,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1372,4,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1372,5,Stem cell transplant,Haematological therapeutic procedures NEC,Haematological and lymphoid tissue therapeutic procedures,Surg,N
1373,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1373,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1373,3,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
1373,4,Generalised oedema,Oedema NEC,General system disorders NEC,Genrl,N
1373,5,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
1373,6,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1373,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1373,8,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1373,9,Serum ferritin increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1374,1,Ear infection bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1374,2,Haemophilus infection,Haemophilus infections,Bacterial infectious disorders,Infec,N
1374,3,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1374,4,Immunodeficiency common variable,Primary immunodeficiency syndromes,Immunodeficiency syndromes,Immun,N
1374,5,Immunoglobulin therapy,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1374,6,Lower respiratory tract infection bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1374,7,Sinusitis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1375,1,Accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1375,2,Bone graft,Bone therapeutic procedures NEC,Bone and joint therapeutic procedures,Surg,N
1375,3,Bone graft removal,Bone therapeutic procedures NEC,Bone and joint therapeutic procedures,Surg,N
1375,4,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
1375,5,Wound,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1376,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1377,1,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1377,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1378,1,Myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
1379,1,Arteriosclerosis coronary artery,Coronary artery disorders NEC,Coronary artery disorders,Card,N
1379,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1379,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1379,4,Stent placement,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1380,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
1380,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
1380,3,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
1381,1,Blood immunoglobulin A decreased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
1381,2,Blood immunoglobulin G decreased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
1381,3,Blood immunoglobulin M decreased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
1381,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1382,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1382,2,Hip arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
1382,3,Post procedural complication,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1382,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1383,1,Bone marrow transplant,Haematological therapeutic procedures NEC,Haematological and lymphoid tissue therapeutic procedures,Surg,N
1383,2,Drug level fluctuating,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1384,1,Tonsillar disorder,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
1385,1,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1385,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1386,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1386,2,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1386,3,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1386,4,Inflammatory bowel disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1386,5,Mucocutaneous ulceration,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
1386,6,Rectal ulcer,Anal and rectal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
1387,1,Anorectal ulcer,Anal and rectal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
1387,2,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1387,3,Mucocutaneous ulceration,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
1388,1,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1388,2,Mucocutaneous ulceration,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
1388,3,Oral disorder,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
1388,4,Tongue ulceration,Tongue disorders,Tongue conditions,Gastr,N
1389,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1389,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
1389,3,Oral administration complication,Administration site reactions NEC,Administration site reactions,Genrl,N
1390,1,Congenital hand malformation,Musculoskeletal and connective tissue disorders of limbs congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
1391,1,Gingival swelling,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
1391,2,Hair growth abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
1391,3,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1391,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1391,5,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1392,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1392,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1392,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1393,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1393,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1393,3,Intervertebral disc space narrowing,Intervertebral disc disorders NEC,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
1393,4,Intervertebral discitis,Bone and joint infections,Infections - pathogen unspecified,Infec,N
1393,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1393,6,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
1393,7,Osteomyelitis,Bone and joint infections,Infections - pathogen unspecified,Infec,N
1393,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1393,9,Spinal cord infection,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1393,10,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1393,11,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1393,12,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1394,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1394,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1394,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1395,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1396,1,Infertility male,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
1397,1,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
1398,1,Dilatation intrahepatic duct acquired,Structural and other bile duct disorders,Bile duct disorders,Hepat,N
1398,2,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1398,3,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
1399,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1400,1,Biliary fibrosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
1400,2,Chronic hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
1400,3,Hepatic lesion,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
1400,4,Hepatocellular carcinoma,Hepatic neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,Y
1400,5,Inflammation,Inflammations,General system disorders NEC,Genrl,N
1400,6,Liver transplant,Hepatic therapeutic procedures,Hepatobiliary therapeutic procedures,Surg,N
1400,7,Tumour invasion,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1401,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1402,1,Burkholderia cepacia complex sepsis,Burkholderia infections,Bacterial infectious disorders,Infec,Y
1403,1,Burkholderia cepacia complex sepsis,Burkholderia infections,Bacterial infectious disorders,Infec,Y
1404,1,Burkholderia cepacia complex sepsis,Burkholderia infections,Bacterial infectious disorders,Infec,Y
1405,1,Cytomegalovirus colitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1405,2,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1405,3,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
1405,4,Metastases to lymph nodes,Metastases to specified sites,Metastases,Neopl,Y
1405,5,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1406,1,Arthritis reactive,Spondyloarthropathies,Joint disorders,Musc,N
1406,2,Endocarditis,Cardiac infections,Infections - pathogen unspecified,Infec,N
1406,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1407,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1407,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1407,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1407,4,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1408,1,Gallbladder disorder,Gallbladder disorders NEC,Gallbladder disorders,Hepat,N
1409,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1409,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1410,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1411,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1412,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1412,2,Skin toxicity,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1413,1,Nasal cavity cancer,Paranasal sinus and nasal cavity neoplasms malignant and unspecified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
1414,1,Anti-neutrophil cytoplasmic antibody positive vasculitis,Vasculitides,Immune disorders NEC,Immun,N
1414,2,Antineutrophil cytoplasmic antibody increased,Autoimmunity analyses,Immunology and allergy investigations,Inv,N
1414,3,Complications of transplanted kidney,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1414,4,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1414,5,Kidney fibrosis,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
1414,6,Kidney transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
1414,7,Nephrectomy,Renal therapeutic procedures,Renal and urinary tract therapeutic procedures,Surg,N
1414,8,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1414,9,Renal transplant,Renal therapeutic procedures,Renal and urinary tract therapeutic procedures,Surg,N
1414,10,Renal tubular atrophy,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1415,1,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
1415,2,Granuloma,Inflammations,General system disorders NEC,Genrl,N
1415,3,Inflammation,Inflammations,General system disorders NEC,Genrl,N
1415,4,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1415,5,Nodule,Mass conditions NEC,Tissue disorders NEC,Genrl,N
1415,6,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1415,7,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1416,1,Biopsy,Histopathology procedures NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
1416,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1416,3,Conductive deafness,Hearing losses,Hearing disorders,Ear,N
1416,4,Diathermy,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1416,5,Ear tube insertion,Middle ear therapeutic procedures,Head and neck therapeutic procedures,Surg,N
1416,6,Effusion,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1416,7,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1416,8,Lung consolidation,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1416,9,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1416,10,Lymphocyte count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1416,11,Lymphocyte morphology abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1416,12,Lymphoid tissue hyperplasia,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1416,13,Lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1416,14,Nasal cavity mass,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1416,15,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
1416,16,Nasal obstruction,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1416,17,Otitis media,Ear infections,Infections - pathogen unspecified,Infec,N
1416,18,Pharyngeal mass,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
1416,19,Plasma cells increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1416,20,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1416,21,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1417,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
1418,1,Abdominal tenderness,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1418,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1418,3,Cytomegalovirus colitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1418,4,Cytomegalovirus test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
1418,5,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1418,6,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1418,7,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1418,8,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1418,9,Inflammation,Inflammations,General system disorders NEC,Genrl,N
1418,10,Kidney transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
1418,11,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1418,12,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
1418,13,Polycystic liver disease,Hepatobiliary abnormalities congenital,Hepatobiliary disorders congenital,Cong,N
1418,14,Renal cyst,Renal neoplasms,Renal disorders (excl nephropathies),Renal,N
1418,15,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1418,16,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
1418,17,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1419,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
1419,2,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1420,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1421,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1422,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1422,2,Blood pressure systolic increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1422,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1422,4,Headache,Headaches NEC,Headaches,Nerv,N
1422,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1423,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1423,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1423,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1423,4,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1423,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1424,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1424,2,Foetal growth restriction,Foetal growth complications,Foetal complications,Preg,N
1425,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1425,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1426,1,Albinism,Inborn errors of amino acid metabolism,Metabolic and nutritional disorders congenital,Cong,N
1426,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1426,3,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1426,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1426,5,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1426,6,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1427,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1427,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1427,3,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
1428,1,Abdominal tenderness,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1428,2,Aortic dissection,Aortic aneurysms and dissections,Aneurysms and artery dissections,Vasc,N
1428,3,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1428,4,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1428,5,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1428,6,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1429,1,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1429,2,Escherichia infection,Escherichia infections,Bacterial infectious disorders,Infec,N
1429,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1429,4,Pseudomonas test positive,Bacteria identification and serology (excl mycobacteria),Microbiology and serology investigations,Inv,N
1430,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1430,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1430,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1430,4,Granuloma,Inflammations,General system disorders NEC,Genrl,N
1430,5,Mycobacterium marinum infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
1430,6,Nodule,Mass conditions NEC,Tissue disorders NEC,Genrl,N
1430,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1430,8,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1430,9,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1431,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1431,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1432,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1433,1,Acute psychosis,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1433,2,Blood magnesium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1433,3,Delirium,Deliria,Deliria (incl confusion),Psych,N
1433,4,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1433,5,Renal cancer,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
1434,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1434,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1434,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
1434,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1435,1,Hidradenitis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1435,2,Pancreatic cyst,Cystic pancreatic disorders,Exocrine pancreas conditions,Gastr,N
1435,3,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1436,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1437,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
1438,1,Cardiopulmonary failure,Heart failures NEC,Heart failures,Card,N
1438,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1438,3,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
1439,1,Arterial thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
1440,1,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,Y
1440,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1441,1,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1441,2,Extranodal marginal zone B-cell lymphoma (MALT type),Extranodal marginal zone B-cell lymphomas (low grade B-cell),Lymphomas non-Hodgkin's B-cell,Neopl,N
1442,1,Extranodal marginal zone B-cell lymphoma (MALT type),Extranodal marginal zone B-cell lymphomas (low grade B-cell),Lymphomas non-Hodgkin's B-cell,Neopl,N
1442,2,Soft tissue mass,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1443,1,Hepatosplenomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
1443,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1443,3,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1444,1,Paternal exposure timing unspecified,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1445,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
1445,2,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1446,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
1446,2,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1447,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
1447,2,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1448,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
1448,2,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1449,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
1449,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1450,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1451,1,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
1452,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1452,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1453,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
1453,2,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,Y
1453,3,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1453,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1453,5,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
1453,6,Haemodynamic instability,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1453,7,Hepatic necrosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1453,8,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1453,9,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1453,10,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
1453,11,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1453,12,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1454,1,Gastrointestinal perforation,"Gastrointestinal ulcers and perforation, site unspecified",Gastrointestinal ulceration and perforation,Gastr,N
1454,2,Post procedural complication,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1455,1,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1455,2,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1456,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1457,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1458,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1458,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1458,3,Blood calcium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1458,4,Blood calcium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1458,5,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
1458,6,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
1458,7,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1458,8,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1458,9,Guillain-Barre syndrome,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
1458,10,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1458,11,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
1458,12,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1458,13,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1458,14,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1458,15,Paraparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1458,16,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1459,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1459,2,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1459,3,Infectious mononucleosis,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1459,4,Infertility,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
1459,5,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1459,6,Nasal septum disorder,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1459,7,Otitis media,Ear infections,Infections - pathogen unspecified,Infec,N
1459,8,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1460,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1460,2,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1460,3,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1460,4,Hirsutism,Hypertrichoses,Skin appendage conditions,Skin,N
1460,5,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
1460,6,Infertility,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
1460,7,Laryngeal stenosis,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
1460,8,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1460,9,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
1460,10,Paronychia,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1460,11,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1461,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1461,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1462,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
1462,2,Bronchostenosis,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1462,3,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
1462,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1462,5,Nasal septum disorder,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1462,6,Oesophageal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
1462,7,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1463,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1463,2,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
1464,1,Alpha haemolytic streptococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
1464,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1464,3,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
1464,4,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1464,5,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1464,6,Cholangiocarcinoma,Bile duct neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,Y
1464,7,Cholangitis,Bile duct infections and inflammations,Bile duct disorders,Hepat,N
1464,8,Cholangitis sclerosing,Bile duct infections and inflammations,Bile duct disorders,Hepat,N
1464,9,Cholestasis,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1464,10,Dilatation intrahepatic duct acquired,Structural and other bile duct disorders,Bile duct disorders,Hepat,N
1464,11,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1464,12,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1464,13,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1464,14,Hepatic fibrosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
1464,15,Hepatic mass,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
1464,16,Hepatic mass,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
1464,17,Metastases to bone,Metastases to specified sites,Metastases,Neopl,N
1464,18,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
1464,19,Portal hypertension,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
1464,20,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1464,21,Transplant abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
1465,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
1465,2,Adenoviral hepatitis,Adenoviral infections,Viral infectious disorders,Infec,N
1466,1,Fungal skin infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
1466,2,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
1466,3,Infertility,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
1466,4,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
1466,5,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1466,6,Vulvovaginal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
1467,1,Antibody test positive,Immunology analyses NEC,Immunology and allergy investigations,Inv,N
1467,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1467,3,Liver transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
1468,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1468,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1468,3,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1468,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1468,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1468,6,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
1468,7,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1468,8,Pustule,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1468,9,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1469,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1470,1,Anal incontinence,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1470,2,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1470,3,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1470,4,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1470,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1470,6,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1470,7,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1470,8,Pseudomonal sepsis,Pseudomonal infections,Bacterial infectious disorders,Infec,N
1470,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1470,10,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1470,11,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1471,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
1471,2,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
1472,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1472,2,Fungal skin infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
1472,3,Granulomatosis with polyangiitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
1472,4,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
1472,5,Infertility,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
1472,6,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
1472,7,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1472,8,Vulvovaginal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
1473,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1474,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1474,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1474,3,Transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1475,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1476,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1476,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1476,3,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
1476,4,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1477,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1478,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1479,1,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
1479,2,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1479,3,Parainfluenzae virus infection,Parainfluenzae viral infections,Viral infectious disorders,Infec,N
1479,4,Upper respiratory tract infection bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1480,1,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1480,2,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1480,3,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1480,4,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1480,5,Parainfluenzae virus infection,Parainfluenzae viral infections,Viral infectious disorders,Infec,N
1481,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1482,1,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1482,2,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1482,3,Parainfluenzae virus infection,Parainfluenzae viral infections,Viral infectious disorders,Infec,N
1482,4,Stenotrophomonas infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1483,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
1483,2,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1483,3,Klebsiella infection,Klebsiella infections,Bacterial infectious disorders,Infec,N
1483,4,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1483,5,Parainfluenzae virus infection,Parainfluenzae viral infections,Viral infectious disorders,Infec,N
1483,6,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
1484,1,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1484,2,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1484,3,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1484,4,Parainfluenzae virus infection,Parainfluenzae viral infections,Viral infectious disorders,Infec,N
1485,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1485,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1486,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1486,2,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1487,1,Bile acid malabsorption,Malabsorption syndromes,Malabsorption conditions,Gastr,N
1487,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1487,3,Gastrointestinal ulcer,"Gastrointestinal ulcers and perforation, site unspecified",Gastrointestinal ulceration and perforation,Gastr,N
1487,4,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
1488,1,Acute myeloid leukaemia recurrent,Leukaemias acute myeloid,Leukaemias,Neopl,Y
1488,2,Bile acid malabsorption,Malabsorption syndromes,Malabsorption conditions,Gastr,N
1488,3,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1488,4,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1489,1,Acute myeloid leukaemia recurrent,Leukaemias acute myeloid,Leukaemias,Neopl,Y
1489,2,Bile acid malabsorption,Malabsorption syndromes,Malabsorption conditions,Gastr,N
1489,3,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1489,4,Gastrointestinal necrosis,Gastrointestinal necrosis and gangrene (excl gangrenous hernia),Gastrointestinal vascular conditions,Gastr,N
1489,5,Graft versus host disease in gastrointestinal tract,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1490,1,Bile acid malabsorption,Malabsorption syndromes,Malabsorption conditions,Gastr,N
1490,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
1490,3,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
1490,4,Intestinal polyp,Benign neoplasms gastrointestinal (excl oral cavity),Benign neoplasms gastrointestinal,Gastr,N
1491,1,Bile acid malabsorption,Malabsorption syndromes,Malabsorption conditions,Gastr,N
1491,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1491,3,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1491,4,Gastrointestinal inflammation,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
1492,1,Bile acid malabsorption,Malabsorption syndromes,Malabsorption conditions,Gastr,N
1492,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1492,3,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1492,4,Gastrointestinal ulcer,"Gastrointestinal ulcers and perforation, site unspecified",Gastrointestinal ulceration and perforation,Gastr,N
1492,5,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
1493,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1493,2,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
1493,3,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1493,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1493,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1494,1,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
1495,1,Blood albumin decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1495,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1495,3,Blood uric acid increased,Metabolism tests NEC,"Metabolic, nutritional and blood gas investigations",Inv,N
1495,4,Immunosuppressant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1495,5,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1496,1,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1497,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1498,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1498,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1498,3,Hypertrichosis,Hypertrichoses,Skin appendage conditions,Skin,N
1498,4,Idiopathic urticaria,Urticarias,Angioedema and urticaria,Skin,N
1498,5,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1498,6,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1499,1,Anal ulcer,Anal and rectal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
1499,2,Anorectal disorder,Anal and rectal disorders NEC,Anal and rectal conditions NEC,Gastr,N
1499,3,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1499,4,Genital herpes,Herpes viral infections,Viral infectious disorders,Infec,N
1499,5,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1499,6,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
1499,7,Proctalgia,Anal and rectal pains,Anal and rectal conditions NEC,Gastr,N
1499,8,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1499,9,Vulval disorder,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
1500,1,Acute graft versus host disease in intestine,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1500,2,Clostridial infection,Clostridia infections,Bacterial infectious disorders,Infec,N
1500,3,Intracranial pressure increased,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
1500,4,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1500,5,Staphylococcal bacteraemia,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1501,1,Acute graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1501,2,Cytomegalovirus colitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1501,3,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1502,1,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
1502,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1502,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1503,1,Eczema herpeticum,Herpes viral infections,Viral infectious disorders,Infec,N
1504,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1504,2,Venous thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
1505,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1505,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1505,3,Nosocomial infection,Infectious transmissions,Ancillary infectious topics,Infec,N
1505,4,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1506,1,Liver transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
1507,1,Blood stem cell transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1508,1,Oral administration complication,Administration site reactions NEC,Administration site reactions,Genrl,N
1509,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
1509,2,Central obesity,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1509,3,Headache,Headaches NEC,Headaches,Nerv,N
1509,4,Meningeal disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1509,5,Sarcoidosis,Acute and chronic sarcoidosis,Immune disorders NEC,Immun,N
1510,1,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1510,2,Pustular psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1510,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1511,1,Nocturia,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
1511,2,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1512,1,Lung adenocarcinoma,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,Y
1512,2,Papilloma viral infection,Papilloma viral infections,Viral infectious disorders,Infec,N
1512,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1512,4,Skin papilloma,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
1513,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1514,1,Complications of transplanted kidney,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1514,2,Kidney transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
1515,1,Bowen's disease,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1515,2,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1515,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1515,4,Nail growth abnormal,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
1515,5,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1515,6,Papilloma viral infection,Papilloma viral infections,Viral infectious disorders,Infec,N
1515,7,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1515,8,Skin papilloma,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
1515,9,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1516,1,Carotid artery stenosis,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,N
1516,2,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
1517,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1517,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1517,3,Granuloma skin,Granulomatous and deep cutaneous inflammatory conditions,Epidermal and dermal conditions,Skin,N
1517,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1517,5,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1517,6,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1517,7,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1518,1,Lung adenocarcinoma,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
1518,2,Metastasis,Metastases to unknown and unspecified sites,Metastases,Neopl,Y
1518,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1518,4,Skin papilloma,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
1519,1,Cutaneous amyloidosis,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
1520,1,Bowen's disease,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1520,2,Nail growth abnormal,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
1520,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1520,4,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1520,5,Skin papilloma,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
1520,6,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1521,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1521,2,Helicobacter infection,Helicobacter infections,Bacterial infectious disorders,Infec,N
1521,3,Pharyngeal haemorrhage,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
1522,1,Tongue neoplasm malignant stage unspecified,Lip and oral cavity neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,Y
1523,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1523,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
1524,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
1524,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
1524,3,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1524,4,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1525,1,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
1525,2,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1525,3,Klebsiella infection,Klebsiella infections,Bacterial infectious disorders,Infec,N
1526,1,Oesophageal carcinoma,Oesophageal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
1527,1,Oral administration complication,Administration site reactions NEC,Administration site reactions,Genrl,N
1528,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
1528,2,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1529,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
1529,2,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1529,3,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1530,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
1530,2,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1530,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1530,4,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1531,1,Graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1531,2,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
1532,1,Bronchitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
1532,2,Graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1532,3,Microangiopathy,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1532,4,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1533,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
1533,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1533,3,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1533,4,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1533,5,Rhinitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1534,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
1534,2,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1534,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1534,4,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1535,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
1535,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1535,3,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1535,4,Graft versus host disease in gastrointestinal tract,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1536,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
1536,2,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1537,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
1537,2,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1537,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1537,4,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1537,5,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1538,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
1538,2,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1538,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1538,4,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1538,5,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1539,1,Bronchitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
1539,2,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1540,1,Graft versus host disease in gastrointestinal tract,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1540,2,Graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1540,3,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1541,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
1541,2,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1542,1,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1542,2,Bronchitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
1542,3,Graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1543,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
1543,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1543,3,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1543,4,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1544,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
1544,2,BK virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
1544,3,Chronic graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1544,4,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1545,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
1545,2,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1546,1,Oral administration complication,Administration site reactions NEC,Administration site reactions,Genrl,N
1547,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1547,2,Blast cell proliferation,Myeloproliferative disorders (excl leukaemias),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1547,3,Delayed puberty,Endocrine abnormalities of puberty,Endocrine disorders of gonadal function,Endo,N
1547,4,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1547,5,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1548,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
1548,2,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1548,3,Concomitant disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1548,4,Delayed puberty,Endocrine abnormalities of puberty,Endocrine disorders of gonadal function,Endo,N
1548,5,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1548,6,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1548,7,Porphyria acute,Inborn errors of porphyrin metabolism,Metabolic and nutritional disorders congenital,Cong,N
1548,8,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1548,9,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1548,10,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1549,1,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1549,2,Delayed engraftment,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1549,3,Graft versus host disease in gastrointestinal tract,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1549,4,Graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1549,5,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1549,6,Hypertrichosis,Hypertrichoses,Skin appendage conditions,Skin,N
1549,7,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
1549,8,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1550,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1550,2,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
1550,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1551,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
1551,2,Autism spectrum disorder,Pervasive developmental disorders NEC,Developmental disorders NEC,Psych,N
1551,3,Bronchiolitis,Viral infections NEC,Viral infectious disorders,Infec,N
1551,4,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1551,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1551,6,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1551,7,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1551,8,Graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1551,9,Hepatosplenomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
1551,10,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1551,11,Learning disorder,Learning disorders,Cognitive and attention disorders and disturbances,Psych,N
1551,12,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
1551,13,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1551,14,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
1551,15,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1552,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1552,2,Acute graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1552,3,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1552,4,Blood pressure abnormal,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1552,5,Chronic graft versus host disease in intestine,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1552,6,Chronic graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1552,7,Cystitis haemorrhagic,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
1552,8,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1552,9,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1552,10,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1552,11,Graft versus host disease in gastrointestinal tract,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1552,12,Joint contracture,Joint related disorders NEC,Joint disorders,Musc,N
1552,13,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
1552,14,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
1552,15,Oesophageal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
1552,16,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1552,17,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1552,18,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1552,19,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1552,20,Skin hypopigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
1552,21,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1553,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1553,2,Immunosuppressant drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1553,3,Infective tenosynovitis,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
1553,4,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
1553,5,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1553,6,Mycobacterium kansasii infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
1553,7,Tendon rupture,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
1553,8,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1554,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1554,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1555,1,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1555,2,Microangiopathic haemolytic anaemia,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
1556,1,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1557,1,Neuroendocrine carcinoma of the skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,Y
1558,1,Neoplasm skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,Y
1559,1,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1560,1,Neuroendocrine carcinoma of the skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1561,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
1561,2,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1562,1,Vulvovaginal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
1563,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1563,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1564,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1564,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1564,3,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
1564,4,Osteoarthritis,Osteoarthropathies,Joint disorders,Musc,N
1564,5,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
1565,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1565,2,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,Y
1565,3,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1565,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1565,5,Serum ferritin increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1566,1,Portal hypertension,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
1567,1,Benign neoplasm of conjunctiva,Ocular neoplasms benign,Ocular neoplasms,Neopl,N
1567,2,Ocular surface squamous neoplasia,Ocular neoplasms malignancy unspecified,Ocular neoplasms,Neopl,N
1567,3,Papilloma conjunctival,Ocular neoplasms benign,Ocular neoplasms,Neopl,N
1568,1,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1568,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1568,3,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1568,4,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
1569,1,Graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1569,2,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,Y
1569,3,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1569,4,Right ventricular systolic pressure increased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1570,1,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1571,1,Acute graft versus host disease in intestine,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1571,2,Acute graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1571,3,Pulmonary arterial hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,Y
1571,4,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1571,5,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1571,6,Respiratory syncytial virus infection,Respiratory syncytial viral infections,Viral infectious disorders,Infec,N
1572,1,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1572,2,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1573,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1573,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1573,3,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1574,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1574,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1574,3,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1575,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1575,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1575,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1576,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1576,2,Neonatal respiratory distress syndrome,Neonatal hypoxic conditions,Neonatal respiratory disorders,Resp,N
1576,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1577,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1577,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1578,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1578,2,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
1578,3,Oral administration complication,Administration site reactions NEC,Administration site reactions,Genrl,N
1579,1,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
1580,1,Left ventricular failure,Left ventricular failures,Heart failures,Card,N
1580,2,Pneumonia aspiration,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
1580,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1581,1,Anal ulcer,Anal and rectal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
1581,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1581,3,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1581,4,Genital herpes,Herpes viral infections,Viral infectious disorders,Infec,N
1581,5,Genital ulceration,Reproductive tract disorders NEC (excl neoplasms),Reproductive tract disorders NEC,Repro,N
1581,6,Graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1581,7,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1581,8,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1581,9,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1582,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1582,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1582,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1582,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1583,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1583,2,Thrombotic thrombocytopenic purpura,Thrombocytopenias,Platelet disorders,Blood,N
1584,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1585,1,Liver transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
1585,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1586,1,Gingival hypertrophy,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
1586,2,Hair growth abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
1586,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1587,1,Blood cholesterol decreased,Cholesterol analyses,Lipid analyses,Inv,N
1588,1,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1588,2,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
1588,3,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1588,4,Polycythaemia,Polycythaemia (excl rubra vera),Red blood cell disorders,Blood,N
1588,5,Soft tissue infection,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
1588,6,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1589,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1589,2,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1590,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1591,1,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
1592,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
1592,2,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
1592,3,Hepatic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
1592,4,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1592,5,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1592,6,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1593,1,Demyelinating polyneuropathy,Chronic polyneuropathies,Peripheral neuropathies,Nerv,N
1593,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1594,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1594,2,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1594,3,Heart transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
1594,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1594,5,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1595,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1595,2,Oral administration complication,Administration site reactions NEC,Administration site reactions,Genrl,N
1596,1,Capillary leak syndrome,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1596,2,Cardiovascular disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1596,3,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1596,4,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1596,5,Hepatosplenomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
1596,6,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1596,7,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1596,8,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1596,9,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
1596,10,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1596,11,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1596,12,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1597,1,Behcet's syndrome,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
1597,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1597,3,Intracranial pressure increased,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
1598,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1598,2,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1598,3,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1599,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1600,1,Angiopathy,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1600,2,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1600,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1600,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1600,5,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1600,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1600,7,Skin erosion,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
1600,8,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1601,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1601,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1601,3,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1601,4,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1601,5,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1602,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1602,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1603,1,Ear discomfort,Ear disorders NEC,Aural disorders NEC,Ear,N
1603,2,Genital burning sensation,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
1603,3,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1604,1,Pharyngeal ulceration,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
1604,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1604,3,Pyoderma gangrenosum,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
1604,4,Splenic lesion,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1605,1,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1605,2,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1606,1,Squamous cell carcinoma of the cervix,Cervix neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
1606,2,Vaginal discharge,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
1607,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1607,2,Type 2 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1608,1,Anogenital warts,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
1608,2,Atrophic vulvovaginitis,Menopausal effects on the genitourinary tract,Menopause related conditions,Repro,N
1608,3,Chronic graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1608,4,Coital bleeding,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
1608,5,Dyspareunia,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
1608,6,Papilloma viral infection,Papilloma viral infections,Viral infectious disorders,Infec,N
1608,7,Skin papilloma,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
1608,8,Uterine adhesions,Uterine disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
1608,9,Vaginal dysplasia,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
1609,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1610,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1610,2,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
1611,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1611,2,Graft versus host disease in gastrointestinal tract,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1611,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1612,1,CSF pressure increased,Cerebrospinal fluid tests (excl microbiology),"Neurological, special senses and psychiatric investigations",Inv,N
1612,2,Colour blindness,Ocular disorders congenital NEC,Eye disorders congenital,Cong,N
1612,3,Intracranial pressure increased,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
1612,4,Papilloedema,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
1612,5,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1612,6,Visual field defect,Visual field disorders,Vision disorders,Eye,N
1612,7,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1613,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1613,2,Graft versus host disease in gastrointestinal tract,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1613,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1614,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1614,2,Graft versus host disease in gastrointestinal tract,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1614,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1615,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1616,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1617,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1618,1,Full blood count abnormal,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
1618,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1618,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1619,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1619,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1619,3,Blood lactate dehydrogenase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
1619,4,Complications of transplanted kidney,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1619,5,Escherichia infection,Escherichia infections,Bacterial infectious disorders,Infec,N
1619,6,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
1619,7,Klebsiella infection,Klebsiella infections,Bacterial infectious disorders,Infec,N
1619,8,Nephrocalcinosis,Renal lithiasis,Urolithiases,Renal,N
1619,9,Red blood cell schistocytes present,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1619,10,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
1619,11,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1619,12,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1619,13,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
1619,14,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1620,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1621,1,Complications of transplanted kidney,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1621,2,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
1621,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1621,4,Polyomavirus test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
1621,5,Renal transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1621,6,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1622,1,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1623,1,Aplasia pure red cell,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1623,2,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1623,3,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
1623,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1623,5,Epstein-Barr virus infection reactivation,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1623,6,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
1623,7,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1623,8,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1623,9,Hypertrichosis,Hypertrichoses,Skin appendage conditions,Skin,N
1623,10,Mucosal erosion,Mucosal findings abnormal,General system disorders NEC,Genrl,N
1623,11,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1623,12,Skin erosion,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
1623,13,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
1624,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1625,1,Methaemoglobinaemia,Haematological disorders,Haematological disorders NEC,Blood,N
1625,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1626,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1627,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
1627,2,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1627,3,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1627,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1627,5,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1627,6,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1628,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1628,2,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1628,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1629,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1629,2,Foetal growth restriction,Foetal growth complications,Foetal complications,Preg,N
1629,3,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
1630,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1630,2,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1631,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1631,2,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1631,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1632,1,Colorectal cancer,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
1632,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1633,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1633,2,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1634,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1634,2,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1635,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1635,2,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,N
1635,3,Foetal growth restriction,Foetal growth complications,Foetal complications,Preg,N
1635,4,Placental disorder,Placental abnormalities (excl neoplasms),"Placental, amniotic and cavity disorders (excl haemorrhages)",Preg,N
1635,5,Vasoconstriction,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1636,1,CD4 lymphocytes increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1636,2,Foetal exposure during delivery,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1636,3,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1636,4,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1636,5,T-lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1637,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1637,2,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1637,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1638,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1638,2,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
1638,3,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1638,4,Complications of transplanted liver,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1638,5,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1638,6,Liver transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
1638,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1638,8,Transaminases abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1638,9,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
1639,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1639,2,T-lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1640,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1640,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1640,3,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1640,4,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1641,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1641,2,Creatinine renal clearance decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1641,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1641,4,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1641,5,Foetal distress syndrome,Foetal complications NEC,Foetal complications,Preg,N
1641,6,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1641,7,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
1641,8,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1642,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1642,2,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1642,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1643,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1643,2,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1643,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1644,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
1644,2,Chronic spontaneous urticaria,Urticarias,Angioedema and urticaria,Skin,N
1644,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1644,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1644,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1644,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1645,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1645,2,Foetal growth restriction,Foetal growth complications,Foetal complications,Preg,N
1645,3,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1645,4,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1646,1,Neoplasm,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1647,1,Acute graft versus host disease in liver,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1647,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1647,3,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1647,4,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1647,5,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1647,6,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1647,7,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1647,8,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1647,9,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1647,10,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
1647,11,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1647,12,Peripheral T-cell lymphoma unspecified recurrent,Peripheral T-cell lymphomas NEC,Lymphomas non-Hodgkin's T-cell,Neopl,N
1647,13,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1647,14,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1647,15,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1648,1,Areflexia,Abnormal reflexes,Neurological disorders NEC,Nerv,N
1648,2,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1648,3,Brachial plexopathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1648,4,Demyelinating polyneuropathy,Chronic polyneuropathies,Peripheral neuropathies,Nerv,N
1648,5,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1648,6,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1648,7,Hypokinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1648,8,Hypotonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
1648,9,Median nerve injury,Peripheral nerve injuries,Injuries NEC,Inj&P,N
1648,10,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1648,11,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1648,12,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1648,13,Neurological decompensation,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1648,14,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1648,15,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1649,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1649,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1649,3,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1649,4,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1649,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1649,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1650,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1651,1,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
1652,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1653,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1654,1,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1654,2,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1654,3,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
1655,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
1655,2,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1655,3,Capillary leak syndrome,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1655,4,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1655,5,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1655,6,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1655,7,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1655,8,Fibrosis,Fibrosis NEC,Tissue disorders NEC,Genrl,N
1655,9,Leukaemia recurrent,Leukaemias NEC,Leukaemias,Neopl,N
1655,10,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1655,11,Mediastinitis,Infections NEC,Infections - pathogen unspecified,Infec,N
1655,12,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1655,13,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1655,14,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1655,15,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1656,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
1656,2,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
1657,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1657,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1657,3,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
1657,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1657,5,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1657,6,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1657,7,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1657,8,Wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1658,1,Blood uric acid increased,Metabolism tests NEC,"Metabolic, nutritional and blood gas investigations",Inv,N
1658,2,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
1659,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1659,2,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1660,1,Chronic spontaneous urticaria,Urticarias,Angioedema and urticaria,Skin,N
1660,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1661,1,Aplasia pure red cell,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1661,2,Epstein-Barr virus infection reactivation,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1661,3,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
1661,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1661,5,Hypertrichosis,Hypertrichoses,Skin appendage conditions,Skin,N
1662,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1662,2,Graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1662,3,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1662,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1663,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
1664,1,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
1664,2,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
1664,3,Microangiopathic haemolytic anaemia,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
1664,4,Red cell fragmentation syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
1664,5,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1664,6,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1664,7,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1665,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1665,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1665,3,Immunosuppressant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1665,4,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1665,5,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1666,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1667,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1668,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1669,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1670,1,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1671,1,Headache,Headaches NEC,Headaches,Nerv,N
1672,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1672,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1672,3,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
1672,4,Suicidal behaviour,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1672,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1673,1,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
1674,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
1674,2,Chronic spontaneous urticaria,Urticarias,Angioedema and urticaria,Skin,N
1674,3,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1674,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1674,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1674,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1674,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1674,8,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
1675,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1675,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1675,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1675,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1676,1,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
1677,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1678,1,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
1678,2,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1679,1,Benign ovarian tumour,Ovarian neoplasms benign,Reproductive neoplasms female benign,Neopl,N
1680,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1681,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1682,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1682,2,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1682,3,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1683,1,Engraft failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1683,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1683,3,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1683,4,Transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1684,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1684,2,Guillain-Barre syndrome,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
1684,3,Platelet engraftment failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1684,4,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1684,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1684,6,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1684,7,Transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1685,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1685,2,Engraft failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1685,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1685,4,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1686,1,Acute graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1686,2,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1686,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1686,4,Normal newborn,Normal newborn status,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
1686,5,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1687,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1688,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1688,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1689,1,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1690,1,Acute graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1690,2,Grip strength decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1690,3,Hypokinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1690,4,Scleroderma,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
1691,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1692,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1693,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1693,2,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1693,3,Diarrhoea haemorrhagic,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1693,4,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
1693,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1694,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1694,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1695,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1695,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1695,3,Escherichia sepsis,Escherichia infections,Bacterial infectious disorders,Infec,Y
1695,4,Feeding disorder,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1695,5,Mucormycosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
1695,6,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1695,7,Oral disorder,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
1695,8,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
1695,9,Tongue necrosis,Tongue disorders,Tongue conditions,Gastr,N
1695,10,Tongue oedema,Tongue signs and symptoms,Tongue conditions,Gastr,N
1696,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1697,1,Aneurysm,Aneurysms and dissections non-site specific,Aneurysms and artery dissections,Vasc,N
1697,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1697,3,Femoral artery aneurysm,Peripheral aneurysms and dissections,Aneurysms and artery dissections,Vasc,N
1697,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1697,5,Peripheral artery aneurysm,Peripheral aneurysms and dissections,Aneurysms and artery dissections,Vasc,N
1697,6,Peripheral ischaemia,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1697,7,Post procedural complication,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1697,8,Scleritis,"Scleral infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
1697,9,Vascular stent thrombosis,Vascular complications associated with device,Complications associated with device,Genrl,N
1698,1,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1699,1,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,Y
1700,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1700,2,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1701,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1701,2,Malabsorption,Malabsorption syndromes,Malabsorption conditions,Gastr,N
1701,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1702,1,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
1703,1,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
1704,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1704,2,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
1704,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1705,1,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1705,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1705,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1706,1,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1706,2,Myopathy,Myopathies,Muscle disorders,Musc,N
1706,3,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1706,4,Visceral leishmaniasis,Leishmania infections,Protozoal infectious disorders,Infec,N
1706,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1707,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1708,1,Headache,Headaches NEC,Headaches,Nerv,N
1708,2,Idiopathic intracranial hypertension,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
1708,3,Papilloedema,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
1708,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1709,1,Transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1710,1,Blood stem cell transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1710,2,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,Y
1711,1,Blood stem cell transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1712,1,Blood stem cell transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1713,1,Blood stem cell transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1714,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1715,1,Leukaemia,Leukaemias NEC,Leukaemias,Neopl,N
1716,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1717,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
1717,2,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1717,3,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
1717,4,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,Y
1717,5,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1717,6,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1717,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1717,8,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1717,9,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
1717,10,Sapovirus test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
1718,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1718,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1718,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1718,4,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
1718,5,Respiratory tract congestion,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
1719,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1720,1,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1721,1,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1722,1,Myopathy,Myopathies,Muscle disorders,Musc,N
1723,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1723,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1723,3,Sjogren's syndrome,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
1724,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1725,1,Chronic spontaneous urticaria,Urticarias,Angioedema and urticaria,Skin,N
1725,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1725,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1725,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1726,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1726,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1727,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1728,1,Anal abscess,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1728,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1728,3,Keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
1729,1,Anal abscess,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1730,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1731,1,Gingival swelling,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
1731,2,Headache,Headaches NEC,Headaches,Nerv,N
1731,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1732,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1732,2,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1733,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1733,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1734,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1735,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1735,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1735,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1736,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1737,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1737,2,Pustular psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1737,3,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1738,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1739,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1740,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1740,2,Chronic graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1740,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1740,4,Haemangioma of skin,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
1740,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1740,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1740,7,Scleroderma,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
1740,8,Skin erosion,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
1740,9,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
1741,1,Fungal skin infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
1741,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
1741,3,Pigmentation disorder,Pigmentation changes NEC,Pigmentation disorders,Skin,N
1741,4,Pyoderma gangrenosum,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
1741,5,Renal transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1741,6,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1741,7,Skin plaque,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1742,1,Acute graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1742,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1742,3,Chronic graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1742,4,Joint range of motion decreased,Joint related signs and symptoms,Joint disorders,Musc,N
1742,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1742,6,Skin hypertrophy,Skin hyperplasias and hypertrophies,Cornification and dystrophic skin disorders,Skin,N
1742,7,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
1743,1,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
1744,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1745,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
1745,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1745,3,Pustular psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1745,4,Seizure cluster,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1746,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1746,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1746,3,Tunnel vision,Neurologic visual problems NEC,Neurological disorders of the eye,Nerv,N
1747,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1748,1,Chronic graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1748,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1749,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1749,2,Pneumonia cytomegaloviral,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1749,3,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1750,1,Acute graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1750,2,Blast crisis in myelogenous leukaemia,Leukaemias myeloid NEC,Leukaemias,Neopl,N
1750,3,Chronic graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1750,4,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1750,5,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1750,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1750,7,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
1751,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1751,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1751,3,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1752,1,Chronic graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1752,2,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1752,3,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1753,1,Acute graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1753,2,Chronic graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1753,3,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1753,4,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1754,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1754,2,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
1755,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1755,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1755,3,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1755,4,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
1756,1,Graves' disease,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
1757,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1758,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1759,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1760,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1761,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1762,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1762,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1763,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1763,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1763,3,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1763,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1763,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1763,6,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1763,7,Hepatorenal failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
1763,8,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1763,9,Myalgia,Muscle pains,Muscle disorders,Musc,N
1763,10,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1763,11,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1764,1,Malignant nervous system neoplasm,Nervous system neoplasms malignant NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
1765,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1766,1,Papilloma conjunctival,Ocular neoplasms benign,Ocular neoplasms,Neopl,N
1767,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1767,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1768,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1769,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1770,1,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1770,2,Hepatorenal failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
1770,3,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1771,1,Idiopathic intracranial hypertension,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
1772,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1772,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1773,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1774,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1775,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1775,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1775,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1776,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1776,2,Heart transplant rejection,Transplant rejections,Immune disorders NEC,Immun,Y
1776,3,Transplant dysfunction,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1776,4,Ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
1777,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1777,2,Heart transplant rejection,Transplant rejections,Immune disorders NEC,Immun,Y
1777,3,Ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
1778,1,Graft loss,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1778,2,Heart transplant rejection,Transplant rejections,Immune disorders NEC,Immun,Y
1779,1,Graft loss,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1779,2,Heart transplant rejection,Transplant rejections,Immune disorders NEC,Immun,Y
1780,1,Graft loss,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1780,2,Heart transplant rejection,Transplant rejections,Immune disorders NEC,Immun,Y
1781,1,Graft loss,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1781,2,Heart transplant rejection,Transplant rejections,Immune disorders NEC,Immun,Y
1782,1,Heart transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
1783,1,Graft loss,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1783,2,Heart transplant rejection,Transplant rejections,Immune disorders NEC,Immun,Y
1784,1,Heart transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
1785,1,Graft loss,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1785,2,Heart transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
1786,1,Graft loss,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1787,1,Graft loss,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1787,2,Heart transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
1788,1,Graft loss,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1788,2,Heart transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
1789,1,Complications of transplanted heart,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,Y
1789,2,Graft loss,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1790,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1791,1,Graft loss,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1791,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
1792,1,Graft loss,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1792,2,Heart transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
1793,1,Complications of transplanted heart,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1793,2,Graft loss,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1794,1,Graft loss,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1794,2,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,Y
1795,1,Bacterial sepsis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1795,2,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1795,3,Candida sepsis,Candida infections,Fungal infectious disorders,Infec,N
1795,4,Oral herpes,Herpes viral infections,Viral infectious disorders,Infec,N
1795,5,Parainfluenzae virus infection,Parainfluenzae viral infections,Viral infectious disorders,Infec,N
1795,6,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
1796,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1796,2,Blood lactate dehydrogenase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
1796,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1796,4,Microangiopathic haemolytic anaemia,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
1796,5,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1796,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1797,1,Microangiopathic haemolytic anaemia,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
1798,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
1798,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1798,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1798,4,Hypothermia,Body temperature altered,Body temperature conditions,Genrl,N
1798,5,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1798,6,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1799,1,Microangiopathic haemolytic anaemia,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
1799,2,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1800,1,Microangiopathic haemolytic anaemia,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
1801,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1802,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1803,1,Chronic spontaneous urticaria,Urticarias,Angioedema and urticaria,Skin,N
1803,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1804,1,Central nervous system lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,Y
1804,2,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1804,3,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
1804,4,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1804,5,IIIrd nerve paralysis,Eye movement disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1804,6,Leukocytosis,Leukocytoses NEC,White blood cell disorders,Blood,N
1804,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1804,8,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1805,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
1805,2,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1805,3,Central nervous system lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
1805,4,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1805,5,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
1805,6,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,Y
1805,7,IIIrd nerve paralysis,Eye movement disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1805,8,Leukocytosis,Leukocytoses NEC,White blood cell disorders,Blood,N
1805,9,Magnetic resonance imaging abnormal,Imaging procedures NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
1805,10,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1806,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1807,1,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1807,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1807,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1807,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1807,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1807,6,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1807,7,Thinking abnormal,Thinking disturbances,Disturbances in thinking and perception,Psych,N
1808,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1808,2,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,Y
1809,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1809,2,Transplant dysfunction,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1810,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1811,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1812,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1813,1,Central nervous system lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,Y
1813,2,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1814,1,Central nervous system lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,Y
1814,2,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1815,1,Headache,Headaches NEC,Headaches,Nerv,N
1815,2,Intracranial pressure increased,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
1815,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1816,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1817,1,Skin depigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
1817,2,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1818,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1819,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1820,1,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
1820,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1821,1,Lymphocyte count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1821,2,Nephrotic syndrome,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
1821,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1821,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1822,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1822,2,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1823,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1823,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1823,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1824,1,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1825,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1826,1,Bladder cancer,Bladder neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
1826,2,Removal of renal transplant,Renal therapeutic procedures,Renal and urinary tract therapeutic procedures,Surg,N
1827,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1828,1,Upper limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1829,1,Upper limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1830,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1830,2,Hypotonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
1830,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1830,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1831,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1832,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1833,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
1834,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1834,2,Demyelinating polyneuropathy,Chronic polyneuropathies,Peripheral neuropathies,Nerv,N
1834,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1834,4,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1834,5,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
1834,6,Skin plaque,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1835,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1835,2,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1836,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1837,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1838,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1838,2,Anuria,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1838,3,Complications of transplanted kidney,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1838,4,Graft haemorrhage,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1838,5,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1838,6,Kidney rupture,Renal and urinary tract injuries NEC,Injuries NEC,Inj&P,N
1838,7,Kidney transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
1838,8,Retroperitoneal haematoma,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,N
1839,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1839,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1840,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1841,1,Transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1842,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1842,2,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1842,3,Pustular psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1843,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1844,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1845,1,Acute graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1846,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1846,2,Pustular psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1847,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1847,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1847,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1848,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1849,1,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1850,1,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1851,1,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1852,1,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1853,1,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1854,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1855,1,Cutaneous T-cell lymphoma stage IV,Mycoses fungoides,Lymphomas non-Hodgkin's T-cell,Neopl,Y
1856,1,Cutaneous T-cell lymphoma stage I,Mycoses fungoides,Lymphomas non-Hodgkin's T-cell,Neopl,N
1856,2,Cutaneous T-cell lymphoma stage II,Mycoses fungoides,Lymphomas non-Hodgkin's T-cell,Neopl,N
1856,3,Cutaneous T-cell lymphoma stage IV,Mycoses fungoides,Lymphomas non-Hodgkin's T-cell,Neopl,N
1856,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1857,1,Cutaneous T-cell lymphoma stage I,Mycoses fungoides,Lymphomas non-Hodgkin's T-cell,Neopl,N
1857,2,Cutaneous T-cell lymphoma stage III,Mycoses fungoides,Lymphomas non-Hodgkin's T-cell,Neopl,N
1857,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1858,1,Cutaneous T-cell lymphoma stage IV,Mycoses fungoides,Lymphomas non-Hodgkin's T-cell,Neopl,Y
1858,2,Malignant transformation,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1858,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1859,1,Cutaneous T-cell lymphoma stage IV,Mycoses fungoides,Lymphomas non-Hodgkin's T-cell,Neopl,N
1859,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1860,1,Cutaneous T-cell lymphoma stage I,Mycoses fungoides,Lymphomas non-Hodgkin's T-cell,Neopl,N
1860,2,Malignant transformation,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1860,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1861,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1862,1,Nasal oedema,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1862,2,Oral mucosal eruption,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1862,3,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1863,1,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1863,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1863,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1863,4,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1863,5,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1863,6,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1863,7,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1863,8,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1863,9,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1864,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1864,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1864,3,Cutibacterium acnes infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1864,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1864,5,Heart transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
1864,6,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1864,7,Lung abscess,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1864,8,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1864,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1865,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1865,2,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1866,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1866,2,Chest X-ray abnormal,Respiratory tract and thoracic imaging procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
1866,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1866,4,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1866,5,Cutibacterium acnes infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1866,6,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1866,7,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1866,8,Lung abscess,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1866,9,Necrosis,Necrosis NEC,Tissue disorders NEC,Genrl,N
1866,10,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1866,11,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1866,12,Purulent discharge,Infections NEC,Infections - pathogen unspecified,Infec,N
1866,13,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1867,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1867,2,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
1867,3,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1867,4,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1867,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1867,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1867,7,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1868,1,HIV-associated neurocognitive disorder,Retroviral infections,Viral infectious disorders,Infec,N
1868,2,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
1868,3,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1869,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
1869,2,HIV infection,Retroviral infections,Viral infectious disorders,Infec,N
1869,3,HIV-associated neurocognitive disorder,Retroviral infections,Viral infectious disorders,Infec,N
1869,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1869,5,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1870,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1870,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1870,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1871,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
1871,2,Atypical mycobacterial infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
1871,3,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1871,4,Obliterative bronchiolitis,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1871,5,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1872,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1873,1,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1873,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1873,3,Hair growth abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
1873,4,Headache,Headaches NEC,Headaches,Nerv,N
1873,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1873,6,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1874,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1875,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1876,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1877,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1877,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1877,3,Groin pain,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1877,4,Heart rate irregular,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1877,5,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1878,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1879,1,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1879,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1879,3,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1880,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1881,1,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1881,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1881,3,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1882,1,Aneurysm,Aneurysms and dissections non-site specific,Aneurysms and artery dissections,Vasc,N
1883,1,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1883,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1884,1,Bipolar disorder,Bipolar disorders,Manic and bipolar mood disorders and disturbances,Psych,N
1885,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1885,2,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
1885,3,Limb injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
1885,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1886,1,Lower limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1887,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
1887,2,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1887,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1887,4,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1887,5,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1887,6,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1887,7,Faecaloma,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
1887,8,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1887,9,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1887,10,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1887,11,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
1888,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1889,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1890,1,Eye inflammation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1890,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
1890,3,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1890,4,Ocular rosacea,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1891,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1892,1,Encephalitis viral,Viral infections NEC,Viral infectious disorders,Infec,Y
1893,1,Acute graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1893,2,Epidermal necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1893,3,Interstitial granulomatous dermatitis,Granulomatous and deep cutaneous inflammatory conditions,Epidermal and dermal conditions,Skin,N
1893,4,Parakeratosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1894,1,Capillary leak syndrome,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1894,2,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1894,3,Graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1894,4,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
1894,5,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1894,6,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1895,1,Lower limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1896,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1896,2,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1896,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1896,4,Headache,Headaches NEC,Headaches,Nerv,N
1896,5,Increased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1896,6,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1896,7,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1897,1,Spinal cord compression,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
1898,1,Abnormal faeces,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
1898,2,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
1898,3,Laboratory test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
1898,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1898,5,Upper limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1899,1,Systemic scleroderma,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
1900,1,Limb injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
1900,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1901,1,Lower limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1902,1,Blood disorder,Haematological disorders,Haematological disorders NEC,Blood,N
1902,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1902,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1902,4,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1903,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1903,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1904,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1905,1,Brain injury,Structural brain disorders NEC,Structural brain disorders,Nerv,N
1905,2,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
1905,3,Encephalitis viral,Viral infections NEC,Viral infectious disorders,Infec,Y
1905,4,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1905,5,Graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1905,6,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1905,7,Viral diarrhoea,Viral infections NEC,Viral infectious disorders,Infec,N
1906,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1907,1,Lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,Y
1908,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1909,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1909,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1910,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1911,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1911,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1911,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1911,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1911,5,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1911,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1911,7,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
1912,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1913,1,Acute graft versus host disease in intestine,Immune and associated conditions NEC,Immune disorders NEC,Immun,Y
1914,1,Acute graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1915,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1916,1,Autoimmune colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1916,2,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1917,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1918,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1918,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1918,3,Lupus-like syndrome,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
1919,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1919,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1919,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1919,4,Exercise tolerance decreased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1919,5,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
1919,6,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1919,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1920,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1920,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1920,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1921,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1921,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1921,3,Pre-eclampsia,Hypertension associated disorders of pregnancy,Maternal complications of pregnancy,Preg,N
1922,1,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,Y
1922,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1922,3,Foetal growth restriction,Foetal growth complications,Foetal complications,Preg,N
1923,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1924,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1925,1,Abnormal sensation in eye,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
1925,2,Conjunctival discolouration,"Conjunctival structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
1925,3,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
1925,4,Erythema of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
1925,5,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1925,6,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
1925,7,Eyelid disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
1925,8,Headache,Headaches NEC,Headaches,Nerv,N
1925,9,Instillation site irritation,Instillation site reactions,Administration site reactions,Genrl,N
1925,10,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
1925,11,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1926,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1926,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1926,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1926,4,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1926,5,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1926,6,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1926,7,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1927,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1927,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1928,1,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
1929,1,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
1930,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1931,1,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1932,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1932,2,Guttate psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1932,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1933,1,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1933,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1934,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1934,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1935,1,Blood pressure inadequately controlled,Blood pressure disorders NEC,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1936,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1936,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1936,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1936,4,Crepitations,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1936,5,Erythrodermic psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1936,6,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1936,7,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1936,8,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1936,9,Reticulocyte count increased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1936,10,Tenderness,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1936,11,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1937,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1938,1,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1939,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1939,2,Groin pain,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1939,3,Hand deformity,Extremity deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
1939,4,Headache,Headaches NEC,Headaches,Nerv,N
1939,5,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1939,6,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1939,7,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1939,8,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1939,9,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1939,10,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
1940,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1940,2,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1940,3,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
1940,4,Gingival hypertrophy,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
1941,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1941,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1941,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1941,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1941,5,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1941,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1942,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1942,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1942,3,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1942,4,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1942,5,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1943,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1943,2,Lymphocyte count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1943,3,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1943,4,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1944,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1944,2,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1944,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1944,4,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1944,5,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1944,6,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1945,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1945,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1946,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1947,1,Blood potassium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1947,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1947,3,Headache,Headaches NEC,Headaches,Nerv,N
1947,4,Varicella zoster virus infection,Herpes viral infections,Viral infectious disorders,Infec,N
1948,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1948,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1948,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1948,4,Musculoskeletal chest pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1949,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1949,2,Tonsillitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1950,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1951,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1952,1,Heart rate irregular,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1953,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1954,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1955,1,Idiopathic generalised epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1955,2,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1956,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1956,2,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1957,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1958,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1959,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1960,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1960,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1960,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1961,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1961,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1962,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1962,2,Product odour abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1962,3,Product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1963,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1964,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1965,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1966,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
1966,2,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1966,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1966,4,Growth failure,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1966,5,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
1966,6,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
1967,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,Y
1967,2,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
1967,3,Bacterial sepsis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1967,4,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1967,5,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1967,6,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1968,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1969,1,Bile duct stone,Obstructive bile duct disorders (excl neoplasms),Bile duct disorders,Hepat,N
1970,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1970,2,Hepatic cyst,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
1971,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1972,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1973,1,Amyloidosis,Amyloidoses,Immune disorders NEC,Immun,N
1973,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1973,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1974,1,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
1974,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1975,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1976,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,Y
1976,2,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
1976,3,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1976,4,Device related sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1976,5,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1976,6,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1977,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1977,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1978,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1979,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1979,2,Evans syndrome,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
1979,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1980,1,Acute graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1980,2,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
1980,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1980,4,Gastroenteritis norovirus,Caliciviral infections,Viral infectious disorders,Infec,N
1980,5,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1980,6,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1980,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1981,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1981,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1981,3,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
1982,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1982,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1982,3,Hair colour changes,Pilar disorders NEC,Skin appendage conditions,Skin,N
1982,4,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1983,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1983,2,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1984,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1985,1,Lower limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1985,2,Road traffic accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1986,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1986,2,Appendicitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1986,3,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1986,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1986,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1986,6,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1986,7,Tonsillitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1987,1,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1988,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1989,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1990,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1990,2,Evans syndrome,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
1991,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1991,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1992,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1993,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1994,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1994,2,Evans syndrome,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
1995,1,Inflammatory myofibroblastic tumour,Soft tissue neoplasms malignant and unspecified NEC (excl sarcomas),Soft tissue neoplasms malignant and unspecified,Neopl,N
1996,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1997,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1997,2,Evans syndrome,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
1998,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1998,2,Upper limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1999,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1999,2,Hypertrichosis,Hypertrichoses,Skin appendage conditions,Skin,N
1999,3,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
2000,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
2001,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
2002,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2003,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2004,1,Pericarditis,Noninfectious pericarditis,Pericardial disorders,Card,N
2005,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
2006,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2006,2,Necrotising oesophagitis,Oesophageal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
2007,1,Papilloma viral infection,Papilloma viral infections,Viral infectious disorders,Infec,N
2008,1,Acanthosis,Skin hyperplasias and hypertrophies,Cornification and dystrophic skin disorders,Skin,N
2008,2,Acute generalised exanthematous pustulosis,Pustular conditions,Epidermal and dermal conditions,Skin,N
2008,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2008,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2008,5,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
2008,6,Nikolsky's sign,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
2008,7,Pustule,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
2008,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2008,9,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
2009,1,Epididymitis,Male reproductive tract infections,Infections - pathogen unspecified,Infec,N
2010,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2010,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2010,3,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
2010,4,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2011,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2011,2,Evans syndrome,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
2012,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
2013,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2013,2,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
2014,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2015,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2016,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2016,2,Kidney transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
2016,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2017,1,Product taste abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2017,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2018,1,Critical illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2019,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2019,2,Head injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
2020,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2021,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2022,1,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
2023,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2024,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2025,1,Epidermodysplasia verruciformis,Papilloma viral infections,Viral infectious disorders,Infec,N
2026,1,Malacoplakia vesicae,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
2027,1,Epstein-Barr virus test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
2027,2,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
2028,1,Escherichia infection,Escherichia infections,Bacterial infectious disorders,Infec,N
2028,2,Groin abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
2028,3,Histology abnormal,Histopathology procedures NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
2028,4,Malacoplakia vesicae,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
2028,5,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
2028,6,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
2029,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
2029,2,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
2030,1,Cyst,Mass conditions NEC,Tissue disorders NEC,Genrl,N
2030,2,Headache,Headaches NEC,Headaches,Nerv,N
2031,1,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
2032,1,Cell death,Cell metabolism disorders NEC,Metabolism disorders NEC,Metab,N
2032,2,Cheilitis,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
2032,3,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2032,4,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2032,5,Lichenoid keratosis,Hyperkeratoses,Cornification and dystrophic skin disorders,Skin,N
2032,6,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2033,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2034,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2034,2,Blood bilirubin decreased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2034,3,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
2034,4,Creatinine renal clearance decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
2034,5,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2034,6,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
2034,7,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
2034,8,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2035,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
2036,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2037,1,Escherichia infection,Escherichia infections,Bacterial infectious disorders,Infec,N
2037,2,Groin abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
2037,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2037,4,Nodule,Mass conditions NEC,Tissue disorders NEC,Genrl,N
2038,1,Acarodermatitis,Ectoparasitic infestations,Ectoparasitic disorders,Infec,N
2039,1,Atypical mycobacterial infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
2039,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2039,3,Haemodynamic instability,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
2039,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2039,5,Idiopathic pneumonia syndrome,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
2039,6,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
2039,7,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2040,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2040,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2040,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2041,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2041,2,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2041,3,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
2041,4,Skin plaque,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2042,1,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
2043,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2043,2,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2043,3,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
2043,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2043,5,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
2043,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2043,7,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
2044,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2045,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2045,2,Acute graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2045,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2045,4,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
2045,5,Gastrointestinal oedema,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
2045,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2045,7,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
2045,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2046,1,Cutaneous T-cell lymphoma,Mycoses fungoides,Lymphomas non-Hodgkin's T-cell,Neopl,N
2046,2,Cutaneous T-cell lymphoma stage IV,Mycoses fungoides,Lymphomas non-Hodgkin's T-cell,Neopl,N
2046,3,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
2046,4,Histology abnormal,Histopathology procedures NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
2046,5,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
2046,6,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2046,7,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
2046,8,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2047,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2048,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2049,1,Central nervous system infection,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
2050,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2051,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2052,1,Cerebral disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
2053,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2054,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2055,1,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2056,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
2056,2,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2057,1,Headache,Headaches NEC,Headaches,Nerv,N
2057,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
2057,3,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
2057,4,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
2057,5,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
2057,6,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
2058,1,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
2058,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2059,1,Skin cancer,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
2060,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2060,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
2060,3,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2060,4,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2060,5,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
2061,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
2061,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2061,3,Palmoplantar pustulosis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
2061,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2062,1,Renal cyst,Renal neoplasms,Renal disorders (excl nephropathies),Renal,N
2062,2,Renal cyst haemorrhage,Renal neoplasms,Renal disorders (excl nephropathies),Renal,N
2063,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2064,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2064,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2065,1,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2065,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2066,1,Heart transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
2067,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2068,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2069,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2070,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2071,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2072,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2073,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2074,1,Asterixis,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2074,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
2074,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2074,4,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2074,5,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
2074,6,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2074,7,Liver transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
2074,8,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
2074,9,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2074,10,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2075,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2075,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
2075,3,Generalised oedema,Oedema NEC,General system disorders NEC,Genrl,N
2075,4,Glomerulonephritis membranous,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
2075,5,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
2075,6,Myelitis transverse,Myelitis (incl infective),Central nervous system infections and inflammations,Nerv,N
2075,7,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
2076,1,Device related infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2076,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2077,1,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
2078,1,Gingival hypertrophy,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
2079,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2079,2,Chronic graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2079,3,Concomitant disease aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2079,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2079,5,Oesophageal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2079,6,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
2079,7,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2080,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2081,1,Critical illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2082,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
2083,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2084,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2084,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
2084,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2085,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2086,1,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
2086,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2086,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2086,4,Scleroderma-like reaction,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
2087,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2088,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2089,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
2089,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2089,3,Headache,Headaches NEC,Headaches,Nerv,N
2089,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2089,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2090,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2091,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2092,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2093,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2094,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2095,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2096,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2096,2,Nocardiosis,Nocardia infections,Bacterial infectious disorders,Infec,N
2097,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2098,1,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
2099,1,Apoptosis,Cell metabolism disorders NEC,Metabolism disorders NEC,Metab,N
2099,2,Bilirubin conjugated increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2099,3,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
2099,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2099,5,Graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2099,6,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2100,1,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
2101,1,Abscess limb,Infections NEC,Infections - pathogen unspecified,Infec,N
2101,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2101,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2101,4,Nocardiosis,Nocardia infections,Bacterial infectious disorders,Infec,N
2101,5,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
2102,1,Blood albumin decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
2102,2,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
2102,3,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
2102,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2103,1,Blood calcium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
2103,2,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
2103,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2103,4,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
2103,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2104,1,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2104,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2104,3,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
2105,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2106,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2107,1,Chronic graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2107,2,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
2107,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2107,4,Skin hyperpigmentation,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
2107,5,Skin hypopigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
2108,1,Chronic graft versus host disease in intestine,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2108,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2108,3,Enterococcal infection,Enterococcal infections,Bacterial infectious disorders,Infec,N
2108,4,Malnutrition,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
2108,5,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
2108,6,Transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
2109,1,Biopsy kidney abnormal,Urinary tract histopathology procedures,Renal and urinary tract investigations and urinalyses,Inv,N
2109,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
2109,3,Escherichia infection,Escherichia infections,Bacterial infectious disorders,Infec,N
2109,4,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
2109,5,Herpes simplex reactivation,Herpes viral infections,Viral infectious disorders,Infec,N
2109,6,Herpes simplex test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
2109,7,Lung consolidation,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
2109,8,Mucocutaneous haemorrhage,Skin haemorrhages,Skin vascular abnormalities,Skin,N
2109,9,Pyelonephritis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
2109,10,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2109,11,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
2109,12,Streptococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
2110,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
2111,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
2111,2,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
2112,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
2112,2,Limb injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
2112,3,Maternal exposure before pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2112,4,Normal newborn,Normal newborn status,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
2112,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2112,6,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2112,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2112,8,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
2113,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2114,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2115,1,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2115,2,Myopathy,Myopathies,Muscle disorders,Musc,N
2116,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
2116,2,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,Y
2117,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2117,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
2117,3,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2117,4,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
2117,5,Blood sodium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
2117,6,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
2117,7,Central nervous system infection,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
2117,8,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2117,9,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2117,10,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
2117,11,Red blood cell count decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2117,12,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2117,13,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2118,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2119,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2120,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2120,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2120,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2120,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2121,1,Escherichia infection,Escherichia infections,Bacterial infectious disorders,Infec,N
2121,2,Groin abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
2121,3,Nodule,Mass conditions NEC,Tissue disorders NEC,Genrl,N
2121,4,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
2122,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
2122,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
2122,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2122,4,Infective exacerbation of chronic obstructive airways disease,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2122,5,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2122,6,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
2122,7,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2122,8,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2122,9,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2123,1,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
2123,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2124,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
2124,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2124,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2124,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2124,5,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2124,6,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
2124,7,Transfusion,Blood and blood product treatment,Haematological and lymphoid tissue therapeutic procedures,Surg,N
2125,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2125,2,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
2125,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
2126,1,Blood albumin decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
2126,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
2126,3,Blood sodium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
2126,4,Graft versus host disease in liver,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2126,5,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
2126,6,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2126,7,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2126,8,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
2126,9,Red blood cell count decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2127,1,Depressive symptom,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
2127,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2127,3,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
2128,1,Blood albumin decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
2128,2,Blood calcium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
2128,3,Blood creatinine decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
2128,4,Blood magnesium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
2128,5,Blood phosphorus decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
2128,6,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2128,7,Haematocrit decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2128,8,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2128,9,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2128,10,Mean cell haemoglobin concentration increased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2128,11,Mean cell haemoglobin increased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2128,12,Monocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2128,13,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
2128,14,Protein total decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
2128,15,Red blood cell count decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2128,16,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2128,17,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2129,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
2129,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
2130,1,Biliary colic,Bile duct infections and inflammations,Bile duct disorders,Hepat,N
2130,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
2130,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2131,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
2131,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2131,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2131,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2131,5,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
2131,6,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2132,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2132,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2132,3,Blood albumin decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
2132,4,Blood lactate dehydrogenase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
2132,5,Blood phosphorus decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
2132,6,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
2132,7,Haematocrit decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2132,8,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2132,9,Lower gastrointestinal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2132,10,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2132,11,Myelitis transverse,Myelitis (incl infective),Central nervous system infections and inflammations,Nerv,N
2132,12,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
2132,13,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
2132,14,Protein total decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
2132,15,Red blood cell count decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2132,16,Red cell distribution width increased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2133,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
2133,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2133,3,Morning sickness,Maternal complications of pregnancy NEC,Maternal complications of pregnancy,Preg,N
2134,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
2135,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
2136,1,Migraine,Migraine headaches,Headaches,Nerv,N
2137,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
2137,2,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
2137,3,Pustular psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
2137,4,Pustule,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
2137,5,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
2138,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
2138,2,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
2139,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2140,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2140,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
2141,1,Blood creatinine decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
2141,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2141,3,Femoral neck fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
2141,4,Globulins decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
2141,5,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2141,6,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2141,7,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
2141,8,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
2141,9,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2141,10,Protein total increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
2141,11,Red blood cell count decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2142,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2143,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2143,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2144,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
2145,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2146,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2147,1,Acute graft versus host disease in intestine,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2147,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2147,3,Blood albumin decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
2147,4,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
2147,5,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2147,6,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
2147,7,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
2147,8,Chronic graft versus host disease in liver,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2147,9,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2147,10,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
2147,11,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2147,12,Protein total decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
2148,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2148,2,Adjusted calcium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
2148,3,Blood albumin decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
2148,4,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
2148,5,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
2148,6,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2148,7,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2148,8,Globulins decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
2148,9,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
2148,10,Haematocrit decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2148,11,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2148,12,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
2148,13,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
2148,14,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2148,15,Protein total decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
2148,16,Red blood cell count decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2149,1,Enterococcal infection,Enterococcal infections,Bacterial infectious disorders,Infec,N
2149,2,Respiratory syncytial virus infection,Respiratory syncytial viral infections,Viral infectious disorders,Infec,N
2149,3,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
2150,1,Graft versus host disease in gastrointestinal tract,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2150,2,Graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2150,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2151,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2152,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2152,2,Graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2152,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2152,4,Skin injury,Skin injuries NEC,Injuries NEC,Inj&P,N
2152,5,Skin plaque,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2153,1,Chronic graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2154,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
2155,1,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
2156,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
2156,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2156,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2157,1,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
2157,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2158,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2159,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
2159,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2159,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2160,1,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2160,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2161,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2161,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2161,3,Anuria,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2161,4,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2162,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2162,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
2163,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
2163,2,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
2163,3,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
2163,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2164,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2164,2,Acute graft versus host disease in liver,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2164,3,Acute graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2164,4,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2164,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2164,6,Graft versus host disease in gastrointestinal tract,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2164,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2165,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2165,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
2166,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2166,2,Anal fistula,Gastrointestinal fistulae,Gastrointestinal conditions NEC,Gastr,N
2166,3,Anal incontinence,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2166,4,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2166,5,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2166,6,Escherichia infection,Escherichia infections,Bacterial infectious disorders,Infec,N
2166,7,Functional gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
2166,8,Genital ulceration,Reproductive tract disorders NEC (excl neoplasms),Reproductive tract disorders NEC,Repro,N
2166,9,Impetigo,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
2166,10,Klebsiella infection,Klebsiella infections,Bacterial infectious disorders,Infec,N
2166,11,Morganella infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2166,12,Nail discolouration,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
2166,13,Proctalgia,Anal and rectal pains,Anal and rectal conditions NEC,Gastr,N
2166,14,Tinea pedis,Tinea infections,Fungal infectious disorders,Infec,N
2167,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2167,2,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2167,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
2168,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
2168,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2168,3,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
2168,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
2169,1,Enterococcal infection,Enterococcal infections,Bacterial infectious disorders,Infec,N
2169,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
2169,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2170,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2170,2,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
2170,3,Graft versus host disease in gastrointestinal tract,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2170,4,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2170,5,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2171,1,Blood cholesterol decreased,Cholesterol analyses,Lipid analyses,Inv,N
2171,2,Eosinophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2171,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2171,4,Red blood cell count decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2172,1,Enterococcal infection,Enterococcal infections,Bacterial infectious disorders,Infec,N
2172,2,Respiratory syncytial virus infection,Respiratory syncytial viral infections,Viral infectious disorders,Infec,N
2172,3,Staphylococcal bacteraemia,Staphylococcal infections,Bacterial infectious disorders,Infec,N
2173,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
2173,2,Hypertrophy,Trophic disorders,Tissue disorders NEC,Genrl,N
2173,3,Liver iron concentration increased,Hepatobiliary histopathology procedures,Hepatobiliary investigations,Inv,N
2173,4,Monocyte count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2173,5,Paroxysmal nocturnal haemoglobinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
2173,6,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2173,7,Red blood cell count decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2173,8,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2173,9,Serum ferritin increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
2174,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
2174,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2174,3,Ischaemia,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
2175,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
2175,2,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
2175,3,Headache,Headaches NEC,Headaches,Nerv,N
2175,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2175,5,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2175,6,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2176,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
2176,2,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
2176,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2176,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
2177,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2178,1,Follicular lymphoma,Follicular lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
2178,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2179,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
2179,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2179,3,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
2179,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2179,5,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
2179,6,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2180,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
2181,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2181,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2181,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2181,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2182,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2183,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
2183,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2184,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2184,2,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2184,3,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
2184,4,Chronic graft versus host disease in intestine,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2184,5,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
2184,6,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2184,7,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
2184,8,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
2184,9,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2184,10,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2184,11,Respiratory syncytial virus infection,Respiratory syncytial viral infections,Viral infectious disorders,Infec,N
2184,12,Rhinovirus infection,Rhinoviral infections,Viral infectious disorders,Infec,N
2185,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
2186,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2186,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2187,1,Chest expansion decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2187,2,Forced expiratory volume decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
2187,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2187,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2188,1,Intestinal pseudo-obstruction,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2189,1,Activated partial thromboplastin time shortened,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
2189,2,Aphthous ulcer,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
2189,3,Apoptosis,Cell metabolism disorders NEC,Metabolism disorders NEC,Metab,N
2189,4,Blood albumin decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
2189,5,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
2189,6,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
2189,7,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2189,8,Gastrointestinal wall thickening,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2189,9,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2189,10,Haematocrit decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2189,11,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
2189,12,Prothrombin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
2189,13,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2189,14,Red blood cell count decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2189,15,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2190,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
2190,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
2190,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2191,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
2191,2,Tonsillitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2192,1,Acute graft versus host disease in liver,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2192,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2192,3,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
2192,4,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2192,5,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
2192,6,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2192,7,Eosinophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2192,8,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2192,9,Monocyte count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2192,10,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2193,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
2194,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
2195,1,Portal hypertension,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
2195,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2196,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2197,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2197,2,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2197,3,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2197,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
2198,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2198,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2199,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2199,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2200,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2200,2,Blood creatinine abnormal,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
2200,3,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
2200,4,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
2200,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2200,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2201,1,Chronic graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2201,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2201,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2201,4,Graft versus host disease in eye,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2202,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2202,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
2202,3,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2202,4,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2202,5,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
2202,6,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2203,1,Gingivitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
2203,2,Loss of libido,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
2203,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2204,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
2205,1,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
2205,2,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2205,3,Immunosuppressant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
2205,4,Impaired quality of life,Social issues NEC,Lifestyle issues,SocCi,N
2205,5,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2206,1,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
2206,2,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2207,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
2207,2,Autoimmune neutropenia,Neutropenias,White blood cell disorders,Blood,N
2207,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2207,4,Renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
2208,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2208,2,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
2209,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2209,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
2210,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2210,2,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2211,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
2211,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
2212,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2212,2,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
2212,3,Mycobacterium kansasii infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
2212,4,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
2212,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2212,6,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2212,7,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2212,8,Tendon rupture,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
2212,9,Tenosynovitis,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
2212,10,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2213,1,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,Y
2213,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2214,1,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2215,1,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
2216,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2216,2,Headache,Headaches NEC,Headaches,Nerv,N
2216,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2216,4,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2217,1,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
2217,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2217,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2217,4,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
2218,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2218,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2218,3,Still's disease,Rheumatoid arthropathies,Joint disorders,Musc,N
2218,4,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2219,1,Anal abscess,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
2219,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
2220,1,Full blood count decreased,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
2220,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2221,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
2221,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2221,3,Mucosal haemorrhage,Mucosal findings abnormal,General system disorders NEC,Genrl,N
2221,4,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
2221,5,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
2221,6,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2222,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2222,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
2222,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2222,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2222,5,Feeling of body temperature change,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2222,6,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2222,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2222,8,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2222,9,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2222,10,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2222,11,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
2223,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2223,2,Tooth abscess,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
2224,1,Actinic keratosis,Skin preneoplastic conditions NEC,Cornification and dystrophic skin disorders,Skin,N
2224,2,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
2224,3,Epstein-Barr virus infection reactivation,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
2224,4,Lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
2224,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2224,6,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2224,7,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
2225,1,Abnormal palmar/plantar creases,Skin and subcutaneous tissue disorders congenital NEC,Skin and subcutaneous tissue disorders congenital,Cong,N
2225,2,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
2225,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
2225,4,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
2225,5,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
2225,6,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2226,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
2226,2,Autoimmune neutropenia,Neutropenias,White blood cell disorders,Blood,N
2226,3,Infection reactivation,Infections NEC,Infections - pathogen unspecified,Infec,N
2226,4,Lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
2226,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2226,6,Renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
2226,7,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
2227,1,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
2228,1,Ephelides,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
2229,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2229,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2229,3,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
2229,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2230,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2231,1,Erythema of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
2231,2,Eyelid oedema,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
2232,1,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
2232,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2232,3,Tongue blistering,Tongue signs and symptoms,Tongue conditions,Gastr,N
2233,1,Epstein Barr virus positive mucocutaneous ulcer,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
2234,1,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
2235,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
2236,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2236,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2237,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
2237,2,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
2237,3,Osteomyelitis,Bone and joint infections,Infections - pathogen unspecified,Infec,N
2237,4,Otitis externa,Ear infections,Infections - pathogen unspecified,Infec,N
2237,5,Scopulariopsis infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
2237,6,Trichophytic granuloma,Tinea infections,Fungal infectious disorders,Infec,N
2237,7,Trichophytosis,Tinea infections,Fungal infectious disorders,Infec,N
2238,1,Blood urea abnormal,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
2238,2,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
2238,3,Organ failure,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2239,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2240,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
2240,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
2241,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2242,1,Rectal cancer metastatic,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,Y
2243,1,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2244,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
2244,2,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
2245,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2245,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2245,3,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2245,4,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2246,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
2246,2,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
2247,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
2247,2,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2247,3,Gastroenteritis norovirus,Caliciviral infections,Viral infectious disorders,Infec,N
2247,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
2247,5,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2247,6,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
2247,7,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
2247,8,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2247,9,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
2247,10,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2247,11,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2247,12,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
2247,13,Vaccination site inflammation,Vaccination site reactions,Administration site reactions,Genrl,N
2248,1,Headache,Headaches NEC,Headaches,Nerv,N
2249,1,Cystoid macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
2249,2,Retinal exudates,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
2249,3,Retinal haemorrhage,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
2249,4,Retinopathy,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
2249,5,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
2250,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2251,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
2251,2,Atypical mycobacterial infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
2251,3,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2251,4,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2251,5,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2251,6,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2251,7,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
2251,8,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
2251,9,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
2252,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
2252,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
2252,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2252,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2252,5,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
2252,6,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2252,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2252,8,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
2252,9,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
2252,10,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2252,11,Still's disease,Rheumatoid arthropathies,Joint disorders,Musc,N
2253,1,BK virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
2253,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2253,3,Encephalitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
2253,4,Epstein-Barr viraemia,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
2253,5,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
2253,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2253,7,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
2253,8,Viraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2254,1,Acute coronary syndrome,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
2254,2,Full blood count abnormal,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
2255,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2255,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2255,3,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
2255,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2255,5,Skin cancer,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
2256,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
2256,2,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
2256,3,Evans syndrome,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
2256,4,Glomerulonephritis membranous,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
2256,5,Myelitis transverse,Myelitis (incl infective),Central nervous system infections and inflammations,Nerv,N
2256,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
2257,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2257,2,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2257,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2257,4,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2257,5,Normal newborn,Normal newborn status,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
2258,1,Acute graft versus host disease in intestine,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2258,2,Acute graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2258,3,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
2258,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2258,5,Fasciitis,Musculoskeletal and connective tissue infections and inflammations NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
2258,6,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2258,7,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
2258,8,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
2258,9,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
2259,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
2259,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2259,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2260,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
2261,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
2261,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2261,3,Enterococcal sepsis,Enterococcal infections,Bacterial infectious disorders,Infec,N
2261,4,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
2261,5,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2261,6,Nosocomial infection,Infectious transmissions,Ancillary infectious topics,Infec,N
2261,7,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
2262,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2262,2,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
2262,3,Skin erosion,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
2262,4,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
2263,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2263,2,Lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
2263,3,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
2264,1,Cold urticaria,Urticarias,Angioedema and urticaria,Skin,N
2265,1,Headache,Headaches NEC,Headaches,Nerv,N
2265,2,Peripheral sensorimotor neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
2265,3,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
2265,4,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
2266,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2266,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2267,1,Skin erosion,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
2267,2,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
2268,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2268,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2269,1,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2269,2,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
2270,1,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2270,2,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
2271,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2271,2,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,Y
2271,3,Kidney transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
2271,4,Lung infiltration,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
2271,5,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2272,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2273,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2273,2,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
2273,3,Kidney transplant rejection,Transplant rejections,Immune disorders NEC,Immun,Y
2273,4,Lung infiltration,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
2273,5,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2273,6,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
2273,7,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
2274,1,Blepharitis,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
2274,2,Blindness unilateral,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2274,3,Eye inflammation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
2274,4,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
2274,5,Keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
2274,6,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
2274,7,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
2274,8,Reaction to preservatives,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
2274,9,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2275,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2275,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
2275,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2275,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2276,1,Enterovirus infection,Enteroviral infections NEC,Viral infectious disorders,Infec,N
2277,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2278,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
2278,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2278,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2279,1,Delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
2279,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2279,3,Major depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
2280,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
2280,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2280,3,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
2280,4,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2280,5,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
2281,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2281,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
2281,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2282,1,Hepatomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
2282,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
2283,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2283,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2283,3,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
2283,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2283,5,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
2283,6,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
2283,7,Skin plaque,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2283,8,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2284,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2285,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
2285,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2286,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
2287,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
2287,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2287,3,Glossodynia,Tongue signs and symptoms,Tongue conditions,Gastr,N
2287,4,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
2288,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
2288,2,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
2289,1,Polyarthritis,Arthropathies NEC,Joint disorders,Musc,N
2289,2,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
2290,1,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2291,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2291,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2291,3,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
2291,4,Headache,Headaches NEC,Headaches,Nerv,N
2291,5,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2291,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2291,7,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2292,1,Blood alkaline phosphatase decreased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
2292,2,Lymphocyte count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2292,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2292,4,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2293,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2294,1,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
2294,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
2295,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2295,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2295,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2296,1,Pyelonephritis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
2297,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2297,2,Immune system disorder,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2297,3,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2298,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2299,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
2300,1,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
2300,2,Migraine,Migraine headaches,Headaches,Nerv,N
2300,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2301,1,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
2302,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2303,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2304,1,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2304,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2305,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2306,1,Mycobacterium abscessus infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
2306,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2306,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2306,4,Respiratory syncytial virus infection,Respiratory syncytial viral infections,Viral infectious disorders,Infec,N
2306,5,Stenotrophomonas infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2307,1,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
2308,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
2308,2,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2308,3,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
2309,1,Coronavirus infection,Coronavirus infections,Viral infectious disorders,Infec,N
2309,2,Mycobacterium abscessus infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
2309,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2309,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2310,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
2310,2,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
2310,3,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2310,4,Engraftment syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2310,5,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
2310,6,Graft versus host disease in gastrointestinal tract,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2310,7,Graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2310,8,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
2311,1,Conjunctival haemorrhage,Conjunctival and corneal bleeding and vascular disorders,Ocular haemorrhages and vascular disorders NEC,Eye,N
2311,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
2311,3,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
2311,4,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
2311,5,Microangiopathic haemolytic anaemia,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
2311,6,Thrombotic thrombocytopenic purpura,Thrombocytopenias,Platelet disorders,Blood,N
2312,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2312,2,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,Y
2313,1,Cytomegalovirus syndrome,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2314,1,Pneumonia cytomegaloviral,Cytomegaloviral infections,Viral infectious disorders,Infec,Y
2315,1,Pneumonia cytomegaloviral,Cytomegaloviral infections,Viral infectious disorders,Infec,Y
2316,1,Complications of transplanted lung,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,Y
2316,2,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2316,3,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
2316,4,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
2316,5,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
2316,6,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2317,1,Complications of transplanted lung,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,Y
2317,2,Cytomegalovirus syndrome,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2317,3,Headache,Headaches NEC,Headaches,Nerv,N
2317,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2318,1,Complications of transplanted lung,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
2318,2,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2318,3,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,Y
2319,1,Complications of transplanted lung,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
2319,2,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
2319,3,Pneumonia cytomegaloviral,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2319,4,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,Y
2320,1,Cytomegalovirus syndrome,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2320,2,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
2320,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
2320,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2321,1,Cytomegalovirus syndrome,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2321,2,Myocarditis toxoplasmal,Toxoplasma infections,Protozoal infectious disorders,Infec,N
2321,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
2322,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2322,2,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
2322,3,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2323,1,Anticoagulation drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
2323,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2324,1,Cytomegalovirus chorioretinitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2324,2,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2324,3,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2324,4,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2324,5,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
2324,6,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
2324,7,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
2324,8,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2324,9,Pneumonia cytomegaloviral,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2324,10,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2324,11,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2324,12,Retinal detachment,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
2324,13,Retinal scar,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
2324,14,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2325,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2325,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2326,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
2326,2,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
2326,3,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
2327,1,Encephalitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
2327,2,Epstein-Barr viraemia,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
2327,3,Growth retardation,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
2327,4,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
2327,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2327,6,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2327,7,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
2327,8,Viraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2328,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
2328,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
2328,3,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
2328,4,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
2328,5,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
2329,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
2329,2,Herpes zoster meningoencephalitis,Herpes viral infections,Viral infectious disorders,Infec,N
2329,3,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
2329,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2329,5,Papilloma,Neoplasms benign site unspecified NEC,Miscellaneous and site unspecified neoplasms benign,Neopl,N
2329,6,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2330,1,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
2330,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2330,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2331,1,Pemphigus,Bullous conditions,Epidermal and dermal conditions,Skin,N
2331,2,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2332,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2332,2,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
2333,1,Mycobacterium abscessus infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
2333,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2333,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2333,4,Respiratory syncytial virus infection,Respiratory syncytial viral infections,Viral infectious disorders,Infec,N
2333,5,Stenotrophomonas infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2334,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2335,1,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
2335,2,Hypertriglyceridaemia,Elevated triglycerides,Lipid metabolism disorders,Metab,N
2335,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
2336,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2336,2,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
2336,3,Mechanical ventilation,Respiratory tract therapeutic procedures NEC,Respiratory tract therapeutic procedures,Surg,N
2336,4,Neonatal respiratory distress syndrome,Neonatal hypoxic conditions,Neonatal respiratory disorders,Resp,N
2336,5,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
2336,6,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
2336,7,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2337,1,Tonsillitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2338,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
2339,1,Menstrual disorder,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
2339,2,Raynaud's phenomenon,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
2340,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2340,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2341,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
2341,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2342,1,Anal cancer,Anal canal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
2342,2,Genital neoplasm malignant female,Female reproductive neoplasms malignant NEC,Reproductive neoplasms female malignant and unspecified,Neopl,N
2342,3,Haemophilus infection,Haemophilus infections,Bacterial infectious disorders,Infec,N
2342,4,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2342,5,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
2343,1,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2343,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2344,1,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
2344,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2344,3,Mechanical ventilation,Respiratory tract therapeutic procedures NEC,Respiratory tract therapeutic procedures,Surg,N
2344,4,Neonatal respiratory distress syndrome,Neonatal hypoxic conditions,Neonatal respiratory disorders,Resp,N
2344,5,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
2344,6,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
2344,7,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2345,1,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
2345,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2345,3,Mechanical ventilation,Respiratory tract therapeutic procedures NEC,Respiratory tract therapeutic procedures,Surg,N
2345,4,Neonatal respiratory distress syndrome,Neonatal hypoxic conditions,Neonatal respiratory disorders,Resp,N
2345,5,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
2345,6,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
2345,7,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2346,1,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
2346,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
2346,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2346,4,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
2347,1,Blepharitis,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
2347,2,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
2347,3,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
2348,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2349,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
2349,2,Headache,Headaches NEC,Headaches,Nerv,N
2349,3,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
2349,4,Tongue ulceration,Tongue disorders,Tongue conditions,Gastr,N
2350,1,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
2350,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2351,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
2351,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2351,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2352,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
2352,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2352,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2352,4,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2352,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2352,6,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2352,7,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2352,8,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2353,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
2353,2,Chronic spontaneous urticaria,Urticarias,Angioedema and urticaria,Skin,N
2353,3,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2353,4,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2353,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2353,6,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2353,7,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2354,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
2354,2,Cholestatic liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
2354,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
2354,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2355,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
2355,2,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
2356,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2357,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2357,2,Appendicitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
2357,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2358,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2359,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2359,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2359,3,Pustular psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
2360,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
2361,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2362,1,Appetite disorder,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2362,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
2362,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2362,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2362,5,Headache,Headaches NEC,Headaches,Nerv,N
2362,6,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
2362,7,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2362,8,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2363,1,Bacterial translocation,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2364,1,Bile duct stone,Obstructive bile duct disorders (excl neoplasms),Bile duct disorders,Hepat,N
2364,2,Biliary sepsis,Hepatobiliary and spleen infections,Infections - pathogen unspecified,Infec,N
2364,3,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
2365,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2365,2,Polyomavirus viraemia,Polyomavirus infections,Viral infectious disorders,Infec,N
2366,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2366,2,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
2366,3,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
2367,1,Mycobacterium kansasii infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
2367,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2368,1,Bacteraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2368,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2368,3,Pneumonia cytomegaloviral,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2368,4,Rotavirus infection,Rotaviral infections,Viral infectious disorders,Infec,N
2368,5,Staphylococcal bacteraemia,Staphylococcal infections,Bacterial infectious disorders,Infec,N
2368,6,Staphylococcal bacteraemia,Staphylococcal infections,Bacterial infectious disorders,Infec,N
2369,1,Biliary sepsis,Hepatobiliary and spleen infections,Infections - pathogen unspecified,Infec,N
2369,2,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
2370,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2370,2,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
2370,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2371,1,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
2371,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2371,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2372,1,Headache,Headaches NEC,Headaches,Nerv,N
2372,2,Intracranial pressure increased,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
2372,3,Papilloedema,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
2372,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2373,1,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2373,2,Encephalomyelitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,Y
2374,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2374,2,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
2374,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
2375,1,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2375,2,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
2376,1,Graft versus host disease in gastrointestinal tract,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2376,2,Graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2376,3,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
2377,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
2377,2,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2377,3,Human herpesvirus 6 infection,Herpes viral infections,Viral infectious disorders,Infec,N
2377,4,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2377,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2377,6,Pneumonia viral,Viral infections NEC,Viral infectious disorders,Infec,N
2377,7,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
2378,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2378,2,Pneumonia cytomegaloviral,Cytomegaloviral infections,Viral infectious disorders,Infec,Y
2379,1,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
2379,2,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
2379,3,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
2379,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2379,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2380,1,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
2380,2,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
2380,3,Polyomavirus viraemia,Polyomavirus infections,Viral infectious disorders,Infec,N
2381,1,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
2381,2,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
2381,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2381,4,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
2381,5,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2381,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2382,1,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
2382,2,Mycobacterium kansasii infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
2382,3,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
2382,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2382,5,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2383,1,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
2383,2,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
2383,3,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
2383,4,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
2383,5,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
2383,6,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2384,1,Haemorrhagic cyst,Mass conditions NEC,Tissue disorders NEC,Genrl,N
2384,2,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
2384,3,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
2384,4,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
2384,5,Polyomavirus viraemia,Polyomavirus infections,Viral infectious disorders,Infec,N
2384,6,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2385,1,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
2385,2,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
2385,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2385,4,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
2385,5,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2386,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
2386,2,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2386,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2386,4,Staphylococcal bacteraemia,Staphylococcal infections,Bacterial infectious disorders,Infec,N
2387,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2387,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2388,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2388,2,Pneumonia cytomegaloviral,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2388,3,Rotavirus infection,Rotaviral infections,Viral infectious disorders,Infec,N
2388,4,Staphylococcal bacteraemia,Staphylococcal infections,Bacterial infectious disorders,Infec,N
2389,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
2389,2,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2389,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2390,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
2390,2,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2390,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2391,1,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
2391,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2392,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2392,2,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
2393,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
2393,2,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2393,3,Micrococcal sepsis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2393,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2394,1,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2394,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2395,1,Acute graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2395,2,Craniocerebral injury,Cerebral injuries NEC,Injuries NEC,Inj&P,N
2395,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2395,4,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2395,5,Dysplasia,Trophic disorders,Tissue disorders NEC,Genrl,N
2395,6,Eosinophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2395,7,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2395,8,Gingivitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
2395,9,Morphoea,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
2395,10,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
2395,11,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2395,12,Oral disorder,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
2395,13,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2395,14,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2395,15,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2395,16,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
2396,1,Blast crisis in myelogenous leukaemia,Leukaemias myeloid NEC,Leukaemias,Neopl,N
2396,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
2396,3,Chronic myeloid leukaemia recurrent,Leukaemias chronic myeloid,Leukaemias,Neopl,N
2396,4,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2396,5,Ejection fraction,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
2396,6,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2396,7,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2396,8,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2396,9,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
2396,10,Poor venous access,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
2396,11,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2396,12,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2396,13,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2397,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2397,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
2397,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2398,1,Chronic graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2398,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2398,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
2398,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2399,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
2399,2,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2399,3,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
2400,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2400,2,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
2401,1,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
2402,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
2403,1,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
2403,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2404,1,Hypertriglyceridaemia,Elevated triglycerides,Lipid metabolism disorders,Metab,N
2405,1,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
2406,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
2407,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2407,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2407,3,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
2408,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
2408,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2409,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2409,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2409,3,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2409,4,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
2409,5,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
2409,6,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
2409,7,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2409,8,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2409,9,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
2409,10,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2409,11,Oropharyngeal discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2409,12,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2409,13,Product use complaint,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2409,14,Recalled product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2409,15,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2409,16,Vitreous floaters,"Choroid and vitreous structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
2410,1,Gingival hypertrophy,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
2410,2,Hirsutism,Hypertrichoses,Skin appendage conditions,Skin,N
2411,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
2411,2,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
2412,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
2412,2,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
2413,1,Epstein-Barr virus associated lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
2414,1,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2415,1,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
2416,1,Skin cancer,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
2417,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2417,2,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2418,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2418,2,Headache,Headaches NEC,Headaches,Nerv,N
2418,3,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2419,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
2419,2,Capillary leak syndrome,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2419,3,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2419,4,Graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2419,5,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
2419,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2419,7,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
2419,8,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
2419,9,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2419,10,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2419,11,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2419,12,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,Y
2419,13,Viraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2420,1,Aphthous ulcer,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
2420,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2420,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2420,4,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
2420,5,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
2420,6,Gastroenteritis norovirus,Caliciviral infections,Viral infectious disorders,Infec,N
2420,7,Herpes simplex oesophagitis,Herpes viral infections,Viral infectious disorders,Infec,N
2420,8,Odynophagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2420,9,Oesophageal ulcer,Oesophageal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
2420,10,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2421,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2421,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2422,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2423,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2424,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2425,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2426,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2427,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2428,1,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
2428,2,Molluscum contagiosum,Molluscum contagiosum viral infections,Viral infectious disorders,Infec,N
2428,3,Quality of life decreased,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
2429,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2430,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2431,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2432,1,Eczema herpeticum,Herpes viral infections,Viral infectious disorders,Infec,N
2432,2,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
2432,3,Molluscum contagiosum,Molluscum contagiosum viral infections,Viral infectious disorders,Infec,N
2432,4,Quality of life decreased,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
2433,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2433,2,Eczema herpeticum,Herpes viral infections,Viral infectious disorders,Infec,N
2433,3,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
2433,4,Molluscum contagiosum,Molluscum contagiosum viral infections,Viral infectious disorders,Infec,N
2434,1,Acute graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2434,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2435,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2436,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2437,1,Actinic keratosis,Skin preneoplastic conditions NEC,Cornification and dystrophic skin disorders,Skin,N
2437,2,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
2437,3,Epstein-Barr virus infection reactivation,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
2437,4,Lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
2437,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2437,6,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2437,7,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
2438,1,Headache,Headaches NEC,Headaches,Nerv,N
2438,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2438,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2439,1,Gingival hypertrophy,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
2439,2,Hirsutism,Hypertrichoses,Skin appendage conditions,Skin,N
2440,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2440,2,BK virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
2441,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2441,2,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2441,3,Product taste abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2441,4,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2442,1,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
2442,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
2442,3,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
2442,4,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
2442,5,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2443,1,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
2443,2,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
2444,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2444,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2444,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2445,1,Eating disorder,Eating disorders NEC,Eating disorders and disturbances,Psych,N
2445,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2445,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2446,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2447,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
2447,2,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
2448,1,Foreign body aspiration,Chest and respiratory tract injuries NEC,Injuries NEC,Inj&P,N
2448,2,Hepatic neoplasm,Hepatobiliary neoplasms malignancy unspecified,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
2448,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2448,4,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
2449,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2450,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2451,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2451,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2451,3,Necrosis ischaemic,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
2451,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2452,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2452,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
2453,1,Varicella,Herpes viral infections,Viral infectious disorders,Infec,N
2454,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
2454,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2455,1,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2456,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2456,2,Dermatitis psoriasiform,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
2456,3,Hepatitis B reactivation,Hepatitis virus infections,Viral infectious disorders,Infec,N
2456,4,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2457,1,Brain abscess,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,Y
2457,2,Headache,Headaches NEC,Headaches,Nerv,N
2457,3,Nocardiosis,Nocardia infections,Bacterial infectious disorders,Infec,N
2457,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2458,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2458,2,Neurodermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2458,3,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
2458,4,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
2459,1,Craniocerebral injury,Cerebral injuries NEC,Injuries NEC,Inj&P,N
2459,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2459,3,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2459,4,Dysplasia,Trophic disorders,Tissue disorders NEC,Genrl,N
2459,5,Eosinophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2459,6,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2459,7,Gingivitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
2459,8,Morphoea,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
2459,9,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
2459,10,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2459,11,Oral disorder,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
2459,12,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2459,13,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2459,14,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2459,15,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
2460,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2460,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
2460,3,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2461,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
2462,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2462,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2462,3,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2462,4,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2463,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2463,2,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
2464,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2464,2,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
2465,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
2466,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2466,2,Pityriasis rubra pilaris,Papulosquamous conditions,Epidermal and dermal conditions,Skin,N
2467,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
2468,1,Blood triglycerides increased,Triglyceride analyses,Lipid analyses,Inv,N
2469,1,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
2469,2,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
2469,3,Mouth haemorrhage,Oral soft tissue haemorrhages,Oral soft tissue conditions,Gastr,N
2469,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2469,5,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
2469,6,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2469,7,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
2469,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2470,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2471,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2471,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2472,1,Learning disability,Learning disorders,Cognitive and attention disorders and disturbances,Psych,N
2473,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2474,1,Dermatitis atopic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2474,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2474,3,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2474,4,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
2474,5,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2475,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2475,2,Pharyngeal inflammation,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
2475,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2475,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2476,1,Bacterial disease carrier,Infectious disorders carrier,Ancillary infectious topics,Infec,N
2476,2,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
2476,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2476,4,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
2476,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2476,6,Pneumocystis jirovecii infection,Pneumocystis infections,Fungal infectious disorders,Infec,N
2476,7,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
2476,8,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2476,9,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
2476,10,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2477,1,Bacterial disease carrier,Infectious disorders carrier,Ancillary infectious topics,Infec,N
2477,2,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
2477,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2477,4,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
2477,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2477,6,Pneumocystis jirovecii infection,Pneumocystis infections,Fungal infectious disorders,Infec,N
2477,7,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
2477,8,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2477,9,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
2477,10,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2478,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2479,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2479,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2479,3,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
2480,1,Myelolipoma,Soft tissue neoplasms benign NEC,Soft tissue neoplasms benign,Neopl,N
2481,1,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
2482,1,Myelolipoma,Soft tissue neoplasms benign NEC,Soft tissue neoplasms benign,Neopl,N
2483,1,Myelolipoma,Soft tissue neoplasms benign NEC,Soft tissue neoplasms benign,Neopl,N
2484,1,Dermatitis atopic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2484,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2484,3,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2484,4,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2485,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2485,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2485,3,Headache,Headaches NEC,Headaches,Nerv,N
2485,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2485,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2486,1,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2487,1,Dermatitis atopic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2487,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2487,3,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2487,4,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2488,1,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2489,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2489,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2489,3,Focal segmental glomerulosclerosis,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
2490,1,Rhabdoid tumour,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2490,2,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2491,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
2491,2,Urticaria cholinergic,Urticarias,Angioedema and urticaria,Skin,N
2492,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2492,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
2492,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2492,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2493,1,Mycobacterial infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
2493,2,Mycobacterium chelonae infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
2494,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2494,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2494,3,Focal segmental glomerulosclerosis,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
2494,4,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
2494,5,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
2495,1,Rhabdoid tumour,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2495,2,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2496,1,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,Y
2497,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
2497,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2498,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
2498,2,Hypogonadism,Endocrine abnormalities of gonadal function NEC,Endocrine disorders of gonadal function,Endo,N
2499,1,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
2500,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
2501,1,Dermatitis atopic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2501,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2501,3,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2501,4,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
2501,5,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2502,1,Transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
2503,1,Gingival hypertrophy,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
2504,1,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2504,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2504,3,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2505,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2505,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2506,1,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
2506,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
2506,3,Foreign body sensation in eyes,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
2506,4,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
2506,5,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2507,1,Conversion disorder,Somatic symptom disorders,Somatic symptom and related disorders,Psych,N
2508,1,BK virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
2508,2,Herpes simplex viraemia,Herpes viral infections,Viral infectious disorders,Infec,N
2508,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
2509,1,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
2509,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
2509,3,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2509,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
2510,1,Bacteraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2510,2,Mycobacterium chelonae infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
2510,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2510,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2510,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2510,6,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
2511,1,Ocular discomfort,Ocular disorders NEC,Eye disorders NEC,Eye,N
2512,1,Bacteraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2512,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2512,3,Enterobacter infection,Enterobacter infections,Bacterial infectious disorders,Infec,N
2512,4,Mycobacterium chelonae infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
2512,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2512,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2512,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2512,8,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2513,1,Bacteraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2513,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2513,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2513,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2513,5,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
2514,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2514,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2514,3,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
2514,4,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
2514,5,Foreign body sensation in eyes,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
2515,1,Hepatic lesion,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
2515,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2515,3,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,Y
2515,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2515,5,Splenic lesion,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
2516,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2516,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
2516,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2516,4,Pharyngeal disorder,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
2516,5,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
2516,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
2517,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2517,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2517,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2517,4,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,Y
2517,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2518,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2518,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
2518,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2518,4,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,Y
2519,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
2519,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2519,3,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,Y
2519,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2519,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2519,6,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2520,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
2520,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2520,3,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,Y
2520,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2521,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2521,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
2521,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2521,4,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2521,5,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
2521,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2522,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2522,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2522,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2522,4,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,Y
2522,5,Small intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
2523,1,Encephalitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
2523,2,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
2523,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2524,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
2524,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2524,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2524,4,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
2524,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2524,6,Tonsillar hypertrophy,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
2525,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2525,2,Hepatic lesion,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
2525,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2525,4,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
2526,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2526,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2526,3,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
2526,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2526,5,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
2526,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2527,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2527,2,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
2527,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2528,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2528,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
2528,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2528,4,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
2528,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2529,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
2529,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2529,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2529,4,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
2529,5,Tonsillitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2530,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2530,2,Headache,Headaches NEC,Headaches,Nerv,N
2530,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2530,4,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2530,5,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
2530,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2531,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2531,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
2531,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2531,4,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
2531,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2532,1,Odynophagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2532,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2532,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2532,4,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
2533,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
2533,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2533,3,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
2534,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
2534,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2534,3,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
2535,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
2535,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2535,3,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
2536,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
2537,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2537,2,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
2537,3,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2537,4,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
2537,5,Wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2538,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2539,1,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
2540,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2540,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2541,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2542,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2542,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2542,3,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
2542,4,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2542,5,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
2542,6,Wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2543,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2543,2,Granulomatosis with polyangiitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
2543,3,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2543,4,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2544,1,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
2545,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2545,2,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2546,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
2546,2,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
2547,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2547,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2547,3,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2548,1,Keratoacanthoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
2548,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2549,1,Lower limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
2550,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2550,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
2551,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2552,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2552,2,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2553,1,Cholestasis of pregnancy,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
2553,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2553,3,Normal newborn,Normal newborn status,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
2554,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2554,2,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2555,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2555,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2556,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2557,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2558,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2559,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2559,2,Keratoacanthoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
2560,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
2560,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2560,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2561,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2561,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2561,3,Irritable bowel syndrome,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
2562,1,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
2562,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
2562,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2562,4,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
2562,5,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2563,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2563,2,Cholestatic liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
2563,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
2563,4,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
2564,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2564,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2564,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2564,4,Still's disease,Rheumatoid arthropathies,Joint disorders,Musc,N
2565,1,Blood pressure fluctuation,Blood pressure disorders NEC,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2565,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2565,3,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
2565,4,Rib fracture,Thoracic cage fractures and dislocations,Bone and joint injuries,Inj&P,N
2566,1,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
2566,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
2567,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2567,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
2567,3,Headache,Headaches NEC,Headaches,Nerv,N
2567,4,Menstrual disorder,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
2568,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2569,1,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
2569,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
2569,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
2569,4,Pulmonary sarcoidosis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
2570,1,Enterococcal infection,Enterococcal infections,Bacterial infectious disorders,Infec,N
2570,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2570,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2570,4,Respiratory syncytial virus infection,Respiratory syncytial viral infections,Viral infectious disorders,Infec,N
2570,5,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
2571,1,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
2572,1,Bone cancer,Bone neoplasms malignant (excl sarcomas),Skeletal neoplasms malignant and unspecified,Neopl,N
2572,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2572,3,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2573,1,Keratoacanthoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
2573,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2574,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2574,2,Product use complaint,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2575,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
2575,2,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
2576,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2576,2,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2576,3,Still's disease,Rheumatoid arthropathies,Joint disorders,Musc,N
2577,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
2577,2,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
2578,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
2578,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
2578,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2578,4,Double stranded DNA antibody,Autoimmunity analyses,Immunology and allergy investigations,Inv,N
2578,5,Headache,Headaches NEC,Headaches,Nerv,N
2578,6,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2578,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2578,8,Osteoarthritis,Osteoarthropathies,Joint disorders,Musc,N
2578,9,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
2578,10,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2578,11,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2578,12,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2578,13,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2578,14,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
2578,15,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2579,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2579,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2580,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2580,2,Transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
2581,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2581,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2582,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2583,1,BK virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
2583,2,Haemorrhagic cyst,Mass conditions NEC,Tissue disorders NEC,Genrl,N
2583,3,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
2583,4,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
2583,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2583,6,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
2583,7,Polyomavirus viraemia,Polyomavirus infections,Viral infectious disorders,Infec,N
2583,8,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2584,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2584,2,Musculoskeletal discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2584,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2585,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
2586,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2586,2,Disseminated varicella zoster virus infection,Herpes viral infections,Viral infectious disorders,Infec,N
2586,3,Fungaemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2586,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2586,5,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
2586,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2587,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2587,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2587,3,Emphysema,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
2587,4,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
2587,5,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2587,6,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2588,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2588,2,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2589,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2589,2,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2590,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2590,2,Headache,Headaches NEC,Headaches,Nerv,N
2590,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2590,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2590,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2591,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2592,1,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2592,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2593,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2593,2,Exposure to SARS-CoV-2,Exposures to agents or circumstances NEC,"Exposures, chemical injuries and poisoning",Inj&P,N
2593,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
2593,4,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2593,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2594,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
2594,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
2594,3,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
2594,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
2594,5,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2595,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
2595,2,Glare,Visual disorders NEC,Vision disorders,Eye,N
2595,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2595,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
2596,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2596,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2597,1,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
2597,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
2597,3,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
2597,4,Product use complaint,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2598,1,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
2599,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2599,2,Diverticular perforation,"Gastrointestinal ulcers and perforation, site unspecified",Gastrointestinal ulceration and perforation,Gastr,N
2599,3,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
2600,1,Papilloedema,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
2600,2,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
2601,1,Papilloedema,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
2601,2,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
2602,1,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
2602,2,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
2603,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2603,2,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
2603,3,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
2604,1,Papilloedema,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
2604,2,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
2605,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2605,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
2605,3,Therapeutic product effect variable,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2606,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2606,2,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
2606,3,Eye inflammation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
2606,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2606,5,Prescribed overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
2607,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2608,1,Papilloedema,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
2608,2,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
2609,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2609,2,Gastrointestinal bacterial overgrowth,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2609,3,Herpes simplex oesophagitis,Herpes viral infections,Viral infectious disorders,Infec,N
2609,4,Norovirus infection,Caliciviral infections,Viral infectious disorders,Infec,N
2609,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2610,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2610,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
2611,1,Herpes simplex oesophagitis,Herpes viral infections,Viral infectious disorders,Infec,N
2611,2,Norovirus infection,Caliciviral infections,Viral infectious disorders,Infec,N
2611,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2612,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
2613,1,Herpes simplex oesophagitis,Herpes viral infections,Viral infectious disorders,Infec,N
2613,2,Norovirus infection,Caliciviral infections,Viral infectious disorders,Infec,N
2613,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2614,1,Drug level fluctuating,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
2614,2,Heart transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
2615,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2616,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2616,2,Herpes simplex oesophagitis,Herpes viral infections,Viral infectious disorders,Infec,N
2616,3,Norovirus infection,Caliciviral infections,Viral infectious disorders,Infec,N
2616,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2617,1,Herpes simplex oesophagitis,Herpes viral infections,Viral infectious disorders,Infec,N
2617,2,Norovirus infection,Caliciviral infections,Viral infectious disorders,Infec,N
2617,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2617,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2618,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
2618,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2619,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2619,2,Norovirus infection,Caliciviral infections,Viral infectious disorders,Infec,N
2620,1,Hepatitis E,Hepatitis virus infections,Viral infectious disorders,Infec,N
2621,1,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
2622,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
2622,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2622,3,Thermohyperaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2622,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2623,1,Hepatitis E,Hepatitis virus infections,Viral infectious disorders,Infec,N
2624,1,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2625,1,Hair growth rate abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
2625,2,Headache,Headaches NEC,Headaches,Nerv,N
2625,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2626,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
2627,1,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
2627,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2627,3,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
2628,1,Asthenopia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
2628,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
2629,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
2630,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2630,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
2631,1,Cytomegalovirus chorioretinitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2631,2,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2631,3,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2631,4,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2631,5,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
2631,6,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
2631,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2631,8,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
2631,9,Pneumonia cytomegaloviral,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2631,10,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2631,11,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2631,12,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2631,13,Retinal detachment,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
2631,14,Retinal scar,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
2631,15,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2632,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
2633,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2633,2,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
2633,3,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
2633,4,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
2633,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
2633,6,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
2633,7,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
2634,1,Immunosuppressant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
2634,2,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,Y
2634,3,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2634,4,Product monitoring error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2634,5,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2635,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2635,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2635,3,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2636,1,Breast enlargement,Breast disorders NEC,Breast disorders,Repro,N
2637,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
2637,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
2637,3,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
2637,4,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
2637,5,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
2638,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2639,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2639,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2640,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2640,2,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
2641,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2642,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2643,1,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2644,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2645,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2646,1,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
2647,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2648,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
2648,2,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2648,3,Rhinovirus infection,Rhinoviral infections,Viral infectious disorders,Infec,N
2649,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2649,2,Periorbital pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
2649,3,Prescribed overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
2649,4,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2650,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
2650,2,Headache,Headaches NEC,Headaches,Nerv,N
2650,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2651,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
2651,2,Foreign body sensation in eyes,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
2651,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2651,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
2652,1,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2653,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2653,2,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
2653,3,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
2653,4,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
2653,5,Eyelid margin crusting,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
2653,6,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
2653,7,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
2654,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
2655,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2656,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2657,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
2657,2,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
2658,1,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
2658,2,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
2658,3,Product administered to patient of inappropriate age,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2658,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2659,1,Death,Death and sudden death,Fatal outcomes,Genrl,N
2660,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2660,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2660,3,Enthesopathy,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
2660,4,Inflammation,Inflammations,General system disorders NEC,Genrl,N
2660,5,Joint range of motion decreased,Joint related signs and symptoms,Joint disorders,Musc,N
2660,6,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
2660,7,Sacroiliitis,Arthropathies NEC,Joint disorders,Musc,N
2660,8,Spinal pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
2660,9,Synovitis,Synovial disorders,Synovial and bursal disorders,Musc,N
2660,10,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2660,11,Vertebral lesion,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
2661,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2661,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2661,3,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
2661,4,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2662,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2663,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2663,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2663,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2663,4,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2663,5,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2664,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
2664,2,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2664,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2665,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
2666,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2666,2,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2667,1,Escherichia infection,Escherichia infections,Bacterial infectious disorders,Infec,N
2667,2,Serratia infection,Serratia infections,Bacterial infectious disorders,Infec,N
2667,3,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
2667,4,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
2668,1,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2669,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
2669,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2669,3,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2670,1,Serratia infection,Serratia infections,Bacterial infectious disorders,Infec,N
2670,2,Skin bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2671,1,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2672,1,Serratia infection,Serratia infections,Bacterial infectious disorders,Infec,N
2672,2,Skin bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2673,1,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
2674,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2674,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2675,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2675,2,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
2675,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
2675,4,Polychromasia,Red blood cell abnormal findings NEC,Red blood cell disorders,Blood,N
2675,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2675,6,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2675,7,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2676,1,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
2676,2,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2676,3,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2677,1,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
2678,1,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
2679,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
2680,1,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
2681,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2682,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
2682,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2683,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
2683,2,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2684,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2685,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2686,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2687,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2688,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2689,1,Headache,Headaches NEC,Headaches,Nerv,N
2690,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2690,2,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2690,3,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
2691,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2692,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
2692,2,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
2692,3,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
2693,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2694,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2695,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
2696,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
2696,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
2696,3,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
2696,4,Duodenal perforation,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
2696,5,Hepatorenal syndrome,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
2696,6,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
2697,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2698,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2699,1,Brain injury,Structural brain disorders NEC,Structural brain disorders,Nerv,N
2700,1,Graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2701,1,Bradykinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
2702,1,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
2703,1,Human herpesvirus 6 infection,Herpes viral infections,Viral infectious disorders,Infec,N
2703,2,Parvovirus infection,Parvoviral infections,Viral infectious disorders,Infec,N
2704,1,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
2704,2,Human herpesvirus 6 infection,Herpes viral infections,Viral infectious disorders,Infec,N
2704,3,Parvovirus infection,Parvoviral infections,Viral infectious disorders,Infec,N
2705,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2706,1,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
2706,2,Human herpesvirus 6 infection,Herpes viral infections,Viral infectious disorders,Infec,N
2706,3,Parvovirus infection,Parvoviral infections,Viral infectious disorders,Infec,N
2707,1,Human herpesvirus 6 infection,Herpes viral infections,Viral infectious disorders,Infec,N
2708,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2708,2,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2709,1,Trichophytic granuloma,Tinea infections,Fungal infectious disorders,Infec,N
2710,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2711,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2711,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
2711,3,Nasal dryness,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
2711,4,Product after taste,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2711,5,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2711,6,Tongue coated,Tongue signs and symptoms,Tongue conditions,Gastr,N
2712,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2712,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2713,1,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
2713,2,External ear disorder,External ear disorders NEC,External ear disorders (excl congenital),Ear,N
2713,3,Headache,Headaches NEC,Headaches,Nerv,N
2713,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2714,1,Human herpesvirus 8 infection,Herpes viral infections,Viral infectious disorders,Infec,N
2714,2,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
2715,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2716,1,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
2717,1,Acute graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2717,2,Human herpesvirus 8 infection,Herpes viral infections,Viral infectious disorders,Infec,N
2717,3,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
2718,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2718,2,Human herpesvirus 8 infection,Herpes viral infections,Viral infectious disorders,Infec,N
2718,3,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
2719,1,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
2720,1,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
2721,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2721,2,Human herpesvirus 8 infection,Herpes viral infections,Viral infectious disorders,Infec,N
2721,3,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
2722,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2723,1,Headache,Headaches NEC,Headaches,Nerv,N
2724,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2725,1,Vaginal odour,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
2726,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2727,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2728,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2729,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2730,1,Autoimmune neutropenia,Neutropenias,White blood cell disorders,Blood,N
2730,2,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
2731,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
2731,2,Enterococcal sepsis,Enterococcal infections,Bacterial infectious disorders,Infec,N
2731,3,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
2731,4,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
2731,5,Nosocomial infection,Infectious transmissions,Ancillary infectious topics,Infec,N
2731,6,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
2732,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
2732,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2732,3,Enterococcal sepsis,Enterococcal infections,Bacterial infectious disorders,Infec,N
2732,4,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
2732,5,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2732,6,Nosocomial infection,Infectious transmissions,Ancillary infectious topics,Infec,N
2732,7,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
2733,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2734,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2735,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2736,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2736,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2736,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2736,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
2736,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2736,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2736,7,Skin hyperpigmentation,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
2736,8,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2736,9,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
2737,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2738,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
2739,1,Combined immunodeficiency,Immune system abnormalities congenital,Immune system disorders congenital,Cong,N
2740,1,Breast discomfort,Breast signs and symptoms,Breast disorders,Repro,N
2740,2,Breast mass,Breast disorders NEC,Breast disorders,Repro,N
2740,3,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
2740,4,Breast swelling,Breast signs and symptoms,Breast disorders,Repro,N
2740,5,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2740,6,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
2740,7,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2740,8,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
2740,9,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
2740,10,Rectal tenesmus,Anal and rectal signs and symptoms,Anal and rectal conditions NEC,Gastr,N
2741,1,Angina unstable,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
2741,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
2741,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2742,1,Pyelonephritis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
2743,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2744,1,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
2744,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2744,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
2745,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2746,1,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
2747,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
2747,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2747,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2748,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2749,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2749,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2749,3,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2750,1,Tic,Tic disorders,Changes in physical activity,Psych,N
2751,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2752,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
2753,1,Death,Death and sudden death,Fatal outcomes,Genrl,N
2754,1,Epstein Barr virus positive mucocutaneous ulcer,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
2754,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
2755,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2756,1,Terminal state,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2757,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
2758,1,Hypothermia,Body temperature altered,Body temperature conditions,Genrl,N
2758,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2759,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2759,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2759,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2759,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
2759,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2759,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2759,7,Skin hyperpigmentation,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
2759,8,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2759,9,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
2760,1,Death,Death and sudden death,Fatal outcomes,Genrl,N
2761,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2762,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
2762,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2763,1,Aplasia pure red cell,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
2763,2,Erosive duodenitis,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
2763,3,Hiatus hernia,Diaphragmatic hernias,Abdominal hernias and other abdominal wall conditions,Gastr,N
2763,4,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
2763,5,Parvovirus B19 infection,Parvoviral infections,Viral infectious disorders,Infec,N
2763,6,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2763,7,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
2764,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2764,2,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
2764,3,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
2765,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2765,2,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
2765,3,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
2765,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2765,5,Renal graft infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
2765,6,Vitamin D increased,Vitamin analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
2766,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2766,2,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
2766,3,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
2767,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2768,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
2768,2,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
2768,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2769,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
2770,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2771,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2771,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
2771,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2771,4,Neurodermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2771,5,Nodule,Mass conditions NEC,Tissue disorders NEC,Genrl,N
2771,6,Skin striae,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
2772,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2772,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2772,3,Nail deformation,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
2772,4,Onychomadesis,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
2772,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2772,6,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2772,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2772,8,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
2772,9,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2772,10,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2772,11,Topical steroid withdrawal reaction,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
2773,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2773,2,Foreign body sensation in eyes,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
2773,3,Headache,Headaches NEC,Headaches,Nerv,N
2773,4,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
2773,5,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
2773,6,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2774,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
2774,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2774,3,Eyelid ptosis,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
2774,4,Keratoneuralgia,Corneal disorders NEC,Eye disorders NEC,Eye,N
2775,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
2776,1,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
2777,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2777,2,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
2778,1,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
2778,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
2779,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2780,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2780,2,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
